4w9u:B (ASP177) to (GLY221) CRYSTAL STRUCTURE OF AN ACYL-COA DEHYDROGENASE FROM BRUCELLA MELITENSIS | SSGCID, NIAID, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, OXIDOREDUCTASE
4w9u:D (ASP177) to (GLY221) CRYSTAL STRUCTURE OF AN ACYL-COA DEHYDROGENASE FROM BRUCELLA MELITENSIS | SSGCID, NIAID, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, OXIDOREDUCTASE
1a0t:Q (ASN388) to (TYR443) SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES | OUTER MEMBRANE PROTEIN, PORIN
1a5h:A (LEU64) to (GLN107) CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE | TRYPSIN LIKE SERINE PROTEASE, FIBRINOLYTIC ENZYME, HYDROLASE
2al6:A (LYS259) to (ASP285) FERM DOMAIN OF FOCAL ADHESION KINASE | FOCAL ADHESION KINASE FERM DOMAIN AUTOPHOSPHORYLATION SITE SRC SH3 BINDING SITE, TRANSFERASE
4wjk:A (LEU118) to (CYS151) METAL ION AND LIGAND BINDING OF INTEGRIN | CELL ADHESION-IMMUNE SYSTEM COMPLEX
4wk2:A (LEU118) to (CYS151) METAL ION AND LIGAND BINDING OF INTEGRIN | CELL ADHESION-FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
4wk4:A (TYR119) to (CYS151) METAL ION AND LIGAND BINDING OF INTEGRIN | CELL ADHESION-FIBRONECTIN RECEPTOR
3ega:A (VAL190) to (THR257) CRYSTAL STRUCTURE OF PELLINO2 FHA DOMAIN AT 1.8 ANGSTROMS RESOLUTION | PELLINO, FHA DOMAIN, E3 UBIQUITIN LIGASE, SUBSTRATE BINDING DOMAIN, PHOSPHOPROTEIN, PROTEIN BINDING
3egb:A (VAL190) to (THR257) STRUCTURE OF PELLINO2 FHA DOMAIN AT 3.3 ANGSTROMS RESOLUTION. | PELLINO, FHA DOMAIN, E3 UBIQUITIN LIGASE, SUBSTRATE BINDING DOMAIN, PHOSPHOPROTEIN, PROTEIN BINDING
3egb:B (VAL190) to (THR257) STRUCTURE OF PELLINO2 FHA DOMAIN AT 3.3 ANGSTROMS RESOLUTION. | PELLINO, FHA DOMAIN, E3 UBIQUITIN LIGASE, SUBSTRATE BINDING DOMAIN, PHOSPHOPROTEIN, PROTEIN BINDING
3rti:B (LEU191) to (ASN226) CRYSTAL STRUCTURE OF RICIN BOUND WITH FORMYCIN MONOPHOSPHATE | GLYCOSIDASE, RIBOSOME-INACTIVATING PROTEIN, LECTIN, GLYCOPROTEIN, LACTOSE BINDING, GLYCOSYLATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2ayh:A (GLY73) to (ASP107) CRYSTAL AND MOLECULAR STRUCTURE AT 1.6 ANGSTROMS RESOLUTION OF THE HYBRID BACILLUS ENDO-1,3-1,4-BETA-D-GLUCAN 4- GLUCANOHYDROLASE H(A16-M) | HYDROLASE (GLUCANASE)
4gzz:C (PRO93) to (ASN130) CRYSTAL STRUCTURES OF BACTERIAL RNA POLYMERASE PAUSED ELONGATION COMPLEXES | RNA POLYMERASE, TRANSCRIPTION, PAUSED TRANSCRIPTION ELONGATION COMPLEX, TRANSCRIPTIONAL PAUSING, DNA DIRECTED RNA TRANSCRIPTION', TRANSCRIPTION-DNA-RNA HYBRID COMPLEX
3rur:D (LYS372) to (VAL397) STAPHYLOCOCCUS AUREUS HEME-BOUND SELENOMETHIONINE-LABELED ISDB-N2 | HEME PROTEIN, HEME UPTAKE, NEAT DOMAIN, HEME BINDING, CELL WALL, METAL TRANSPORT
4wnx:A (ALA57) to (GLU122) NETRIN 4 LACKING THE C-TERMINAL DOMAIN | BASEMENT MEMBRANE, LAMININ BINDING, N-LINKED GLYCOSYLATION, EPIDERMAL GROWTH FACTOR LIKE DOMAIN, LAMININ BINDING PROTEIN
1amh:A (ARG62) to (LYS107) UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S) | SERINE PROTEASE, ACTIVATION DOMAIN, SUBSTRATE SPECIFICITY HYDROLASE
2oqe:C (TRP443) to (ALA480) CRYSTAL STRUCTURE OF HANSENULA POLYMORPHA AMINE OXIDASE IN COMPLEX WITH XE TO 1.6 ANGSTROMS | PROTEIN-DERIVED COFACTOR, TPQ, XE, XENON COMPLEX, OXIDOREDUCTASE
2oqe:E (GLY444) to (ALA480) CRYSTAL STRUCTURE OF HANSENULA POLYMORPHA AMINE OXIDASE IN COMPLEX WITH XE TO 1.6 ANGSTROMS | PROTEIN-DERIVED COFACTOR, TPQ, XE, XENON COMPLEX, OXIDOREDUCTASE
2oqe:F (TRP443) to (ALA480) CRYSTAL STRUCTURE OF HANSENULA POLYMORPHA AMINE OXIDASE IN COMPLEX WITH XE TO 1.6 ANGSTROMS | PROTEIN-DERIVED COFACTOR, TPQ, XE, XENON COMPLEX, OXIDOREDUCTASE
3ejl:A (VAL45) to (ARG68) REPLACEMENT OF VAL3 IN HUMAN THYMIDYLATE SYNTHASE AFFECTS ITS KINETIC PROPERTIES AND INTRACELLULAR STABILITY | TRANSFERASE, METHYLTRANSFERASE, NUCLEOTIDE BIOSYNTHESIS
1apw:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4h44:D (LYS123) to (SER164) 2.70 A CYTOCHROME B6F COMPLEX STRUCTURE FROM NOSTOC PCC 7120 | ALPHA HELIX, BETA-SHEET, PLASTOQUINOL-PLASTOCYANIN OXIDOREDUCTASE, PLASTOCYANIN, THYLAKOID MEMBRANES, PHOTOSYNTHESIS
4wqs:N (LYS698) to (HIS729) THERMUS THERMOPHILUS RNA POLYMERASE BACKTRACKED COMPLEX | TRANSCRIPTION, RNA CLEAVAGE, TRANSFERASE-DNA-RNA COMPLEX
1aqp:A (SER80) to (ALA122) RIBONUCLEASE A COPPER COMPLEX | HYDROLASE (PHOSPHORIC DIESTER)
2ox7:C (THR36) to (GLN69) CRYSTAL STRUCTURE OF PROTEIN EF1440 FROM ENTEROCOCCUS FAECALIS | STRUCTURAL GENOMICS, HYPOTHETICAL PROTEIN, PSI, PROTEIN STRUCTURE INITIATIVE, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, UNKNOWN FUNCTION
4h8s:C (GLY282) to (PRO313) CRYSTAL STRUCTURE OF HUMAN APPL2BARPH DOMAIN | BAR DOMAIN, PLECKSTRIN HOMOLOGY DOMAIN, ADAPTOR PROTEIN, RAB BINDING, SIGNALING PROTEIN
1b0e:A (THR64) to (ARG107) CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH MDL 101,146 | SERINE PROTEASE, FLUOROETHYL KETONES, HYDROLASE
1nyw:B (LEU10) to (GLU38) THE HIGH RESOLUTION STRUCTURES OF RMLC FROM STREPTOCCUS SUIS IN COMPLEX WITH DTDP-D-GLUCOSE | JELLY ROLL-LIKE STRUCTURE; BETA SHEET, ISOMERASE
1nzc:A (LEU10) to (GLU38) THE HIGH RESOLUTION STRUCTURES OF RMLC FROM STREPTOCOCCUS SUIS IN COMPLEX WITH DTDP-D-XYLOSE | JELLY ROLL-LIKE STRUCTURE; BETA SHEET, ISOMERASE
1nzc:C (LEU10) to (GLU38) THE HIGH RESOLUTION STRUCTURES OF RMLC FROM STREPTOCOCCUS SUIS IN COMPLEX WITH DTDP-D-XYLOSE | JELLY ROLL-LIKE STRUCTURE; BETA SHEET, ISOMERASE
2bdb:A (THR64) to (ARG107) PORCINE PANCREATIC ELASTASE COMPLEXED WITH ASN-PRO-ILE AND ALA-ALA AT PH 5.0 | SERINE PROTEINASE, HYDROLASE
2bdv:A (TRP102) to (ASN152) X-RAY CRYSTAL STRUCTURE OF PHAGE-RELATED PROTEIN BB2244 FROM BORDETELLA BRONCHISEPTICA. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BOR24. | ALPHA-BETA PROTEIN, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
2be5:N (GLY697) to (HIS729) CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH INHIBITOR TAGETITOXIN | RNA POLYMERASE HOLOENZYME, TAGETITOXIN, ANTIBIOTIC, TRANSCRIPTION REGULATION, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, TRANSFERASE
4wyn:A (ILE81) to (ALA122) THE CRYSTAL STRUCTURE OF THE A109G MUTANT OF RNASE A | CONFORMATIONAL DYNAMICS, HYDROLASE
3euy:A (ILE81) to (ALA122) CRYSTAL STRUCTURE OF RIBONUCLEASE A IN 50% DIOXANE | RNASE, ORGANIC SOLVENTS, MULTIPLE SOLVENT CRYSTAL STRUCTURES, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, HYDROLASE, NUCLEASE, SECRETED
1bc4:A (THR64) to (GLY106) THE SOLUTION STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTES OF RANA CATESBEIANA (BULLFROG), NMR, 15 STRUCTURES | HYDROLASE, PHOSPHORIC DIESTER, RC-RNASE, CYTOTOXIC PROTEIN, SIALIC ACID BINDING LECTIN
1bda:A (HIS63) to (GLN107) CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE) | TRYPSIN LIKE SERINE PROTEASE, FIBRINOLYTIC ENZYMES, PLASMINOGEN ACTIVATORS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3s2o:A (GLY13) to (ALA43) FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS | PROTEASE, ALZHEIMER'S DISEASE, ASPARTIC PROTEASE, ASPARTYL PROTEASE, BASE, BETA-SECRETASE, GLYCOPROTEIN, MEMAPSIN 2, AMYLOID PRECURSOR PROTEIN SECRETASES, ASPARTIC ENDOPEPTIDASES, FRAGMENT-BASED DRUG DESIGN, FLUORESCENCE POLARISATION, TRANSMEMBRANE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1bp1:A (PRO35) to (ILE80) CRYSTAL STRUCTURE OF BPI, THE HUMAN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN | BACTERICIDAL, PERMEABILITY-INCREASING, LIPID-BINDING, LIPOPOLYSACCHARIDE-BINDING, ANTIBIOTIC
3s5x:A (ALA2) to (ASP42) STRUCTURE OF THE CYANOBACTERIAL OSCILLATORIA AGARDHII AGGLUTININ (OAA) IN COMPLEX WITH A3,A6 MANNOPENTAOSE | BETA BARREL LIKE PROTEIN, ANTI-HIV LECTIN, CARBOHYDRATE, PROTEIN BINDING
3s5x:A (ASN69) to (ASP109) STRUCTURE OF THE CYANOBACTERIAL OSCILLATORIA AGARDHII AGGLUTININ (OAA) IN COMPLEX WITH A3,A6 MANNOPENTAOSE | BETA BARREL LIKE PROTEIN, ANTI-HIV LECTIN, CARBOHYDRATE, PROTEIN BINDING
1o7d:D (PHE743) to (ASP796) THE STRUCTURE OF THE BOVINE LYSOSOMAL A-MANNOSIDASE SUGGESTS A NOVEL MECHANISM FOR LOW PH ACTIVATION | HYDROLASE, GLYCOSYL HYDROLASE FAMILY 38, A-MANNOSIDASE, LYSOSOMAL
3s6y:B (GLN397) to (GLU431) STRUCTURE OF REOVIRUS ATTACHMENT PROTEIN SIGMA1 IN COMPLEX WITH ALPHA- 2,6-SIALYLLACTOSE | TRIPLE BETA-SPIRAL, BETA-BARREL, BETA-SPIRAL REPEAT, GREEK KEY MOTIF, TRIMER,, VIRAL ATTACHMENT PROTEIN, SIALIC ACID RECEPTOR JUNCTIONAL ADHESION MOLECULE A, VIRAL CAPSID, VIRAL PROTEIN
4x8v:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (METHYL {3-[(2R)-1-{(2R)-2- (3,4-DIMETHOXYPHENYL)-2-[(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL) AMINO]ACETYL}PYRROLIDIN-2-YL]-4-(PROPAN-2-YLSULFONYL) PHENYL}CARBAMATE) | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM- BINDING
4x8s:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-BROMO-2-METHOXYPHENOL | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM- BINDING
4x8u:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-1H-INDOLE-2- CARBOXYLIC ACID | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM- BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1oa2:C (GLY41) to (THR72) COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY | HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, ENDOGLUCANASE, GLYCOSYL HYDROLASE, GH FAMILY 12, TRICHODERMA REESEI CEL12A
1oa2:E (SER43) to (THR72) COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY | HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, ENDOGLUCANASE, GLYCOSYL HYDROLASE, GH FAMILY 12, TRICHODERMA REESEI CEL12A
2pfr:B (GLY90) to (GLY124) HUMAN N-ACETYLTRANSFERASE 2 | ARYLAMINE N-ACETYLTRANSFERASE 2, ARYLAMIDE ACETYLASE 2, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE
1bxq:A (ASP88) to (SER109) ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR. | HYDROLASE, PHOSPHONATE INHIBITORS
1od1:A (ASP92) to (SER113) ENDOTHIAPEPSIN PD135,040 COMPLEX | ACID PROTEINASE, INHIBITOR, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1od2:B (GLY1876) to (PRO1920) ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN | LIGASE, ACC, ACETYL-COA, ACETYL-COA CARBOXYLASE, OBESITY
1c1m:A (GLN30) to (THR54) PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR) | SERINE PROTEASE, HYDROLASE, PANCREAS ELASTASE, XENON
3fg7:B (THR618) to (GLY663) THE CRYSTAL STRUCTURE OF VILLIN DOMAIN 6 | ACTIN BINDING PROTEIN, VILLIN HEAD PIECE, VILLIN, GELSOLIN, ACTIN CAPPING, ACTIN-BINDING, CALCIUM, CYTOPLASM, CYTOSKELETON, STRUCTURAL PROTEIN
4xfp:B (ILE120) to (GLY173) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
4xfp:C (ILE120) to (GLY173) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
4xfp:D (ILE120) to (GLY173) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
2bzz:A (LEU1080) to (HIS1129) CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5'-ATP, AP3A, AP4A AND AP5A | ENDONUCLEASE, EOSINOPHIL, HYDROLASE, NUCLEASE, RIBONUCLEASE, RNASE US, RNASE-2, INHIBITOR, 5'-ATP, AP3A, AP4A, AP5A, CHEMOTAXIS, GLYCOPROTEIN, POLYMORPHISM, SENSORY TRANSDUCTION
4i1k:A (ILE70) to (SER93) CRYSTAL STRUCTURE OF VRN1 (RESIDUES 208-341) | B3 DOMAIN BETA-BARREL, DNA BINDING PROTEIN
1oh2:Q (ASN388) to (TYR443) SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES | MEMBRANE PROTEIN, OUTER MEMBRANE PROTEIN, TRANSPORT, SUGAR TRANSPORT, TRANSMEMBRANE
2pqs:D (THR71) to (LYS105) CRYSTAL STRUCTURE OF THE BOVINE LACTADHERIN C2 DOMAIN | C2 DOMAIN, LACTADHERIN, MEMBRANE BINDING, CELL ADHESION
3fkz:A (ILE81) to (ALA122) X-RAY STRUCTURE OF THE NON COVALENT SWAPPED FORM OF THE S16G/T17N/A19P/A20S/K31C/S32C MUTANT OF BOVINE PANCREATIC RIBONUCLEASE | 3D-DOMAIN SWAPPING, BOVINE SEMINAL RIBONUCLEASE, NON- COVALENT DIMER, ANTITUMOR ACTIVITY, QUATERNARY STRUCTURE FLEXIBILITY, PROTEIN MUTATIONS AND EVOLUTION, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, HYDROLASE, NUCLEASE, SECRETED
3fl0:A (ILE81) to (ALA122) X-RAY STRUCTURE OF THE NON COVALENT SWAPPED FORM OF THE Q28L/K31C/S32C MUTANT OF BOVINE PANCREATIC RIBONUCLEASE IN COMPLEX WITH 2'-DEOXYCYTIDINE-2'-DEOXYGUANOSINE-3',5'- MONOPHOSPHATE | 3D-DOMAIN SWAPPING, BOVINE SEMINAL RIBONUCLEASE, NON- COVALENT DIMER, ANTITUMOR ACTIVITY, QUATERNARY STRUCTURE FLEXIBILITY, PROTEIN MUTATIONS AND EVOLUTION, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, HYDROLASE, NUCLEASE, SECRETED
3fl0:B (ILE81) to (ALA122) X-RAY STRUCTURE OF THE NON COVALENT SWAPPED FORM OF THE Q28L/K31C/S32C MUTANT OF BOVINE PANCREATIC RIBONUCLEASE IN COMPLEX WITH 2'-DEOXYCYTIDINE-2'-DEOXYGUANOSINE-3',5'- MONOPHOSPHATE | 3D-DOMAIN SWAPPING, BOVINE SEMINAL RIBONUCLEASE, NON- COVALENT DIMER, ANTITUMOR ACTIVITY, QUATERNARY STRUCTURE FLEXIBILITY, PROTEIN MUTATIONS AND EVOLUTION, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, HYDROLASE, NUCLEASE, SECRETED
3fl1:A (ILE81) to (ALA122) X-RAY STRUCTURE OF THE NON COVALENT SWAPPED FORM OF THE A19P/Q28L/K31C/S32C MUTANT OF BOVINE PANCREATIC RIBONUCLEASE IN COMPLEX WITH 2'-DEOXYCYTIDINE-2'- DEOXYGUANOSINE-3',5'-MONOPHOSPHATE | 3D-DOMAIN SWAPPING, BOVINE SEMINAL RIBONUCLEASE, NON- COVALENT DIMER, ANTITUMOR ACTIVITY, QUATERNARY STRUCTURE FLEXIBILITY, PROTEIN MUTATIONS AND EVOLUTION, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, HYDROLASE, NUCLEASE, SECRETED
3fl3:A (ILE81) to (ALA122) X-RAY STRUCTURE OF THE LIGAND FREE NON COVALENT SWAPPED FORM OF THE A19P/Q28L/K31C/S32C MUTANT OF BOVINE PANCREATIC RIBONUCLEASE | 3D-DOMAIN SWAPPING, BOVINE SEMINAL RIBONUCLEASE, NON- COVALENT DIMER, ANTITUMOR ACTIVITY, QUATERNARY STRUCTURE FLEXIBILITY, PROTEIN MUTATIONS AND EVOLUTION, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, HYDROLASE, NUCLEASE, SECRETED
2c4f:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121 | BLOOD COAGULATION, SERINE PROTEASE, EGF, EGF-LIKE DOMAIN, GLA, RECEPTOR ENZYME, GLYCOPROTEIN, HYDROLASE, PROTEASE, HYDROXYLATION, LIPOPROTEIN, PALMITATE, TRANSMEMBRANE
4xln:C (ALA92) to (ASN130) CRYSTAL STRUCTURE OF T. AQUATICUS TRANSCRIPTION INITIATION COMPLEX CONTAINING BUBBLE PROMOTER AND RNA | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION-DNA-RNA COMPLEX
4xln:I (ALA92) to (ASN130) CRYSTAL STRUCTURE OF T. AQUATICUS TRANSCRIPTION INITIATION COMPLEX CONTAINING BUBBLE PROMOTER AND RNA | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION-DNA-RNA COMPLEX
1ck7:A (ARG315) to (PRO352) GELATINASE A (FULL-LENGTH) | HYDROLASE (METALLOPROTEASE), FULL-LENGTH, METALLOPROTEINASE, GELATINASE A
1cn1:A (LEU107) to (GLY149) CRYSTAL STRUCTURE OF DEMETALLIZED CONCANAVALIN A. THE METAL- BINDING REGION | LECTIN (AGGLUTININ)
2q13:A (GLY282) to (ALA313) CRYSTAL STRUCTURE OF BAR-PH DOMAIN OF APPL1 | APPL1, BAR DOMAIN, PH DOMAIN, BAR-PH DOMAIN, PROTEIN TRANSPORT
1cqq:A (GLY123) to (SER144) TYPE 2 RHINOVIRUS 3C PROTEASE WITH AG7088 INHIBITOR | VIRAL PROTEIN, HYDROLASE
1owi:A (TRP14) to (SER42) SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | PLASMINOGEN ACTIVATION, HYDROLASE, SERINE PROTEASE, GLYCOPROTEIN, KRINGLE, EGF-LIKE DOMAIN
4xlr:C (ALA92) to (ASN130) CRYSTAL STRUCTURE OF T.AQUATICUS TRANSCRIPTION INITIATION COMPLEX WITH CARD CONTAINING BUBBLE PROMOTER AND RNA | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION-DNA COMPLEX
4xlr:I (ALA92) to (ASN130) CRYSTAL STRUCTURE OF T.AQUATICUS TRANSCRIPTION INITIATION COMPLEX WITH CARD CONTAINING BUBBLE PROMOTER AND RNA | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION-DNA COMPLEX
4ieg:B (VAL281) to (PRO303) STRUCTURE AND INTERACTIONS OF THE RNA-DEPENDENT RNA POLYMERASE FROM BACTERIOPHAGE PHI12 (P1 CRYSTAL FORM) | RNA-DIRECTED RNA POLYMERASE, TRANSFERASE
4ieg:D (VAL281) to (PRO303) STRUCTURE AND INTERACTIONS OF THE RNA-DEPENDENT RNA POLYMERASE FROM BACTERIOPHAGE PHI12 (P1 CRYSTAL FORM) | RNA-DIRECTED RNA POLYMERASE, TRANSFERASE
1cvw:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA) | BLOOD COAGULATION, FACTOR VIIA, SERINE PROTEASE, EGF, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4xls:C (ALA92) to (ASN130) CRYSTAL STRUCTURE OF T. AQUATICUS TRANSCRIPTION INITIATION COMPLEX WITH CARD CONTAINING UPSTREAM FORK PROMOTER. | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION
4xls:I (ALA92) to (ASN130) CRYSTAL STRUCTURE OF T. AQUATICUS TRANSCRIPTION INITIATION COMPLEX WITH CARD CONTAINING UPSTREAM FORK PROMOTER. | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION
2q7u:A (ALA121) to (VAL161) CRYSTAL STRUCTURE OF THE F PLASMID TRAI RELAXASE DOMAIN WITH THE SCISSILE THYMIDINE BASE AND IMIDODIPHOSPHATE | RELAXASE, HYDROLASE, CONJUGATION, ALTERNATIVE INITIATION, ATP-BINDING, DNA-BINDING, HELICASE, NUCLEOTIDE-BINDING, PLASMID
1czv:A (THR69) to (PRO101) CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN COAGULATION FACTOR V: DIMERIC CRYSTAL FORM | COAGULATION, MEMBRANE-BINDING, DISCOIDIN FAMILY, CALCIUM- INDEPENDENT, BLOOD CLOTTING
1czv:B (THR69) to (PRO101) CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN COAGULATION FACTOR V: DIMERIC CRYSTAL FORM | COAGULATION, MEMBRANE-BINDING, DISCOIDIN FAMILY, CALCIUM- INDEPENDENT, BLOOD CLOTTING
1czt:A (LYS66) to (PRO101) CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN COAGULATION FACTOR V | COAGULATION, MEMBRANE-BINDING, DISCOIDIN FAMILY, CALCIUM- INDEPENDENT, BLOOD CLOTTING
1p4d:A (ALA121) to (VAL161) F FACTOR TRAI RELAXASE DOMAIN | 5-STRAND ANTIPARALLEL BETA SHEET, ALPHA-BETA, 3 HISTIDINE MG(II) COORDINATION, HYDROLASE
1p4d:B (ALA121) to (VAL161) F FACTOR TRAI RELAXASE DOMAIN | 5-STRAND ANTIPARALLEL BETA SHEET, ALPHA-BETA, 3 HISTIDINE MG(II) COORDINATION, HYDROLASE
1p4t:A (HIS14) to (VAL44) CRYSTAL STRUCTURE OF NEISSERIAL SURFACE PROTEIN A (NSPA) | BETA BARREL, OUTER MEMBRANE PROTEIN, MEMBRANE PROTEIN
3sxx:F (GLY444) to (ALA480) HANSENULA POLYMORPHA COPPER AMINE OXIDASE-1 IN COMPLEX WITH CO(II) | OXIDOREDUCTASE, PEROXISOME
1d6u:A (ASN540) to (ILE606) CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE | REACTION INTERMEDIATE, OXIDOREDUCTASE
1d6u:B (ASN540) to (ILE606) CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE | REACTION INTERMEDIATE, OXIDOREDUCTASE
1d7f:A (THR647) to (ASN681) CRYSTAL STRUCTURE OF ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP. 1011 DETERMINED AT 1.9 A RESOLUTION | CYCLODEXTRIN GLUCANOTRANSFERASE, CGTASE, TRANSFERASE
1d7p:M (THR2241) to (PHE2274) CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN FACTOR VIII AT 1.5 A RESOLUTION AT 1.5 A | BETA SANDWICH, BLOOD CLOTTING
1dab:A (GLY448) to (GLY472) THE STRUCTURE OF BORDETELLA PERTUSSIS VIRULENCE FACTOR P.69 PERTACTIN | PERTUSSIS BETA HELIX, CELL ADHESION
3g5u:A (GLY1035) to (GLY1066) STRUCTURE OF P-GLYCOPROTEIN REVEALS A MOLECULAR BASIS FOR POLY-SPECIFIC DRUG BINDING | P-GLYCOPROTEIN, MULTIDRUG RESISTANCE, PGP, CYCLIC PEPTIDE, MEMBRANE PROTEIN
3g5u:B (GLY1035) to (GLY1066) STRUCTURE OF P-GLYCOPROTEIN REVEALS A MOLECULAR BASIS FOR POLY-SPECIFIC DRUG BINDING | P-GLYCOPROTEIN, MULTIDRUG RESISTANCE, PGP, CYCLIC PEPTIDE, MEMBRANE PROTEIN
1ded:A (THR647) to (ASN681) CRYSTAL STRUCTURE OF ALKALOPHILIC ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH AN INHIBITOR, ACARBOSE, AT 2.0 A RESOLUTION | CYCLODEXTRIN GLUCANOTRANSFERASE, CGTASE, ACARBOSE, TRANSFERASE
4ind:A (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:B (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:C (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:D (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:E (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:F (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:G (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:H (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:I (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:J (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:K (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:L (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:M (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:N (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:O (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:P (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:Q (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:R (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:S (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
4ind:T (ASN268) to (LEU299) THE TRIPLE JELLY ROLL FOLD AND TURRET ASSEMBLY IN AN ARCHAEAL VIRUS | STIV, JELLY ROLL, TURRET, ARCHAEAL VIRUS, C381, SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS, VIRAL PROTEIN
3t0u:B (TRP443) to (ALA480) HANSENULA POLYMORPHA COPPER AMINE OXIDASE-1 IN COMPLEX WITH CU(I) | OXIDOREDUCTASE, PEROXISOME
4ip2:A (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID-LIKE DECARBOXYLASE, PA0254, HUDA, VIRULENCE ATTENUATION FACTOR, UNKNOWN FUNCTION
4ip2:B (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID-LIKE DECARBOXYLASE, PA0254, HUDA, VIRULENCE ATTENUATION FACTOR, UNKNOWN FUNCTION
4ip2:C (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID-LIKE DECARBOXYLASE, PA0254, HUDA, VIRULENCE ATTENUATION FACTOR, UNKNOWN FUNCTION
2qmh:D (HIS201) to (SER229) STRUCTURE OF V267F MUTANT HPRK/P | V267F MUTATION, ATP-BINDING, CARBOHYDRATE METABOLISM, KINASE, MAGNESIUM, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, METAL BINDING PROTEIN
2qmh:J (HIS201) to (SER229) STRUCTURE OF V267F MUTANT HPRK/P | V267F MUTATION, ATP-BINDING, CARBOHYDRATE METABOLISM, KINASE, MAGNESIUM, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, METAL BINDING PROTEIN
4xsz:C (PRO95) to (ASN139) CRYSTAL STRUCTURE OF CBR 9393 BOUND TO ESCHERICHIA COLI RNA POLYMERASE HOLOENZYME | BACTERIAL RNA POLYMERASE ANTIBIOTIC COMPLEX, TRANSCRIPTION-ANTIBIOTIC COMPLEX
4xsz:I (PRO95) to (ASN139) CRYSTAL STRUCTURE OF CBR 9393 BOUND TO ESCHERICHIA COLI RNA POLYMERASE HOLOENZYME | BACTERIAL RNA POLYMERASE ANTIBIOTIC COMPLEX, TRANSCRIPTION-ANTIBIOTIC COMPLEX
4xuo:A (VAL119) to (GLU150) STRUCTURE OF THE CBM22-1 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C | BINDING SITE, CARBOHYDRATES, ENZYME STABILITY, SUBSTRATE SPECIFICITY, TEMPERATURE, ENDO-1, 4-BETA-XYLANASE, XYLAN-BINDING DOMAIN, CALCIUM, THERMOPHILIC ENZYMES, THERMOSTABILIZING DOMAINS, SUGAR BINDING PROTEIN
4isi:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (6S)-N-(4- CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO- 4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3gdv:C (VAL61) to (THR93) CRYSTAL STRUCTURE OF DEGS H198P/D320A MUTANT MODIFIED BY DFP AND IN COMPLEX WITH YQF PEPTIDE | PROTEASE, STRESS-SENSOR, HTRA, PDZ OMP, HYDROLASE, PERIPLASM, SERINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
4isq:B (LYS1173) to (PHE1225) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
2qqj:A (THR340) to (TYR375) CRYSTAL STRUCTURE OF THE B1B2 DOMAINS FROM HUMAN NEUROPILIN-2 | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
1dpo:A (SER61) to (LYS107) STRUCTURE OF RAT TRYPSIN | HYDROLASE, SERINE PROTEASE, DIGESTION, PANCREAS, ZYMOGEN, SIGNAL, MULTIGENE FAMILY
2cw5:A (PHE199) to (VAL235) CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 | ALPHA AND BETA PROTEIN (A/B), BETA BARREL, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, UNKNOWN FUNCTION
2cw5:B (GLY198) to (VAL235) CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 | ALPHA AND BETA PROTEIN (A/B), BETA BARREL, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, UNKNOWN FUNCTION
4iws:A (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID LIKE SPLIT BETA-BARREL DOMAIN, 3-POLYPRENYL-4-HYDROXYBENZOATE DECARBOXYLASE HUDA, LYASE
4iws:B (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID LIKE SPLIT BETA-BARREL DOMAIN, 3-POLYPRENYL-4-HYDROXYBENZOATE DECARBOXYLASE HUDA, LYASE
4iws:C (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID LIKE SPLIT BETA-BARREL DOMAIN, 3-POLYPRENYL-4-HYDROXYBENZOATE DECARBOXYLASE HUDA, LYASE
4iws:D (TYR151) to (THR186) PUTATIVE AROMATIC ACID DECARBOXYLASE | UBID LIKE SPLIT BETA-BARREL DOMAIN, 3-POLYPRENYL-4-HYDROXYBENZOATE DECARBOXYLASE HUDA, LYASE
1dva:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA | PROTEIN-PEPTIDE COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1dva:I (LEU64) to (ARG107) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA | PROTEIN-PEPTIDE COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ppk:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ppl:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ppm:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4xzu:G (THR2241) to (PHE2274) CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY | IMMUNOGLOBULIN, BLOOD COAGULATION, ANTIBODY, DISCOIDIN, IMMUNE SYSTEM
1dyu:A (ASN540) to (ILE606) THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE: X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS. | OXIDOREDUCTASE, TPQ, COPPER AMINE OXIDASE, EC 1.4.3.4, WILDTYPE, CATALYTIC BASE
1pu3:A (TYR65) to (GLY101) THE SOLUTION NMR STRUCTURE AND DYNAMICS OF A RECOMBINANT ONCONASE WITH ALTERED N-TERMINAL AND MET23 RESIDUES | BOWL-SHAPED FOLDING OF THE TWO SHEETS, HYDROLASE
2d39:B (HIS132) to (PHE158) TRIVALENT RECOGNITION UNIT OF INNATE IMMUNITY SYSTEM; CRYSTAL STRUCTURE OF HUMAN M-FICOLIN FIBRINOGEN-LIKE DOMAIN | INNATE IMMUNITY SYSTEM, FICOLIN, M-FICOLIN, LECTIN PATHWAY, IMMUNE SYSTEM
2d39:C (HIS132) to (PHE158) TRIVALENT RECOGNITION UNIT OF INNATE IMMUNITY SYSTEM; CRYSTAL STRUCTURE OF HUMAN M-FICOLIN FIBRINOGEN-LIKE DOMAIN | INNATE IMMUNITY SYSTEM, FICOLIN, M-FICOLIN, LECTIN PATHWAY, IMMUNE SYSTEM
2d3p:D (LEU107) to (ASP149) CRATYLIA FLORIBUNDA SEED LECTIN CRYSTALLIZED AT BASIC PH | LECTIN PLANT, SUGAR BINDING PROTEIN
4y35:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 290 | FAGMENT SCREENING, HYDROLASE, INHIBITION
4y37:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGEMENT 305 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3a:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 181 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
1pvx:A (GLY33) to (GLY64) DO-1,4-BETA-XYLANASE, ROOM TEMPERATURE, PH 4.5 | THERMOPHILIC, XYLANASE, FAMILY-11 OF GLYCOSYL HYDROLASES
4y3h:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 189 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3r:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 306 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3s:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 266 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3w:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 35 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3w:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 35 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3x:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 171 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1e35:B (THR64) to (ARG107) PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-TOLUENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR TWO MINUTES | HYDROLASE(SERINE PROTEASE), SERINE PROTEASE, HYDROLASE, SERINE PROTEINASE
4y4a:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 286 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4c:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 158 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4d:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B51 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y4j:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B97 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y4t:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 114 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4j2q:B (VAL130) to (VAL177) CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION | ARRESTIN FOLD, SIGNAL TERMINATION, GPCR, OUTER SEGMENT, SIGNALING PROTEIN, P44, RHODOPSIN, G-PROTEIN, SPLICE VARIANT MUTANT ARRESTIN, S-ANTIGEN, DEACTIVATION, VISUAL SIGNAL TRANSDUCTION
4y4z:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 73 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
2d7f:S (LEU107) to (GLY149) CRYSTAL STRUCTURE OF A LECTIN FROM CANAVALIA GLADIATA SEEDS COMPLEXED WITH ALPHA-METHYL-MANNOSIDE AND ALPHA- AMINOBUTYRIC ACID | LECTIN, NONPROTEIN AMINO ACID, DIOCLEINAE, PLANT PROTEIN
4y53:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 54 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y57:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 63 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5a:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 206 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5b:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 261 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5c:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 267 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5e:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 268 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4j3o:D (ASP36) to (THR65) CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH | BETA BARREL, IMMUNGLOBULINE-LIKE FOLD, TYPE 1 PILUS ASSEMBLY, PILUS SUBUNIT TRANSLOCATION, ADHESION, D-MANNOSE-BINDING, BACTERIAL OUTER MEMBRANE, CELL ADHESION-CHAPERONE-MEMBRANE PROTEIN COMPLEX
4y5l:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN ITS APO FORM | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5l:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN ITS APO FORM | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5k:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 274 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5m:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 328 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5n:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 337 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5p:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 338 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
2dar:A (VAL13) to (CYS75) SOLUTION STRUCTURE OF FIRST LIM DOMAIN OF ENIGMA-LIKE PDZ AND LIM DOMAINS PROTEIN | LIM DOMAIN, ENIGMA HOMOLOG PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, METAL BINDING PROTEIN
1e5o:E (ASP87) to (SER108) ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2 | HYDROLASE, ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6m:C (MET15) to (PRO43) STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG418 | PLASMEPSIN II HYDROXYETHYLAMINE-BASD INHIBITOR, HYDROLASE
2de8:A (THR52) to (ARG98) CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH A UNIQUE CONFORMATION INDUCED BY TRIS | NATIVE STRUCURE, SERINE PROTEASE, HYDROLASE
4j6g:B (LEU166) to (GLY205) CRYSTAL STRUCTURE OF LIGHT AND DCR3 COMPLEX | LIGHT, DCR3, TNF, TNFR, TNF14, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW HVEM, N-GLYCOSYLATION, MEMBRANE, SECRETED PROTEIN, CYTOKINE, IFN, JELLY-ROLL FOLD, BIND TNF RECEPTOR HVEM AND LTBR, LTBR, PROTEIN STRUCTURE INITIATIVE, ATOMS-TO-ANIMALS: THE IMMUNE FUNCTION NETWORK, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM
1e8b:A (PRO59) to (THR98) SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN | EXTRACELLULAR MATRIX GLYCOPROTEIN, CELL ADHESION
3th3:H (LEU64) to (ARG107) MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+ | HYDROLASE, BLOOD CLOTTING, SERINE PROTEASE, BLOOD COAGULATION, SOLUBLE TISSUE FACTOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1eas:A (THR64) to (ARG107) NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 3. DESIGN, SYNTHESIS, X-RAY CRYSTALLOGRAPHIC ANALYSIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS FOR A SERIES OF ORALLY ACTIVE 3-AMINO-6-PHENYLPYRIDIN- 2-ONE TRIFLUOROMETHYL KETONES | HYDROLASE (SERINE PROTEASE)
1q8k:A (GLY30) to (SER57) SOLUTION STRUCTURE OF ALPHA SUBUNIT OF HUMAN EIF2 | TRANSLATION, TRANSLATION INITIATION, EUKARYOTIC TRANSLATION INITIATION FACTOR 2
4jer:A (ASP72) to (GLY93) 1.1A RESOLUTION APO STRUCTURE OF THE HEMOPHORE HASA FROM YERSINIA PESTIS (TETRAGONAL FORM) | HEME BINDING PROTEIN, TRANSPORT PROTEIN
4ya8:A (MET15) to (PRO43) STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG394 | PLASMEPSIN II, MALARIA, INHIBITOR, HYDROLASE
2dsq:B (GLU24) to (CYS59) STRUCTURAL BASIS FOR THE INHIBITION OF INSULIN-LIKE GROWTH FACTORS BY IGF BINDING PROTEINS | IGF, IGFBP, INSULIN, PROTEIN BINDING/HORMONE/GROWTH FACTOR COMPLEX
1qaf:A (ASN540) to (ILE606) THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS | CATALYTIC DOMAIN MAINLY ANTI-PARALLEL BETA SHEET, THREE PERIPHERAL ALPHA-BETA DOMAINS, OXIDOREDUCTASE
1qak:B (ASN540) to (ILE606) THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS | OXIDOREDUCTASE, COPPER, TPQ, PERIPLASMIC, CATALYTIC BASE MUTANT
1qal:A (ASN540) to (ILE606) THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS | MUSHROOM SHAPED HOMODIMER WITH MAINLY BETA STRUCTURE. THERE ARE 3 SMALL PERIPHERAL ALPHA/BETA DOMAINS., OXIDOREDUCTASE
2rce:B (VAL61) to (THR93) DFP MODIFIED DEGS DELTA PDZ | DFP MODIFIED ACTIVE SITE SERINE, HYDROLASE, PROTEASE, SERINE PROTEASE
2rce:D (VAL59) to (THR93) DFP MODIFIED DEGS DELTA PDZ | DFP MODIFIED ACTIVE SITE SERINE, HYDROLASE, PROTEASE, SERINE PROTEASE
1eie:A (ILE81) to (ALA122) CRYSTAL STRUCTURE OF F120W MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A | RIBONUCLEASE, RNASE A, BOVINE PANCREAS, HYDROLASE
4yck:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 211 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yct:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 216 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd3:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 224 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd5:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 236 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd6:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 240 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
2re3:B (ARG76) to (THR115) CRYSTAL STRUCTURE OF A DUF1285 FAMILY PROTEIN (SPO_0140) FROM SILICIBACTER POMEROYI DSS-3 AT 2.50 A RESOLUTION | STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, UNKNOWN FUNCTION
4ydg:B (VAL74) to (ILE101) CRYSTAL STRUCTURE OF COMPOUND 10 IN COMPLEX WITH HTLV-1 PROTEASE | HTLV-1 PROTEASE, HYDROLASE
1qgf:A (THR64) to (ARG107) PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA- TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2- ONE | SERINE PROTEASE, HYDROLASE, SERINE PROTEINASE
1epm:E (ASP87) to (SER108) A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1epo:E (ASP87) to (SER108) ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME) | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1qhr:B (LEU64) to (LYS107) NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS | PROTEINASE, BLOOD COAGULATION, TRYPSIN LIKE PROTEINASE, COMPLEX (SERINE PROTEASE-INHIBITOR), BLOOD CLOTTING-HYDROLASE INHIBITOR COMPLEX
4yfk:C (PRO95) to (ASN139) ESCHERICHIA COLI RNA POLYMERASE IN COMPLEX WITH SQUARAMIDE COMPOUND 8. | SWITCH REGION, SQUARAMIDE, TRANSCRIPTION-INHIBITOR COMPLEX, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX
3h0q:B (GLY1876) to (PRO1920) CRYSTAL STRUCTURE OF THE CARBOXYLTRANSFERASE DOMAIN OF ACETYL-COENZYME A CARBOXYLASE IN COMPLEX WITH COMPOUND 3 | TRANSFERASE, ACETYL-COA CARBOXYLASE, CARBOXYLTRANSFERASE, INHIBITOR, LIGASE
2ri9:B (LEU2302) to (HIS2329) PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH A SUBSTRATE ANALOG | ALTERNATIVE CONFORMATIONS, MODULATION OF ACTIVITY, GLYCOPROTEIN, GLYCOSIDASE, HYDROLASE, SECRETED
1qj6:B (LEU64) to (LYS107) NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, BLOOD COAGULATION-INHIBITOR COMPLEX, PROTEINASE, BLOOD COAGULATION, TRYPSIN LIKE PROTEINASE, PROTEASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3h0s:C (GLY1876) to (GLU1914) CRYSTAL STRUCTURE OF THE CARBOXYLTRANSFERASE DOMAIN OF ACETYL-COENZYME A CARBOXYLASE IN COMPLEX WITH COMPOUND 7 | TRANSFERASE, ACETYL-COA CARBOXYLASE, CARBOXYLTRANSFERASE, INHIBITOR, ACC, CT, ATP-BINDING, BIOTIN, CYTOPLASM, FATTY ACID BIOSYNTHESIS, LIGASE, LIPID SYNTHESIS, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING
1est:A (THR64) to (ARG107) THE ATOMIC STRUCTURE OF CRYSTALLINE PORCINE PANCREATIC ELASTASE AT 2.5 ANGSTROMS RESOLUTION. COMPARISONS WITH THE STRUCTURE OF ALPHA- CHYMOTRYPSIN | HYDROLASE (SERINE PROTEINASE), HYDROLASE
1et6:B (THR97) to (GLN131) CRYSTAL STRUCTURE OF THE SUPERANTIGEN SMEZ-2 FROM STREPTOCOCCUS PYOGENES | BETA GRASP, OB FOLD, SUPERANTIGEN FOLD, IMMUNE SYSTEM
3h1w:A (SER7) to (SER57) CRYSTAL STRUCTURE OF MANNOSE 6-PHOSPHATE ISOMERASE BOUND WITH ZINC AND YTTRIUM | ZINC BOUND, YTTRIUM BOUND, CUPIN, ISOMERASE
2rnf:B (VAL78) to (PRO114) X-RAY CRYSTAL STRUCTURE OF HUMAN RIBONUCLEASE 4 IN COMPLEX WITH D(UP) | RIBONUCLEASE, HYDROLASE, PHOSPHODIESTERASE
2rns:A (ILE81) to (ALA122) REFINEMENT OF THE CRYSTAL STRUCTURE OF RIBONUCLEASE S. COMPARISON WITH AND BETWEEN THE VARIOUS RIBONUCLEASE A STRUCTURES | HYDROLASE(PHOSPHORIC DIESTER,RNA)
1ewf:A (ASP36) to (ILE80) THE 1.7 ANGSTROM CRYSTAL STRUCTURE OF BPI | BACTERICIDAL, PERMEABILITY-INCREASING, LIPID-BINDING, LIPOPOLYSACCHARIDE-BINDING, ANTIBIOTIC
4yfx:C (PRO95) to (ASN139) ESCHERICHIA COLI RNA POLYMERASE IN COMPLEX WITH MYXOPYRONIN B | SWITCH REGION, SQUARAMIDE, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX
4yfx:D (GLU418) to (HIS450) ESCHERICHIA COLI RNA POLYMERASE IN COMPLEX WITH MYXOPYRONIN B | SWITCH REGION, SQUARAMIDE, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX
4yg2:C (PRO95) to (ASN139) X-RAY CRYSTAL STRUCTUR OF ESCHERICHIA COLI RNA POLYMERASE SIGMA70 HOLOENZYME | RNA POLYMERASE, TRANSFERASE-TRANSCRIPTION COMPLEX
4yg2:I (PRO95) to (ASN139) X-RAY CRYSTAL STRUCTUR OF ESCHERICHIA COLI RNA POLYMERASE SIGMA70 HOLOENZYME | RNA POLYMERASE, TRANSFERASE-TRANSCRIPTION COMPLEX
4ygw:B (ILE81) to (ALA122) RNASE S IN COMPLEX WITH STABILIZED S PEPTIDE | RNASE, UNNATURAL AMINO ACIDS, SIDE CHAIN LINK, HYDROLASE
2tnf:B (SER81) to (GLY121) 1.4 A RESOLUTION STRUCTURE OF MOUSE TUMOR NECROSIS FACTOR, TOWARDS MODULATION OF ITS SELCTIVITY AND TRIMERISATION | LYMPHOKINE, CYTOKINE, CYTOTOXIN, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL-ANCHOR
1qrz:C (SER613) to (LYS651) CATALYTIC DOMAIN OF PLASMINOGEN | MICROPLASMINOGEN, SERINE PROTEASE, ZYMOGEN, CHYMOTRYPSIN FAMILY, HYDROLASE
3u1u:A (ALA412) to (VAL436) CRYSTAL STRUCTURE OF RNA POLYMERASE-ASSOCIATED PROTEIN RTF1 HOMOLOG PLUS-3 DOMAIN | PLUS-3, TRANSCRIPTION ELONGATION, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSCRIPTION
3hb8:D (VAL45) to (ARG68) STRUCTURES OF THYMIDYLATE SYNTHASE R163K WITH SUBSTRATES AND INHIBITORS SHOW SUBUNIT ASYMMETRY | TRANSFERASE, METHYL TRANSFERASE, METHYLTRANSFERASE, NUCLEOTIDE BIOSYNTHESIS
2eba:A (HIS171) to (GLU219) CRYSTAL STRUCTURE OF THE PUTATIVE GLUTARYL-COA DEHYDROGENASE FROM THERMUS THERMOPHILUS | GLUTARYL-COA DEHYDROGENASE, THERMUS THERMOPHILIUS, FAD, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, OXIDOREDUCTASE
2eba:H (HIS171) to (GLU219) CRYSTAL STRUCTURE OF THE PUTATIVE GLUTARYL-COA DEHYDROGENASE FROM THERMUS THERMOPHILUS | GLUTARYL-COA DEHYDROGENASE, THERMUS THERMOPHILIUS, FAD, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, OXIDOREDUCTASE
2eba:I (HIS171) to (GLU219) CRYSTAL STRUCTURE OF THE PUTATIVE GLUTARYL-COA DEHYDROGENASE FROM THERMUS THERMOPHILUS | GLUTARYL-COA DEHYDROGENASE, THERMUS THERMOPHILIUS, FAD, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, OXIDOREDUCTASE
1qzn:A (GLU8) to (ASP44) CRYSTAL STRUCTURE ANALYSIS OF A TYPE II COHESIN DOMAIN FROM THE CELLULOSOME OF ACETIVIBRIO CELLULOLYTICUS | KEYWORDS: COHESINS TYPE II; CELLULOSOME;, STRUCTURAL PROTEIN
3hb9:C (ASN241) to (ALA278) CRYSTAL STRUCTURE OF S. AUREUS PYRUVATE CARBOXYLASE A610T MUTANT | TIM BARREL, PYRUVATE, LIGASE
2ec9:H (LEU64) to (ARG107) CRYSTAL STRUCTURE ANALYSIS OF HUMAN FACTOR VIIA , SOULUBLE TISSUE FACTOR COMPLEXED WITH BCX-3607 | PROTEIN-COFACTOR COMPLEX, FVIIA AND SOULUBLE TISSUE FACTOR, INHIBITOR, BLOOD CLOTTING
4jx0:B (PRO69) to (ASP112) CRYSTAL STRUCTURE OF A TWO DOMAIN PROTEIN WITH UNKNOWN FUNCTION (BF3416) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.90 A RESOLUTION | TWO DOMAINS PROTEIN, DUF1735 OF PF08522 FAMILY, F5_F8_TYPE_C OF PF00754 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN FUNCTION
3u6b:B (PRO328) to (PRO352) EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028 | TRANSLATION FACTOR-ANTIBIOTIC COMPLEX
1fak:H (LEU64) to (ARG107) HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT | COMPLEX(SERINE PROTEASE/COFACTOR/LIGAND), BLOOD COAGULATION, SERINE PROTEASE, COMPLEX, CO-FACTOR, RECEPTOR ENZYME, INHIBITOR, GLA, EGF, COMPLEX (SERINE PROTEASE/COFACTOR/LIGAND), BLOOD CLOTTING
3hdx:A (TYR358) to (PHE394) CRYSTAL STRUCTURE OF SUSD SUPERFAMILY PROTEIN (NP_809182.1) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.50 A RESOLUTION | NP_809182.1, SUSD SUPERFAMILY PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, CARBOHYDRATE METABOLISM, POLYSACCHARIDE BINDING PROTEIN
4jyv:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[3- ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3- SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4jzd:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(4- CARBAMIMIDOYLPHENYL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1- HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID | GLYCOPROTEIN, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jze:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(1- AMINOISOQUINOLIN-6-YL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1- HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID | GLYCOPROTEIN, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ylq:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (FT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR | TRYPSIN-FOLD, PROTEIN-PROTEIN COMPLEX, HYDROLASE
4ym9:A (THR64) to (ARG107) CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE (PPE) IN COMPLEX WITH THE NOVEL INHIBITOR JM102 | PORCINE PANCREATIC ELASTASE, INHIBITOR, HYDROLASE
2v00:A (ASP92) to (SER113) X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1 | FRAGMENT HIT, B- SECRETASE, ENDOTHIAPEPSIN, BACE, ZYMOGEN, PROTEASE, HYDROLASE, ISOCYTOSINE, ALZHEIMER'S DISEASE, FRAGMENT-BASED LEAD GENERATION, ASPARTYL PROTEASE, SURROGATE PROTEIN
2ep6:A (HIS156) to (VAL194) SOLUTION STRUCTURE OF THE SECOND C2 DOMAIN FROM HUMAN MCTP2 PROTEIN | BETA SANDWICH, CA2+ BINDING, MEMBRANE BINDING, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, MEMBRANE PROTEIN
3udg:A (LEU83) to (GLN108) STRUCTURE OF DEINOCOCCUS RADIODURANS SSB BOUND TO SSDNA | SSB, OB FOLD, BETA-BARREL, SINGLE-STRANDED DNA-BINDING, DNA BINDING PROTEIN-DNA COMPLEX
4yt6:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-{[(R)-[5-ETHOXY-2-FLUORO- 3-(PROPAN-2-YLOXY)PHENYL](4-PHENYL-1H-IMIDAZOL-2-YL) METHYL]AMINO}BENZENECARBOXIMIDAMIDE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1rbw:A (ILE81) to (ALA122) RIBONUCLEASE A (E.C.3.1.27.5) WITH GUANIDINIUM | HYDROLASE (NUCLEIC ACID, RNA)
4yu5:A (VAL608) to (VAL635) CRYSTAL STRUCTURE OF SELENOMETHIONINE VARIANT OF BACILLUS ANTHRACIS IMMUNE INHIBITOR A2 PEPTIDASE ZYMOGEN | HYDROLASE, METALLOPEPTIDASE, METZINCIN
4yu5:B (VAL608) to (VAL635) CRYSTAL STRUCTURE OF SELENOMETHIONINE VARIANT OF BACILLUS ANTHRACIS IMMUNE INHIBITOR A2 PEPTIDASE ZYMOGEN | HYDROLASE, METALLOPEPTIDASE, METZINCIN
1rfq:A (ILE151) to (HIS173) ACTIN CRYSTAL DYNAMICS: STRUCTURAL IMPLICATIONS FOR F-ACTIN NUCLEATION, POLYMERIZATION AND BRANCHING MEDIATED BY THE ANTI-PARALLEL DIMER | ANTI-PARALLEL DIMER, POLYMERIZATION, NUCLEATION, FILAMENT, STRUCTURAL PROTEIN
4k81:E (PRO235) to (SER266) CRYSTAL STRUCTURE OF THE GRB14 RA AND PH DOMAINS IN COMPLEX WITH GTP- LOADED H-RAS | ADAPTOR PROTEIN, SIGNALING PROTEIN
1riq:A (GLY167) to (PRO210) THE CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF THE ALANYL-TRNA SYNTHETASE | BETA SHEET AND FLANKING HELICES, CLASS II AMINOACYL-TRNA SYNTHETASE, HELIX-LOOP-HELIX MOTIF, LIGASE
2vbe:A (SER420) to (VAL449) TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6 | VIRAL ADHESION PROTEIN, TAILSPIKE, VIRAL PROTEIN, OLIGOMERIC RIGHT-HANDED PARALLEL BETA-HELIX
1rnz:A (ILE81) to (ALA122) RIBONUCLEASE A CRYSTALLIZED FROM 2.5M SODIUM CHLORIDE, 3.3M SODIUM FORMATE | HYDROLASE, NUCLEASE, ENDONUCLEASE, GLYCOPROTEIN, SIGNAL
4kbj:A (PRO126) to (ASN163) STRUCTURE OF MTB RNAP BETA SUBUNIT B1 AND B2 DOMAINS | STRUCTURAL GENOMICS, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, DNA DEPENDENT RNA POLYMERASE, CARD, TRCF,SIGMA FACTORS, DNA, TRANSFERASE
4kbm:A (PRO126) to (ASN163) STRUCTURE OF THE MTB CARD/RNAP BETA SUBUNIT B1-B2 DOMAINS COMPLEX | STRUCTURAL GENOMICS, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, TUDOR, DNA-DEPENDENT RNA POLYMERASE, TRANSCRIPTION REGULATOR,PROTEIN- PROTEIN COMPLEX, CARD, DNA, SIGMA FACTOR, TRANSFERASE-TRANSCRIPTION COMPLEX
4kc0:B (ARG221) to (ALA261) MSTING | MOUSE STING, IMMUNE SYSTEM
4kc8:A (GLN381) to (GLY409) CRYSTAL STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1 IN COMPLEX WITH TRIS | BETA-PROPELLER, GH43, GLYCOSIDE HYDROLASE, ARABINANASE, HYDROLASE
3hnb:M (THR2241) to (LEU2273) FACTOR VIII TRP2313-HIS2315 SEGMENT IS INVOLVED IN MEMBRANE BINDING AS SHOWN BY CRYSTAL STRUCTURE OF COMPLEX BETWEEN FACTOR VIII C2 DOMAIN AND AN INHIBITOR | SMALL MOLECULE INHIBITOR/BLOOD CLOTTING, BLOOD CLOTTING
3hny:M (THR2241) to (LEU2273) FACTOR VIII TRP2313-HIS2315 SEGMENT IS INVOLVED IN MEMBRANE BINDING AS SHOWN BY CRYSTAL STRUCTURE OF COMPLEX BETWEEN FACTOR VIII C2 DOMAIN AND AN INHIBITOR | BLOOD CLOTTING, ACUTE PHASE, BLOOD COAGULATION, CALCIUM, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, HEMOPHILIA, METAL-BINDING, PHARMACEUTICAL, POLYMORPHISM, SECRETED, SULFATION
3ho3:A (TYR303) to (ARG337) CRYSTAL STRUCTURE OF HEDGEHOG-INTERACTING PROTEIN (HHIP) | RECEPTOR ECTODOMAIN, SIX-BLADED-PROPELLER DOMAIN, EGF DOMAIN, DISULFIDE BOND, CELL MEMBRANE, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, SECRETED, SIGNALING PROTEIN
3ho8:C (LYS243) to (ALA278) CRYSTAL STRUCTURE OF S. AUREUS PYRUVATE CARBOXYLASE IN COMPLEX WITH COENZYME A | TIM BARREL, PYRUVATE, LIGASE
3ho8:B (ASN241) to (ALA278) CRYSTAL STRUCTURE OF S. AUREUS PYRUVATE CARBOXYLASE IN COMPLEX WITH COENZYME A | TIM BARREL, PYRUVATE, LIGASE
3hob:M (THR2241) to (PHE2274) FACTOR VIII TRP2313-HIS2315 SEGMENT IS INVOLVED IN MEMBRANE BINDING AS SHOWN BY CRYSTAL STRUCTURE OF COMPLEX BETWEEN FACTOR VIII C2 DOMAIN AND AN INHIBITOR | BLOOD CLOTTING, ACUTE PHASE, BLOOD COAGULATION, CALCIUM, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, HEMOPHILIA, METAL-BINDING, PHARMACEUTICAL, POLYMORPHISM, SECRETED, SULFATION
3hob:A (THR2241) to (LEU2273) FACTOR VIII TRP2313-HIS2315 SEGMENT IS INVOLVED IN MEMBRANE BINDING AS SHOWN BY CRYSTAL STRUCTURE OF COMPLEX BETWEEN FACTOR VIII C2 DOMAIN AND AN INHIBITOR | BLOOD CLOTTING, ACUTE PHASE, BLOOD COAGULATION, CALCIUM, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, HEMOPHILIA, METAL-BINDING, PHARMACEUTICAL, POLYMORPHISM, SECRETED, SULFATION
4kfe:C (TRP443) to (ALA480) CRYSTAL STRUCTURE OF HANSENULA POLYMORPHA COPPER AMINE OXIDASE-1 REDUCED BY METHYLAMINE AT PH 7.0 | AMINE OXIDASE, OXIDOREDUCTASE, PEROXISOME
4kfe:E (TRP443) to (ALA480) CRYSTAL STRUCTURE OF HANSENULA POLYMORPHA COPPER AMINE OXIDASE-1 REDUCED BY METHYLAMINE AT PH 7.0 | AMINE OXIDASE, OXIDOREDUCTASE, PEROXISOME
4kfe:F (GLY444) to (ALA480) CRYSTAL STRUCTURE OF HANSENULA POLYMORPHA COPPER AMINE OXIDASE-1 REDUCED BY METHYLAMINE AT PH 7.0 | AMINE OXIDASE, OXIDOREDUCTASE, PEROXISOME
3uou:A (THR78) to (ARG124) CRYSTAL STRUCTURE OF THE KUNITZ-TYPE PROTEASE INHIBITOR SHPI-1 LYS13LEU MUTANT IN COMPLEX WITH PANCREATIC ELASTASE | PROTEIN-PROTEIN INTERACTION, HYDROLASE (SERINE PROTEASE), KUNITZ-TYPE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ryp:2 (VAL-3) to (GLY30) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
3hpe:B (VAL29) to (ASP69) CRYSTAL STRUCTURE OF YCEI (HP1286) FROM HELICOBACTER PYLORI | HP1286, HELICOBACTER PYLORI, ERUCAMIDE, FATTY-ACID BINDING, TRANSPORT PROTEIN
2fir:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF DFPR-VIIA/STF | FACTOR VIIA, SOLUBLE TISSUE FACTOR, OXYANION HOLE, SERINE PROTEASE, BLOOD COAGULATION, BLOOD CLOTTING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z6k:B (ALA3) to (ALA25) ALCOHOL DEHYDROGENASE FROM THE ANTARCTIC PSYCHROPHILE MORAXELLA SP. TAE 123 | COLD-ADAPTED ENZYME, OXIDOREDUCTASE, NAD-DEPENDENT ALCOHOL DEHYDROGENASE, ZINC-BINDING PROTEIN
4z6k:D (ALA3) to (ALA25) ALCOHOL DEHYDROGENASE FROM THE ANTARCTIC PSYCHROPHILE MORAXELLA SP. TAE 123 | COLD-ADAPTED ENZYME, OXIDOREDUCTASE, NAD-DEPENDENT ALCOHOL DEHYDROGENASE, ZINC-BINDING PROTEIN
2vji:A (THR613) to (SER649) TAILSPIKE PROTEIN OF E.COLI BACTERIOPHAGE HK620 | VIRAL PROTEIN, VIRAL ADHESION PROTEIN, ENDO-N- ACETYLGLUCOSAMINIDASE, RIGHT-HANDED PARALLEL BETA-HELIX, HYDROLASE, TAILSPIKE
2flb:H (LEU64) to (ARG107) DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR | ACTIVE SITE-DIRECTED, SHORT HYDROGEN BOND-MEDIATED, PYRAZOLE-BASED INHIBITOR, HYDROLASE/BLOOD CLOTTING COMPLEX
2vkx:D (TYR572) to (ASP625) HUMAN NCAM, FN3 DOMAINS 1 AND 2, M610R MUTANT | ADHESION RECEPTOR, CELL ADHESION
3uwn:A (GLY241) to (HIS271) THE 3-MBT REPEAT DOMAIN OF L3MBTL1 IN COMPLEX WITH A METHYL-LYSINE MIMIC | STRUCTURAL GENOMICS CONSORTIUM, SGC, MBT REPEAT, HISTONE MODIFICATION, TRANSCRIPTION
2foc:A (GLN30) to (THR57) STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 55% DIMETHYLFORMAMIDE | ELASTASE; SOLVENT MAPPING; ORGANIC SOLVENTS; PROTEIN BINDING SITES; MULTIPLE SOLVENT CRYSTAL STRUCTURES, HYDROLASE
2fof:A (GLN30) to (THR57) STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% ISOPROPANOL | ELASTASE; SOLVENT MAPPING; ORGANIC SOLVENTS; PROTEIN BINDING SITES; MULTIPLE SOLVENT CRYSTAL STRUCTURES, HYDROLASE
4za4:A (GLY155) to (PRO189) STRUCTURE OF A. NIGER FDC1 WITH THE PRENYLATED-FLAVIN COFACTOR IN THE IMINIUM FORM. | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
4za5:A (GLY155) to (PRO189) STRUCTURE OF A. NIGER FDC1 WITH THE PRENYLATED-FLAVIN COFACTOR IN THE IMINIUM AND KETIMINE FORMS. | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
4za7:A (GLY155) to (PRO189) STRUCTURE OF A. NIGER FDC1 IN COMPLEX WITH ALPHA-METHYL CINNAMIC ACID | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
4za8:A (GLY155) to (PRO189) CRYSTAL STRUCTURE OF A NIGER FDC1 IN COMPLEX WITH PENTA-FLUOROCINNAMIC ACID | (DE)CARBOXYLASE, PRENYLATED FLAVIN, UBID-LIKE ENZYME, LYASE
4za9:A (GLY155) to (PRO189) STRUCTURE OF A. NIGER FDC1 IN COMPLEX WITH A PHENYLPYRUVATE DERIVED ADDUCT TO THE PRENYLATED FLAVIN COFACTOR | UBID-ENZYME, PRENYLATED FLAVIN, (DE)CARBOXYLASE, LYASE
4zaa:A (GLY155) to (PRO189) STRUCTURE OF A. NIGER FDC1 IN COMPLEX WITH 4-VINYL GUAIACOL | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
4zab:A (GLY155) to (PRO189) STRUCTURE OF A. NIGER FDC1 IN COMPLEX WITH ALPHA-FLUORO CINNAMIC ACID | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
4zac:A (GLY157) to (PRO191) STRUCTURE OF S. CEREVISIAE FDC1 WITH THE PRENYLATED-FLAVIN COFACTOR IN THE IMINIUM FORM. | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
4zad:B (GLY161) to (LEU191) STRUCTURE OF C. DUBLIENSIS FDC1 WITH THE PRENYLATED-FLAVIN COFACTOR IN THE IMINIUM FORM. | (DE)CARBOXYLASE, PRENYLATED FLAVIN BINDING, UBID-TYPE ENZYME, LYASE
3uyq:A (GLU106) to (ILE143) HCA 3 | PROTON SHUTTLE, HCA III, PROTON TRANSFER, LYASE
3uyu:B (ALA177) to (VAL199) STRUCTURAL BASIS FOR THE ANTIFREEZE ACTIVITY OF AN ICE-BINDING PROTEIN (LEIBP) FROM ARCTIC YEAST | RIGHT-HANDED BETA-HELIX FOLD, ICE BINDING PROTEIN, ANTIFREEZE PROTEIN
3htz:A (GLY167) to (PRO210) CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF ALANYL-TRNA SYNTHETASE IN COMPLEX WITH L-SERINE: RE-REFINED | ADENOSINE TRIPHOSPHATE, ALANINE-TRNA LIGASE, BINDING SITES, GENETIC CODE, PROTEIN CONFORMATION, AMINOACYL-TRNA SYNTHETASE, ATP-BINDING, CYTOPLASM, LIGASE, NUCLEOTIDE- BINDING, PROTEIN BIOSYNTHESIS
1sac:A (ASN32) to (ASN59) THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT | AMYLOID PROTEIN
4zea:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B91 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1gkt:A (ASP92) to (SER113) NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASE-INHIBITOR, ASPARTIC PROTEINASE, HYDROLYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1sdd:B (THR1933) to (ILE1965) CRYSTAL STRUCTURE OF BOVINE FACTOR VAI | COAGULATION, COPPER-BINDING PROTEIN, COFACTOR, BLOOD CLOTTING
1sdd:B (THR2093) to (PRO2125) CRYSTAL STRUCTURE OF BOVINE FACTOR VAI | COAGULATION, COPPER-BINDING PROTEIN, COFACTOR, BLOOD CLOTTING
3hy1:B (GLY176) to (PRO228) CRYSTAL STRUCTURE OF CATALYTIC FRAGMENT OF E. COLI ALARS G237A IN COMPLEX WITH SERSA | AMINOACYL-TRNA SYNTHETASE, LIGASE, PROTEIN BIOSYNTHESIS, NUCLEOTIDE- BINDING, AMINO ACID-BINDING, ATP-BINDING, METAL-BINDING, ZINC-FINGER
3v4z:B (PRO186) to (PRO226) D-ALANINE--D-ALANINE LIGASE FROM YERSINIA PESTIS | STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, PEPTIDOGLYCAN SYNTHESIS, LIGASE
2g0k:A (GLY61) to (GLU106) SOLUTION STRUCTURE OF NEOCARZINOSTATIN APO-PROTEIN | BETA SANDWICH, IGG FOLD, ANTIBIOTIC
1sjb:C (ALA17) to (CYS47) X-RAY STRUCTURE OF O-SUCCINYLBENZOATE SYNTHASE COMPLEXED WITH O-SUCCINYLBENZOIC ACID | RACEMASE, LYASE, ISOMERASE
4ksb:A (GLY1035) to (SER1067) STRUCTURES OF P-GLYCOPROTEIN REVEAL ITS CONFORMATIONAL FLEXIBILITY AND AN EPITOPE ON THE NUCLEOTIDE-BINDING DOMAIN | TRANSPORTER, ATP BINDING, MEMBRANE, MEMBRANE PROTEIN, TRANSPORT PROTEIN
4ksc:A (GLY1035) to (SER1067) STRUCTURES OF P-GLYCOPROTEIN REVEAL ITS CONFORMATIONAL FLEXIBILITY AND AN EPITOPE ON THE NUCLEOTIDE-BINDING DOMAIN | TRANSPORTER, ATP BINDING, MEMBRANE, MEMBRANE PROTEIN, TRANSPORT PROTEIN
2g3n:E (ILE3) to (LEU60) CRYSTAL STRUCTURE OF THE SULFOLOBUS SOLFATARICUS ALPHA- GLUCOSIDASE MALA IN COMPLEX WITH BETA-OCTYL-GLUCOPYRANOSIDE | HYDROLASE, ALPHA-GLUCOSIDASE, ENZYME-CARBOHYDRATE COMPLEX, GLYCOSIDE HYDROLASE FAMILY 31, MULTIDOMAIN PROTEIN, (BETA/ALPHA)8 BARREL, RETAINING MECHANISM
3var:A (THR156) to (ALA213) CRYSTAL STRUCTURE OF DNPEP, ZNZN FORM | ALPHA-BETA-ALPHA SANDWICH, ASPARTYL AMINOPEPTIDASE, BINUCLEAR METAL CENTER, M18 PEPTIDASE, MH CLAN, TETRAHEDRAL AMINOPEPTIDASE, HYDROLASE
2vtw:A (GLY224) to (LEU253) STRUCTURE OF THE C-TERMINAL HEAD DOMAIN OF THE FOWL ADENOVIRUS TYPE 1 SHORT FIBRE | VIRAL PROTEIN, CELO, ADENOVIRUS, FIBER PROTEIN, SHORT FIBRE HEAD
2vtw:A (THR359) to (GLY395) STRUCTURE OF THE C-TERMINAL HEAD DOMAIN OF THE FOWL ADENOVIRUS TYPE 1 SHORT FIBRE | VIRAL PROTEIN, CELO, ADENOVIRUS, FIBER PROTEIN, SHORT FIBRE HEAD
2vtw:C (THR359) to (GLY395) STRUCTURE OF THE C-TERMINAL HEAD DOMAIN OF THE FOWL ADENOVIRUS TYPE 1 SHORT FIBRE | VIRAL PROTEIN, CELO, ADENOVIRUS, FIBER PROTEIN, SHORT FIBRE HEAD
2vtw:D (GLY224) to (LEU253) STRUCTURE OF THE C-TERMINAL HEAD DOMAIN OF THE FOWL ADENOVIRUS TYPE 1 SHORT FIBRE | VIRAL PROTEIN, CELO, ADENOVIRUS, FIBER PROTEIN, SHORT FIBRE HEAD
2vtw:F (GLY224) to (LEU253) STRUCTURE OF THE C-TERMINAL HEAD DOMAIN OF THE FOWL ADENOVIRUS TYPE 1 SHORT FIBRE | VIRAL PROTEIN, CELO, ADENOVIRUS, FIBER PROTEIN, SHORT FIBRE HEAD
1spu:A (ASN540) to (ILE606) STRUCTURE OF OXIDOREDUCTASE | OXIDOREDUCTASE, COPPER, TPQ, PERIPLASMIC, SIGNAL
1spu:B (ASN540) to (ILE606) STRUCTURE OF OXIDOREDUCTASE | OXIDOREDUCTASE, COPPER, TPQ, PERIPLASMIC, SIGNAL
1sqo:A (TRP14) to (SER51) SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | PLASMINOGEN ACTIVATION, HYDROLASE, SERINE PROTEASE, GLYCOPROTEIN, KRINGLE, EGF-LIKE DOMAIN
1suh:A (PRO5) to (GLY40) AMINO-TERMINAL DOMAIN OF EPITHELIAL CADHERIN IN THE CALCIUM BOUND STATE, NMR, 20 STRUCTURES | CADHERIN, CALCIUM BINDING, CELL ADHESION
3i7j:B (GLY184) to (SER209) CRYSTAL STRUCTURE OF A BETA-LACTAMASE (MB2281C) FROM MYCOBACTERIUM BOVIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MBR246 | ALPHA-BETA PROTEIN., STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, HYDROLASE
2gbx:D (ASP117) to (PHE154) CRYSTAL STRUCTURE OF BIPHENYL 2,3-DIOXYGENASE FROM SPHINGOMONAS YANOIKUYAE B1 BOUND TO BIPHENYL | RIESKE OXYGENASE, OXIDOREDUCTASE, NON HEME IRON, DIOXYGENASE
1gyk:A (PHE33) to (ASN59) SERUM AMYLOID P COMPONENT CO-CRYSTALLISED WITH MOBDG AT NEUTRAL PH | PENTRAXIN, AMYLOID LECTIN, GLYCOPROTEIN, PLASMA, POLYMORPHISM
1gyk:B (PHE33) to (ASN59) SERUM AMYLOID P COMPONENT CO-CRYSTALLISED WITH MOBDG AT NEUTRAL PH | PENTRAXIN, AMYLOID LECTIN, GLYCOPROTEIN, PLASMA, POLYMORPHISM
1gyk:C (PHE33) to (ASN59) SERUM AMYLOID P COMPONENT CO-CRYSTALLISED WITH MOBDG AT NEUTRAL PH | PENTRAXIN, AMYLOID LECTIN, GLYCOPROTEIN, PLASMA, POLYMORPHISM
1gyk:D (PHE33) to (ASN59) SERUM AMYLOID P COMPONENT CO-CRYSTALLISED WITH MOBDG AT NEUTRAL PH | PENTRAXIN, AMYLOID LECTIN, GLYCOPROTEIN, PLASMA, POLYMORPHISM
1gyk:E (PHE33) to (ASN59) SERUM AMYLOID P COMPONENT CO-CRYSTALLISED WITH MOBDG AT NEUTRAL PH | PENTRAXIN, AMYLOID LECTIN, GLYCOPROTEIN, PLASMA, POLYMORPHISM
2gdq:B (LYS20) to (GLU50) CRYSTAL STRUCTURE OF MANDELATE RACEMASE/MUCONATE LACTONIZING ENZYME FROM BACILLUS SUBTILIS AT 1.8 A RESOLUTION | MANDELATE RACEMASE/MUCONATE LACTONIZING ENZYME, TIM-BARREL, ENOLASE, OCTAMER, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, UNKNOWN FUNCTION
3vg1:A (GLY13) to (GLY41) CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BUR436, DERIVED FROM A SOAKING EXPERIMENT | BETA-SECRETASE, MEMAPSIN2, BACE1, ASPARTIC PROTEINASE, ALZHEIMER'S DISEASE, ENZYME INHIBITOR COMPLEX, STRUCTURE-BASED DRUG DESIGN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4l1u:A (LYS413) to (VAL436) CRYSTAL STRUCTURE OF HUMAN RTF1 PLUS3 DOMAIN IN COMPLEX WITH SPT5 CTR PHOSPHOPEPTIDE | TUTOR, PLUS3, PEPTIDE BINDING PROTEIN, SPT5 CTR BINDING, TRANSCRIPTION, PAF1 COMPLEX, RTF1, ORF ASSOCIATION REGION, CHROMATIN, TRANSCRIPTION-PEPTIDE COMPLEX
3icu:A (TYR46) to (GLY82) PROTEASE-ASSOCIATED DOMAIN OF THE E3 LIGASE GRAIL | E3 LIGASE, ENERGY, PA DOMAIN, TRANSMEMBRANE,PROTEIN TURNOVER, UBL CONJUGATION PATHWAY, GLYCOPROTEIN,STRUCTURAL GENOMICS CONSORTIUM, SGC, LIGASE, MEMBRANE, METAL-BINDING, ZINC-FINGER
1h4u:A (PRO401) to (SER444) DOMAIN G2 OF MOUSE NIDOGEN-1 | EXTRACELLULAR MATRIX PROTEIN
1h4w:A (ARG62) to (LYS107) STRUCTURE OF HUMAN TRYPSIN IV (BRAIN TRYPSIN) | SERINE PROTEASE, SIGNAL TRANSDUCTION, INHIBITOR RESISTANCE, ALZHEIMER DISEASE, HYDROLASE
4l6b:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP128 | ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2gnn:A (ARG29) to (CYS68) CRYSTAL STRUCTURE OF THE ORF VIRUS NZ2 VARIANT OF VEGF-E | VEGF, ORF, S-SAD,, HORMONE-GROWTH FACTOR COMPLEX
4zng:C (PHE322) to (PHE352) X-RAY CRYSTALLOGRAPHY OF RECOMBINANT LACTOCOCCUS LACTIS PROLIDASE | HYDROLASE, METALLOENZYME, PITA-BREAD, DIPEPTIDASE
2w0q:A (ASN540) to (ILE606) E. COLI COPPER AMINE OXIDASE IN COMPLEX WITH XENON | TPQ, XENON, COPPER, E. COLI, CALCIUM, PERIPLASM, OXYGEN ENTRY, METAL-BINDING, OXIDOREDUCTASE, COPPER AMINE OXIDASE
1h5w:C (GLY61) to (VAL92) 2.1A BACTERIOPHAGE PHI-29 CONNECTOR | VIRUS, CONNECTOR, PORTAL, SH3-LIKE, HELIX BUNDLE
1h8v:C (GLY41) to (THR72) THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 ENDOGLUCANASE 3, CEL12A, AT 1.9 A RESOLUTION | HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, GH FAMILY 12, GLYCOSYL HYDROLASE
1h8v:E (SER43) to (THR72) THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 ENDOGLUCANASE 3, CEL12A, AT 1.9 A RESOLUTION | HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, GH FAMILY 12, GLYCOSYL HYDROLASE
3in4:A (GLY75) to (GLY103) BACE1 WITH COMPOUND 38 | BACE-1, INHIBITOR, ALTERNATIVE SPLICING, ASPARTYL PROTEASE, DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, PROTEASE, TRANSMEMBRANE, ZYMOGEN
1teh:A (PHE130) to (ASP161) STRUCTURE OF HUMAN LIVER CHICHI ALCOHOL DEHYDROGENASE (A GLUTATHIONE- DEPENDENT FORMALDEHYDE DEHYDROGENASE) | NAD+ DEPENDENT ALCOHOL DEHYDROGENASE GLUTATHIONE DEPENDENT FORMALDEHYDE DEHYDROGENASE, OXIDOREDUCTASE
2gy7:A (TYR298) to (ILE325) ANGIOPOIETIN-2/TIE2 COMPLEX CRYSTAL STRUCTURE | RECEPTOR-LIGAND COMPLEX, SIGNALING PROTEIN
2w78:B (THR582) to (LEU633) STRUCTURES OF P. AERUGINOSA FPVA BOUND TO HETEROLOGOUS PYOVERDINES: FPVA-PVD(ATCC13535)-FE COMPLEX | RECEPTOR, TONB BOX, TRANSPORT, SIDEROPHORE, CELL MEMBRANE, IRON TRANSPORT, CELL OUTER MEMBRANE, TONB-DEPENDENT TRANSPORTER
4ljz:C (PRO95) to (ASN139) CRYSTAL STRUCTURE ANALYSIS OF THE E.COLI HOLOENZYME | DNA DIRECTED RNA POLYMERASE, TRANSFERASE
4ljz:I (PRO95) to (ASN139) CRYSTAL STRUCTURE ANALYSIS OF THE E.COLI HOLOENZYME | DNA DIRECTED RNA POLYMERASE, TRANSFERASE
1tq9:B (ILE81) to (ALA122) NON-COVALENT SWAPPED DIMER OF BOVINE SEMINAL RIBONUCLEASE IN COMPLEX WITH 2'-DEOXYCYTIDINE-2'-DEOXYADENOSINE-3',5'- MONOPHOSPHATE | PROTEIN-DINUCLEOTIDE COMPLEX, CYTOTOXIC ACTION, HYDROLASE
2wez:A (GLY74) to (GLY102) HUMAN BACE-1 IN COMPLEX WITH 1-ETHYL-N-((1S,2R)-2-HYDROXY-3- (((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-4-(2-OXO-1-PYRROLIDINYL)-1H-INDOLE-6-CARBOXAMIDE | HYDROLASE, MEMAPSIN-2, POLYMORPHISM, GLYCOPROTEIN, ASP-2, BACE-1, ZYMOGEN, PROTEASE, MEMBRANE, TRANSMEMBRANE, BETA-SECRETASE, DISULFIDE BOND, ASPARTYL PROTEASE, ALTERNATIVE SPLICING, BETA-SITE APP CLEAVING ENZYME
2wf3:A (GLY74) to (GLY102) HUMAN BACE-1 IN COMPLEX WITH 6-(ETHYLAMINO)-N-((1S,2R)-2- HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-( PHENYLMETHYL)PROPYL)-1-METHYL-1,3,4,5-TETRAHYDRO-2,1- BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-DIOXIDE | HYDROLASE, MEMAPSIN-2, POLYMORPHISM, GLYCOPROTEIN, ASP-2, BACE-1, ZYMOGEN, PROTEASE, MEMBRANE, TRANSMEMBRANE, BETA-SECRETASE, DISULFIDE BOND, ASPARTYL PROTEASE, ALTERNATIVE SPLICING, BETA-SITE APP CLEAVING ENZYME
1hqm:C (ALA92) to (ASN130) CRYSTAL STRUCTURE OF THERMUS AQUATICUS CORE RNA POLYMERASE- INCLUDES COMPLETE STRUCTURE WITH SIDE-CHAINS (EXCEPT FOR DISORDERED REGIONS)-FURTHER REFINED FROM ORIGINAL DEPOSITION-CONTAINS ADDITIONAL SEQUENCE INFORMATION | TRANSFERASE, TRANSCRIPTION, DNA-DIRECTED RNA POLYMERASE, 3D- STRUCTURE
4ll4:A (ILE215) to (GLY252) THE STRUCTURE OF THE TRX AND TXNIP COMPLEX | ARRESTIN-LIKE DOMAIN, ANTITUMOR PROTEIN-PROTEIN BINDING COMPLEX
4ll4:C (ILE215) to (TRP250) THE STRUCTURE OF THE TRX AND TXNIP COMPLEX | ARRESTIN-LIKE DOMAIN, ANTITUMOR PROTEIN-PROTEIN BINDING COMPLEX
4zzp:A (GLY82) to (GLY104) DICTYOSTELIUM PURPUREUM CELLOBIOHYDROLASE CEL7A APO STRUCTURE | HYDROLASE, GLYCOSIDE HYDROLASE, CELLOBIOHYDROLASE, CELLULASE
2wgq:B (ASN540) to (ILE606) ZINC SUBSTITUTED E COLI COPPER AMINE OXIDASE, A MODEL FOR THE PRECURSOR FOR 2,4,5-TRIHYDROXYPHENYLALANINEQUINONE FORMATION | TPQ, ZINC, COPPER, CALCIUM, PERIPLASM, AMINE OXIDASE, METAL-BINDING, OXIDOREDUCTASE
1hv7:A (THR67) to (ARG113) PORCINE PANCREATIC ELASTASE COMPLEXED WITH GW311616A | SERINE PROTEASE-INHIBITOR COMPLEX, HYDROLASE
1hwm:B (MET64) to (ASN100) EBULIN,ORTHORHOMBIC CRYSTAL FORM MODEL | RIBOSOME-INACTIVATING PROTEIN, RICIN-LIKE, HYDROLASE
1hxu:A (THR238) to (ILE273) OMPF PORIN MUTANT KK | PORIN, BETA BARREL, MEMBRANE PROTEIN
3vu1:A (ARG872) to (VAL920) CRYSTAL STRUCTURE OF THE C-TERMINAL GLOBULAR DOMAIN OF OLIGOSACCHARYLTRANSFERASE (PHAGLB-L, O74088_PYRHO) FROM PYROCOCCUS HORIKOSHII | GLYCOTRANSFERASE, ASN-GLYCOSYLATION, MEMBRANE, TRANSFERASE
2wlj:A (HIS236) to (PHE271) POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM | METAL TRANSPORT
2wlk:A (HIS236) to (PHE271) STRUCTURE OF THE ATP-SENSITIVE INWARD RECTIFIER POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM | INTEGRAL MEMBRANE PROTEIN, IONIC CHANNEL, METAL TRANSPORT, ION TRANSPORT, TRANSPORT
2wlk:B (HIS236) to (PHE271) STRUCTURE OF THE ATP-SENSITIVE INWARD RECTIFIER POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM | INTEGRAL MEMBRANE PROTEIN, IONIC CHANNEL, METAL TRANSPORT, ION TRANSPORT, TRANSPORT
2wlo:B (HIS236) to (PHE271) POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM | METAL TRANSPORT, MEMBRANE PROTEIN
1u0l:B (ASN315) to (GLU355) CRYSTAL STRUCTURE OF YJEQ FROM THERMOTOGA MARITIMA | GTPASE, PERMUTATION, OB-FOLD, ZINC-FINGER, STRUCTURAL GENOMICS, BSGC STRUCTURE FUNDED BY NIH, PROTEIN STRUCTURE INITIATIVE, PSI, BERKELEY STRUCTURAL GENOMICS CENTER, HYDROLASE
1u0l:C (MET616) to (ASP654) CRYSTAL STRUCTURE OF YJEQ FROM THERMOTOGA MARITIMA | GTPASE, PERMUTATION, OB-FOLD, ZINC-FINGER, STRUCTURAL GENOMICS, BSGC STRUCTURE FUNDED BY NIH, PROTEIN STRUCTURE INITIATIVE, PSI, BERKELEY STRUCTURAL GENOMICS CENTER, HYDROLASE
2wo0:B (ASN540) to (ILE606) EDTA TREATED E. COLI COPPER AMINE OXIDASE | OXIDOREDUCTASE, AMINE OXIDATION, COPPER AMINE OXIDASE, TPQ, METAL-BINDING
2woh:B (ASN540) to (ILE606) STRONTIUM SOAKED E. COLI COPPER AMINE OXIDASE | TPQ, METAL-BINDING, OXIDOREDUCTASE, AMINE OXIDATION
2wq9:A (GLY59) to (GLY92) CRYSTAL STRUCTURE OF RBP4 BOUND TO OLEIC ACID | DISEASE MUTATION, SENSORY TRANSDUCTION, SIGNALING PROTEIN, RETINOL-BINDING, VISION, VITAMIN A
1i78:A (TRP203) to (TYR248) CRYSTAL STRUCTURE OF OUTER MEMBRANE PROTEASE OMPT FROM ESCHERICHIA COLI | INTEGRAL OUTER MEMBRANE PROTEIN, PROTEASE, BETA BARREL, HYDROLASE
1i78:B (GLU205) to (VAL256) CRYSTAL STRUCTURE OF OUTER MEMBRANE PROTEASE OMPT FROM ESCHERICHIA COLI | INTEGRAL OUTER MEMBRANE PROTEIN, PROTEASE, BETA BARREL, HYDROLASE
2wr6:A (GLY59) to (GLY92) STRUCTURE OF THE COMPLEX OF RBP4 WITH LINOLEIC ACID | SIGNALING PROTEIN, SENSORY TRANSDUCTION, FATTY ACID, VISION
1ibq:B (ASP87) to (SER108) ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS | ASPERGILLOPEPSIN, ASPARTIC PROTEINASE, HYDROLASE
1iby:C (PRO16) to (VAL42) RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA | RED COPPER, CUPREDOXIN, BETA HAIRPIN, NITROSOCYANIN, NITROSOMONAS EUROPAEA, METAL BINDING PROTEIN
1ic0:B (PRO16) to (VAL42) RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA | RED COPPER, CUPREDOXIN, BETA HAIRPIN, NITROSOCYANIN, NITROSOMONAS EUROPAEA, CU-MAD, METAL BINDING PROTEIN
4m4d:A (SER108) to (ALA156) CRYSTAL STRUCTURE OF LIPOPOLYSACCHARIDE BINDING PROTEIN | BETA BARREL, IMMUNE RESPONSE, LIPOPOLYSACCHARIDE, BLOOD, LIPID BINDING PROTEIN
2ibg:A (GLU479) to (ASN515) CRYSTAL STRUCTURE OF HEDGEHOG BOUND TO THE FNIII DOMAINS OF IHOG | IHOG, HEDGEHOG, FIBRONECTIN TYPE III, PROTEIN BINDING
4m9a:A (GLY164) to (ASN216) CRYSTAL STRUCTURE OF ACYL-COA DEHYDROGENASE FROM BURKHOLDERIA THAILANDENSIS E264 | SSGCID, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, ACYL-COA DEHYDROGENASE, FAD, FADH2, OXIDOREDUCTASE
4m9a:D (GLY164) to (ASN216) CRYSTAL STRUCTURE OF ACYL-COA DEHYDROGENASE FROM BURKHOLDERIA THAILANDENSIS E264 | SSGCID, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, ACYL-COA DEHYDROGENASE, FAD, FADH2, OXIDOREDUCTASE
3j2q:B (MET2079) to (THR2114) MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS | BLOOD COAGULATION, COFACTOR, FACTOR VIII, HEMOPHILIA, BLOOD CLOTTING
1iw7:D (GLY697) to (HIS729) CRYSTAL STRUCTURE OF THE RNA POLYMERASE HOLOENZYME FROM THERMUS THERMOPHILUS AT 2.6A RESOLUTION | RNA POLYMERASE HOLOENZYME, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, TRANSFERASE
1uvo:A (THR52) to (ARG98) STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL A) | HYDROLASE, CHYMOTRYPSIN-FOLD, BETA-BARREL, CADMIUM BINDING, DATA COLLECTION WAVELENGTH 1A
2iml:A (ILE15) to (LYS46) CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM ARCHAEOGLOBUS FULGIDUS BINDING RIBOFLAVIN 5'-PHOSPHATE | FMN BINDING, PSI-2, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, FLAVOPROTEIN
2iml:B (ILE15) to (LYS46) CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM ARCHAEOGLOBUS FULGIDUS BINDING RIBOFLAVIN 5'-PHOSPHATE | FMN BINDING, PSI-2, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, FLAVOPROTEIN
2iml:C (ILE15) to (LYS46) CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM ARCHAEOGLOBUS FULGIDUS BINDING RIBOFLAVIN 5'-PHOSPHATE | FMN BINDING, PSI-2, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, FLAVOPROTEIN
2iml:D (ILE15) to (LYS46) CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM ARCHAEOGLOBUS FULGIDUS BINDING RIBOFLAVIN 5'-PHOSPHATE | FMN BINDING, PSI-2, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, FLAVOPROTEIN
1izn:C (PHE62) to (PRO110) CRYSTAL STRUCTURE OF ACTIN FILAMENT CAPPING PROTEIN CAPZ | HETERODIMER, CAPPING PROTEIN, ACTIN FILAMENT BARBED END CAPPING, PROTEIN BINDING
2x32:B (GLY91) to (ASN129) STRUCTURE OF A POLYISOPRENOID BINDING DOMAIN FROM SACCHAROPHAGUS DEGRADANS IMPLICATED IN PLANT CELL WALL BREAKDOWN | CARBOHYDRATE-BINDING PROTEIN, OXIDOREDUCTION, MARINE BACTERIA, POLYISOPRENOID TRANSPORT
2iou:A (ASP108) to (ALA151) MAJOR TROPISM DETERMINANT P1 (MTD-P1) VARIANT COMPLEXED WITH BORDETELLA BROCHISEPTICA VIRULENCE FACTOR PERTACTIN EXTRACELLULAR DOMAIN (PRN-E). | MTD; PRN; PERTACTIN, VIRAL PROTEIN-MEMBRANE PROTEIN COMPLEX
2iou:G (GLY481) to (GLY505) MAJOR TROPISM DETERMINANT P1 (MTD-P1) VARIANT COMPLEXED WITH BORDETELLA BROCHISEPTICA VIRULENCE FACTOR PERTACTIN EXTRACELLULAR DOMAIN (PRN-E). | MTD; PRN; PERTACTIN, VIRAL PROTEIN-MEMBRANE PROTEIN COMPLEX
1j16:A (SER61) to (LYS107) BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT | SERINE PROTEASE, HYDROLASE, SERINE PROTEINASE
2x4m:B (TRP199) to (PHE242) YERSINIA PESTIS PLASMINOGEN ACTIVATOR PLA | OMPTIN, TRANSMEMBRANE, ASPARTYL PROTEASE, CELL OUTER MEMBRANE, PROTEASE, HYDROLASE
5aii:C (THR81) to (TYR113) DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | HYDROLASE
5aii:F (THR81) to (TYR113) DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | HYDROLASE
5aii:H (THR81) to (TYR113) DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | HYDROLASE
5aii:I (THR81) to (TYR113) DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | HYDROLASE
5aii:M (THR81) to (TYR113) DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | HYDROLASE
5aii:N (THR81) to (TYR113) DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | HYDROLASE
1j2g:A (ILE120) to (ILE164) CRYSTAL STRUCTURE OF URATE OXIDASE FROM BACILLUS SP. TB-90 CO- CRYSTALLIZED WITH 8-AZAXANTHINE | T-FOLD BARREL, PURINE, OXIDOREDUCTASE
1j2g:C (ILE120) to (ILE164) CRYSTAL STRUCTURE OF URATE OXIDASE FROM BACILLUS SP. TB-90 CO- CRYSTALLIZED WITH 8-AZAXANTHINE | T-FOLD BARREL, PURINE, OXIDOREDUCTASE
2x53:V (VAL2) to (GLN58) STRUCTURE OF THE PHAGE P2 BASEPLATE IN ITS ACTIVATED CONFORMATION WITH SR | BASEPLATE, VIRAL PROTEIN
1j7z:B (ILE81) to (ALA122) OSMOLYTE STABILIZATION OF RIBONUCLEASE | OSMOLYTE SOAKING, SARCOSINE, TRIMETHYLAMINE-N-OXIDE, BETAINE, TAURINE, HYDROLASE
3wlv:B (ILE120) to (ILE164) THERMOSTABLE URATE OXIDASE FROM BACILLUS SP. TB-90 | TUNNEL FOLD MOTIF, OXIDASE, OXIDOREDUCTASE
3wlv:C (ILE120) to (ILE164) THERMOSTABLE URATE OXIDASE FROM BACILLUS SP. TB-90 | TUNNEL FOLD MOTIF, OXIDASE, OXIDOREDUCTASE
2x8s:B (GLY382) to (GLY413) CRYSTAL STRUCTURE OF THE ABN2 D171A MUTANT IN COMPLEX WITH ARABINOTRIOSE | HYDROLASE
3wno:B (PHE625) to (ASN659) D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH CYCLOISOMALTOOCTAOSE | C2 TYPE IMMUNOGLOBULIN FOLD, (BETA/ALPHA)8-BARREL, BETA-JELLY ROLL, GREEK KEY, GLYCOSIDE HYDROLASE, ALPHA-1,6-GLUCAN, TRANSFERASE
3wnp:B (SER623) to (ILE658) D308A, F268V, D469Y, A513V, AND Y515S QUINTUPLE MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOUNDECAOSE | C2 TYPE IMMUNOGLOBULIN FOLD, (BETA/ALPHA)8-BARREL, BETA-JELLY ROLL, GREEK KEY, GLYCOSIDE HYDROLASE, ALPHA-1,6-GLUCAN, TRANSFERASE
1jd2:T (VAL-3) to (GLY30) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1vax:B (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS | OXIDOREDUCTASE
1vax:D (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS | OXIDOREDUCTASE
1vax:E (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS | OXIDOREDUCTASE
1vay:B (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS WITH INHIBITOR 8-AZAXANTHINE | OXIDOREDUCTASE
1vay:E (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS WITH INHIBITOR 8-AZAXANTHINE | OXIDOREDUCTASE
4mmz:A (LYS42) to (PRO69) INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN | INTEGRIN, A DOMAIN, HYBRID DOMAIN, PSI, EGF REPEATS, BETA TAIL, CALF, THIGH, BETA PROPELLER, RGD MOTIF, FIBRONECTIN, VITRONECTIN, CELL ADHESION
2ixl:A (LEU10) to (GLU38) RMLC S. SUIS WITH DTDP-RHAMNOSE | EPIMERISE, EPIMERASE, ISOMERASE, EPIMERIZE
2j0h:A (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO ACETYL-CHOLINE | GLYCOPROTEIN, FICRINOGEN-LIKE, INNATE IMMUNITY, PATTERN RECOGNITION PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, LECTIN- LIKE
2j0y:A (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO B-1,3-D-GLUCAN | GLYCOPROTEIN, FICRINOGEN-LIKE, INNATE IMMUNITY, PATTERN RECOGNITION PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, LECTIN- LIKE
2j2p:A (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYL-CYSTEIN (150MM) | GLYCOPROTEIN, FICRINOGEN-LIKE, INNATE IMMUNITY, PATTERN RECOGNITION PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, LECTIN- LIKE
2j2p:F (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYL-CYSTEIN (150MM) | GLYCOPROTEIN, FICRINOGEN-LIKE, INNATE IMMUNITY, PATTERN RECOGNITION PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, LECTIN- LIKE
2j3f:A (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYL-D-GALACTOSAMINE | SUGAR BINDING PROTEIN, COLLAGEN, IMMUNOLOGY, GLYCOPROTEIN
2j3f:D (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYL-D-GALACTOSAMINE | SUGAR BINDING PROTEIN, COLLAGEN, IMMUNOLOGY, GLYCOPROTEIN
2j3o:A (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYL-D-GLUCOSAMINE | SUGAR BINDING PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, GLYCOPROTEIN
2j3o:B (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYL-D-GLUCOSAMINE | SUGAR BINDING PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, GLYCOPROTEIN
2j3u:A (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO GALACTOSE | LECTIN, COLLAGEN, IMMUNOLOGY, GLYCOPROTEIN, SUGAR BINDING PROTEIN
2j3u:D (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO GALACTOSE | LECTIN, COLLAGEN, IMMUNOLOGY, GLYCOPROTEIN, SUGAR BINDING PROTEIN
1jmz:B (ASN111) to (PRO140) CRYSTAL STRUCTURE OF A QUINOHEMOPROTEIN AMINE DEHYDROGENASE FROM PSEUDOMONAS PUTIDA WITH INHIBITOR | AMINE DEHYDROGENASE, OXIDOREDUCTASE
3wsj:B (VAL74) to (ILE101) HTLV-1 PROTEASE IN COMPLEX WITH THE HIV-1 PROTEASE INHIBITOR INDINAVIR | RETROVIRAL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2j61:B (HIS94) to (PHE120) L-FICOLIN COMPLEXED TO N-ACETYLGLUCOSAMINE (FORME C) | GLYCOPROTEIN, FICRINOGEN-LIKE, INNATE IMMUNITY, PATTERN RECOGNITION PROTEIN, LECTIN, COLLAGEN, IMMUNOLOGY, LECTIN- LIKE
4mv1:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH ADP AND PHOSPHATE | ATP-GRASP, LIGASE
4mv3:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH AMPPCP AND BICARBONATE | ATP-GRASP, LIGASE
4mv4:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH AMPPCP AND MG2 | ATP-GRASP, LIGASE
4mv7:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FORM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH PHOSPHONOFORMATE | ATP-GRASP, LIGASE
4mv9:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH BICARBONATE | ATP-GRASP, LIGASE
5ayc:A (ARG86) to (ARG111) CRYSTAL STRUCTURE OF RUMINOCOCCUS ALBUS 4-O-BETA-D-MANNOSYL-D-GLUCOSE PHOSPHORYLASE (RAMP1) IN COMPLEXES WITH SULFATE AND 4-O-BETA-D- MANNOSYL-D-GLUCOSE | GLYCOSIDE HYDROLASE FAMILY 130, TRANSFERASE
3j8b:F (ALA113) to (ASP149) MODEL OF THE HUMAN EIF3 PCI-MPN OCTAMER DOCKED INTO THE 43S-HCV IRES EM MAP | TRANSLATION
3j8c:F (ALA113) to (ASP149) MODEL OF THE HUMAN EIF3 PCI-MPN OCTAMER DOCKED INTO THE 43S EM MAP | TRANSLATION
4mz9:A (GLN82) to (MET111) REVISED STRUCTURE OF E. COLI SSB | SINGLE STRAND DNA-BINDING DOMAIN, SSB, RECO, EXOI, RECQ, DNAG, HOLC, DNA BINDING PROTEIN
3wz7:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (6) | ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1w14:U (TRP29) to (SER54) UROKINASE TYPE PLASMINOGEN ACTIVATOR | UROKINASE, HYDROLASE, PLASMINOGEN ACTIVATOR
1jyd:A (GLY59) to (GLY92) CRYSTAL STRUCTURE OF RECOMBINANT HUMAN SERUM RETINOL-BINDING PROTEIN AT 1.7 A RESOLUTION | RETINOL BINDING PROTEIN, LIPOCALIN SUPERFAMILY, BETA BARREL, TRANSPORT PROTEIN
1jyj:A (GLY59) to (GLY92) CRYSTAL STRUCTURE OF A DOUBLE VARIANT (W67L/W91H) OF RECOMBINANT HUMAN SERUM RETINOL-BINDING PROTEIN AT 2.0 A RESOLUTION | RETINOL BINDING PROTEIN, LIPOCALIN FAMILY, BETA BARREL, TRANSPORT PROTEIN
2je8:A (GLN704) to (CYS737) STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON | BETA-MANNOSIDASE, GLYCOSIDE HYDROLASE, HYDROLASE
2je8:B (GLN704) to (CYS737) STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON | BETA-MANNOSIDASE, GLYCOSIDE HYDROLASE, HYDROLASE
2xsg:B (ALA500) to (ASP525) STRUCTURE OF THE GH92 FAMILY GLYCOSYL HYDROLASE CCMAN5 | HYDROLASE, MANNOSIDASE
2jec:A (SER110) to (ASP151) CRYSTAL STRUCTURE OF RECOMBINANT DIOCLEA GRANDIFLORA LECTIN MUTANT E123A-H131N-K132Q COMPLEXED WITH 5-BROMO-4-CHLORO-3- INDOLYL-A-D-MANNOSE | CONA-LIKE, METAL-BINDING, LEGUME LECTIN, CARBOHYDRATE BINDING PROTEIN, SUGAR-BINDING PROTEIN
1w7x:H (LEU64) to (ARG107) FACTOR7- 413 COMPLEX | HYDROLASE, SERINE PROTEASE, COAGULATION, ENZYME COMPLEX
1w8b:H (LEU64) to (ARG107) FACTOR7 - 413 COMPLEX | SERINE PROTEASE, COAGULATION, ENZYME COMPLEX, HYDROLASE
3zgd:A (GLY378) to (ALA407) CRYSTAL STRUCTURE OF A KEAP1 MUTANT | TRANSCRIPTION, CRYSTAL CONTACT ENGINEERING
5brc:F (GLU132) to (LEU172) OXYGENASE COMPONENT OF 3-NITROTOLUENE DIOXYGENASE FROM DIAPHOROBACTER SP. STRAIN DS2 | RIESKE NON-HEME OXYGENASE, IRON-SULFUR CLUSTERS, OXIDOREDUCTASE, NITROAROMATIC COMPOUNDS DEGRADER, METAL BINDING PROTEIN
5brc:I (GLU132) to (LEU172) OXYGENASE COMPONENT OF 3-NITROTOLUENE DIOXYGENASE FROM DIAPHOROBACTER SP. STRAIN DS2 | RIESKE NON-HEME OXYGENASE, IRON-SULFUR CLUSTERS, OXIDOREDUCTASE, NITROAROMATIC COMPOUNDS DEGRADER, METAL BINDING PROTEIN
4na9:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 3'-AMINO-5'-[(2S,4R)-6- CARBAMIMIDOYL-4-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-2-YL]BIPHENYL-2- CARBOXYLIC ACID | SERINE PROTEASE, HYDROLASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, GLYCOPROTEIN, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5brr:E (HIS63) to (GLN107) MICHAELIS COMPLEX OF TPA-S195A:PAI-1 | TISSUE-TYPE PLASMINOGEN ACTIVATOR CATALYTIC DOMAIN, PLASMINOGEN ACTIVATOR INHIBITOR 1, STRUCTURE-ACTIVITY RELATIONSHIP, THROMBOLYSIS, HYDROLASE INHIBITOR-HYDROLASE COMPLEX
2jwy:A (GLY77) to (ASN115) SOLUTION NMR STRUCTURE OF UNCHARACTERIZED LIPOPROTEIN YAJI FROM ESCHERICHIA COLI. NORTHEAST STRUCTURAL GENOMICS TARGET ER540 | LIPOPROTEIN, YAJI, STRUCTURAL GENOMICS, GFT NMR, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, MEMBRANE, PALMITATE, PSI-2, PROTEIN STRUCTURE INITIATIVE
4ng9:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN- 6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(3- SULFAMOYLBENZYL)ETHANAMIDE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4nga:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN- 6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-[2-(PROPAN-2- YLSULFONYL)BENZYL]ETHANAMIDE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1kaw:A (LEU83) to (MET111) STRUCTURE OF SINGLE STRANDED DNA BINDING PROTEIN (SSB) | DNA-BINDING PROTEIN, SINGLE STRANDED DNA BINDING PROTEIN, SSB
1kaw:B (LEU83) to (MET111) STRUCTURE OF SINGLE STRANDED DNA BINDING PROTEIN (SSB) | DNA-BINDING PROTEIN, SINGLE STRANDED DNA BINDING PROTEIN, SSB
1kaw:C (LEU83) to (MET111) STRUCTURE OF SINGLE STRANDED DNA BINDING PROTEIN (SSB) | DNA-BINDING PROTEIN, SINGLE STRANDED DNA BINDING PROTEIN, SSB
1kaw:D (LEU83) to (MET111) STRUCTURE OF SINGLE STRANDED DNA BINDING PROTEIN (SSB) | DNA-BINDING PROTEIN, SINGLE STRANDED DNA BINDING PROTEIN, SSB
1wlk:D (VAL64) to (ILE113) L122E MUTANT OF FMN-BINDING PROTEIN FROM DESULFOVIBRIO VULGARIS (MIYAZAKI F) | ELECTRON TRANSPORT, FLAVOPROTEIN, FMN
5bzz:A (ILE253) to (THR321) CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE | PHOSPHATASE, C2 DOMAIN, HYDROLASE
2kx6:A (PHE92) to (VAL122) SIGNALING STATE OF PHOTOACTIVE YELLOW PROTEIN | SAXS, DEER, PYP INTERMEDIATE, SIGNALING STATE, PB, SIGNALING PROTEIN
1kex:A (THR65) to (THR99) CRYSTAL STRUCTURE OF THE B1 DOMAIN OF HUMAN NEUROPILIN-1 | BETA BARREL, JELLY-ROLL, PROTEIN BINDING
1wqj:B (GLU24) to (CYS59) STRUCTURAL BASIS FOR THE REGULATION OF INSULIN-LIKE GROWTH FACTORS (IGFS) BY IGF BINDING PROTEINS (IGFBPS) | PROTEIN-PROTEIN COMPLEX, DISULFIDE RICH, DISULFIDE BOND LADDER, PROTEIN BINDING/HORMONE/GROWTH FACTOR COMPLEX
1wqv:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D- THR-MET-P-AMINOBENZAMIDINE | SERINE PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1kfi:A (ILE485) to (LEU516) CRYSTAL STRUCTURE OF THE EXOCYTOSIS-SENSITIVE PHOSPHOPROTEIN, PP63/PARAFUSIN (PHOSPHOGLUCOMUTASE) FROM PARAMECIUM | PARAFUSIN, PHOSPHOPROTEIN PP63, EXOCYTOSIS, ISOMERASE
1wss:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPTIDE-MIMETIC INHIBITOR THAT HAS TWO CHARGED GROUPS IN P2 AND P4 | SERINE PROTEASE, HYDROLASE-BLOOD CLOTTING COMPLEX
1wtg:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE | SERINE PROTEASE, HYDROLASE/BLOOD CLOTTING COMPLEX
1wun:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE | SERINE PROTEASE, HYDROLASE/BLOOD CLOTTING COMPLEX
1wv7:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE | SERINE PROTEASE, HYDROLASE/BLOOD CLOTTING COMPLEX
2lq7:A (ALA380) to (SER442) E2 BINDING SURFACE ON UBA3 BETA-GRASP DOMAIN UNDERGOES A CONFORMATIONAL TRANSITION | E1 ENZYME, BETA GRASP DOMAIN, LIGASE
1kkl:A (HIS201) to (SER229) L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS HPR | PHOSPHORYLATION, PROTEIN KINASE, BACTERIA, PROTEIN/PROTEIN INTERACTION, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX, TRANSFERASE,HYDROLASE/TRANSPORT PROTEIN COMPLEX
1kkl:B (HIS201) to (SER229) L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS HPR | PHOSPHORYLATION, PROTEIN KINASE, BACTERIA, PROTEIN/PROTEIN INTERACTION, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX, TRANSFERASE,HYDROLASE/TRANSPORT PROTEIN COMPLEX
1kkl:C (HIS201) to (SER229) L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS HPR | PHOSPHORYLATION, PROTEIN KINASE, BACTERIA, PROTEIN/PROTEIN INTERACTION, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX, TRANSFERASE,HYDROLASE/TRANSPORT PROTEIN COMPLEX
1kkm:B (HIS201) to (SER229) L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS P-SER-HPR | PHOSPHORYLATION, PROTEIN KINASE, BACTERIA, PROTEIN/PROTEIN INTERACTION, PHOSPHOSERINE, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX
1kkm:C (HIS201) to (SER229) L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS P-SER-HPR | PHOSPHORYLATION, PROTEIN KINASE, BACTERIA, PROTEIN/PROTEIN INTERACTION, PHOSPHOSERINE, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX, TRANSFERASE, HYDROLASE/TRANSPORT PROTEIN COMPLEX
3zsc:A (ASN211) to (GLU242) CATALYTIC FUNCTION AND SUBSTRATE RECOGNITION OF THE PECTATE LYASE FROM THERMOTOGA MARITIMA | LYASE, HYDROLASE
1kli:H (LEU64) to (ARG107) COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA | EXTRINSIC COAGULATION PATHWAY, SERINE PROTEASE ACTIVATION, RATIONAL DRUG DESIGN, SUBSTRATE-ASSISTED CATALYSIS, HYDROLASE
5c5b:B (GLY282) to (PRO313) CRYSTAL STRUCTURE OF HUMAN APPL BAR-PH HETERODIMER | HETERODIMER, PROTEIN TRANSPORT
5c5b:D (GLY282) to (PRO313) CRYSTAL STRUCTURE OF HUMAN APPL BAR-PH HETERODIMER | HETERODIMER, PROTEIN TRANSPORT
2mwh:A (ASN69) to (GLY108) NMR SOLUTION STRUCTURE OF LIGAND-FREE OAA | PROTEIN BINDING, SUGAR BINDING PROTEIN-ANTIVIRAL PROTEIN COMPLEX
2yhf:I (GLY130) to (SER174) 1.9 ANGSTROM CRYSTAL STRUCTURE OF CLEC5A | IMMUNE SYSTEM
4ny0:D (LYS259) to (ASP285) CRYSTAL STRUCTURE OF FERM DOMAIN OF HUMAN FOCAL ADHESION KINASE | FERM DOMAIN, FOCAL ADHESION KINASE, FOCAL TARGETING DOMAIN, INTEGRIN SIGNALING, TRANSFERASE
3zyi:B (PRO65) to (TRP127) NETRING2 IN COMPLEX WITH NGL2 | CELL ADHESION, LRRC4 COMPLEX, SYNAPSE
1l5g:A (LYS42) to (PRO69) CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND | GENU, HYBRID DOMAIN, BETA-TAIL DOMAIN, PSI DOMAIN, EGF DOMAIN, MIDAS, ADMIDAS, LIMBS, CAGE MOTIF, PROPELLER, A-DOMAIN, THIGH DOMAIN, CALF DOMAIN, RGD LIGAND, CELL ADHESION
2ymw:A (GLY200) to (GLY247) STRUCTURE OF THE EPSILON-LYSINE OXIDASE FROM MARINOMONAS MEDITERRANEA | OXIDOREDUCTASE
2nuk:A (GLY146) to (GLY187) SOLUBLE DOMAIN OF THE RIESKE IRON-SULFUR PROTEIN FROM RHODOBACTER SPHAEROIDES | IRON SULFUR CLUSTER, OXIDOREDUCTASE
1xhn:B (GLY33) to (TYR70) THE CRYSTAL STRUCTURE OF CELLULAR REPRESSOR OF E1A- STIMULATED GENES (CREG) | BETA-BARREL, UNKNOWN FUNCTION
1xhn:D (GLY33) to (PRO73) THE CRYSTAL STRUCTURE OF CELLULAR REPRESSOR OF E1A- STIMULATED GENES (CREG) | BETA-BARREL, UNKNOWN FUNCTION
1xhx:A (LYS490) to (GLU515) PHI29 DNA POLYMERASE, ORTHORHOMBIC CRYSTAL FORM | DNA POLYMERASE, PROTEIN-PRIMED, STRAND DISPLACEMENT, PROCESSIVITY, REPLICATION, TRANSFERASE
1xhx:B (LYS490) to (GLU515) PHI29 DNA POLYMERASE, ORTHORHOMBIC CRYSTAL FORM | DNA POLYMERASE, PROTEIN-PRIMED, STRAND DISPLACEMENT, PROCESSIVITY, REPLICATION, TRANSFERASE
4o8t:B (ILE95) to (GLY145) STRUCTURE OF SORTASE A C207A MUTANT FROM STREPTOCOCCUS PNEUMONIAE | 8-STRANDED BETA BARREL, SORTASE-FOLD, CYSTEINE TRANSPEPTIDASE, HYDROLASE
3jwn:N (PHE1) to (VAL36) COMPLEX OF FIMC, FIMF, FIMG AND FIMH | FIMBRIA, CELL ADHESION, FIMH, FIMC, FIMF,FIMG, CHAPERONE, FIBRIUM, IMMUNOGLOBULIN DOMAIN, FIMBRIUM, PERIPLASM, DISULFIDE BOND, PROTEIN BINDING-CELL ADHESION COMPLEX
2nwf:A (GLY146) to (GLY187) SOLUBLE DOMAIN OF RIESKE IRON SULFUR PROTEIN | RIESKE [2FE-2S] ISP, OXIDOREDUCTASE
4odb:A (LEU341) to (SER370) CRYSTAL STRUCTURE OF THE T1L REOVIRUS ATTACHMENT PROTEIN SIGMA1 IN COMPLEX WITH JUNCTIONAL ADHESION MOLECULE-A | IMMUNOGLOBULIN FOLD, GREEK KEY MOTIF, BETA SPIRAL, VIRAL ATTACHMENT PROTEIN, CAPSID PROTEIN, VIRAL RECEPTOR, CELL ADHESION MOLECULE, VIRAL PROTEIN
4odb:B (LEU341) to (SER370) CRYSTAL STRUCTURE OF THE T1L REOVIRUS ATTACHMENT PROTEIN SIGMA1 IN COMPLEX WITH JUNCTIONAL ADHESION MOLECULE-A | IMMUNOGLOBULIN FOLD, GREEK KEY MOTIF, BETA SPIRAL, VIRAL ATTACHMENT PROTEIN, CAPSID PROTEIN, VIRAL RECEPTOR, CELL ADHESION MOLECULE, VIRAL PROTEIN
4odb:C (LEU341) to (SER370) CRYSTAL STRUCTURE OF THE T1L REOVIRUS ATTACHMENT PROTEIN SIGMA1 IN COMPLEX WITH JUNCTIONAL ADHESION MOLECULE-A | IMMUNOGLOBULIN FOLD, GREEK KEY MOTIF, BETA SPIRAL, VIRAL ATTACHMENT PROTEIN, CAPSID PROTEIN, VIRAL RECEPTOR, CELL ADHESION MOLECULE, VIRAL PROTEIN
2yzc:B (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH ALLANTOATE | URICASE, OXIDOREDUCTASE, ALLANTOATE
2yzd:C (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH 8-AZAXANTHIN (INHIBITOR) | URICASE, OXIDOREDUCTASE, 8-AZAXANTHIN
2yzd:G (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH 8-AZAXANTHIN (INHIBITOR) | URICASE, OXIDOREDUCTASE, 8-AZAXANTHIN
2yzd:H (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH 8-AZAXANTHIN (INHIBITOR) | URICASE, OXIDOREDUCTASE, 8-AZAXANTHIN
2yze:B (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS | URICASE, OXIDOREDUCTASE
2yze:D (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS | URICASE, OXIDOREDUCTASE
2yzg:C (ARG196) to (ILE238) CRYSTAL STRUCTURE OF D-ALA:D-ALA LIGASE FROM THERMUS THERMOPHILUS HB8 | D-ALANINE:D-ALANINE LIGASE, CELL SHAPE, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE
2yzm:C (ARG196) to (ILE238) STRUCTURE OF D-ALANINE:D-ALANINE LIGASE WITH SUBSTRATE FROM THERMUS THERMOPHILUS HB8 | D-ALANINE:D-ALANINE LIGASE, CELL SHAPE, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE
2yzn:B (ARG196) to (PRO239) CRYSTAL STRUCTURE OF D-ALANINE:D-ALANINE LIGASE WITH AMPPNP FROM THERMUS THERMOPHILUS HB8. | D-ALANINE:D-ALANINE LIGASE, CELL SHAPE, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE
2yzn:C (ARG196) to (ILE238) CRYSTAL STRUCTURE OF D-ALANINE:D-ALANINE LIGASE WITH AMPPNP FROM THERMUS THERMOPHILUS HB8. | D-ALANINE:D-ALANINE LIGASE, CELL SHAPE, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE
3k5f:B (MET18) to (GLY41) HUMAN BACE-1 COMPLEX WITH AYH011 | ASPARTYL PROTEASE, ALZHEIMER'S DISEASE, STRUCTURE-BASED DESIGN, DISULFIDE BOND, ENDOPLASMIC RETICULUM, ENDOSOME, GLYCOPROTEIN, GOLGI APPARATUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, MEMBRANE, PROTEASE, TRANSMEMBRANE
3k5f:C (MET18) to (GLY41) HUMAN BACE-1 COMPLEX WITH AYH011 | ASPARTYL PROTEASE, ALZHEIMER'S DISEASE, STRUCTURE-BASED DESIGN, DISULFIDE BOND, ENDOPLASMIC RETICULUM, ENDOSOME, GLYCOPROTEIN, GOLGI APPARATUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, MEMBRANE, PROTEASE, TRANSMEMBRANE
4oin:C (PRO93) to (ASN130) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX SOAKED WITH GE23077 | GE23077, TRANSCRIPTION INHIBITOR, TRANSCRIPTION OPEN COMPLEX, TRANSCRIPTION INITIATION COMPLEX, I SITE, I+1 SITE, RNA POLYMERASE, DNA/RNA/NTP BINDING, POLYMERIZATION OF RIBONUCLEOTIDES, NUCLEOID, TRANSCRIPTION, TRANSFERASE-ANTIBIOTIC COMPLEX
3k5h:A (MET188) to (PRO222) CRYSTAL STRUCTURE OF CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE SYNTHASE FROM ASPERIGILLUS CLAVATUS COMPLEXED WITH ATP | PURINE BIOSYNTHESIS, ATP-GRASP, LYASE
2z76:A (VAL94) to (TYR127) X-RAY CRYSTAL STRUCTURE OF RV0760C FROM MYCOBACTERIUM TUBERCULOSIS AT 1.82 ANGSTROM RESOLUTION | ALPHA+BETA CONICAL BARREL, STRUCTURAL GENOMICS, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, ISOMERASE
3k5o:B (LEU253) to (ASP276) CRYSTAL STRUCTURE OF E.COLI POL II | APO, DNA DAMAGE, DNA REPAIR, DNA-BINDING, DNA-DIRECTED DNA POLYMERASE, NUCLEOTIDYLTRANSFERASE, SOS RESPONSE, TRANSFERASE
4oio:C (PRO93) to (ASN130) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS PRE-INSERTION SUBSTRATE COMPLEX FOR DE NOVO TRANSCRIPTION INITIATION | DE NOVO TRANSCRIPTION INITIATION, SUBSTRATE COMPLEX, TRANSCRIPTION INITIATION, I SITE, I+1 SITE, RNA POLYMERASE, DNA/RNA/NTP BINDING, POLYMERIZATION OF RIBONUCLEOTIDES, NUCLEOID, TRANSCRIPTION, TRANSFERASE
4oip:C (PRO93) to (ASN130) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX SOAKED WITH GE23077, ATP, AND CMPCPP | GE23077, TRANSCRIPTION INHIBITOR, TRANSCRIPTION OPEN COMPLEX, TRANSCRIPTION INITIATION COMPLEX, I SITE, I+1 SITE, CMPCPP, RNA POLYMERASE, DNA/RNA/NTP BINDING, POLYMERIZATION OF RIBONUCLEOTIDES, NUCLEOID, TRANSCRIPTION, TRANSFERASE-ANTIBIOTIC COMPLEX
4oip:D (GLY697) to (HIS729) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX SOAKED WITH GE23077, ATP, AND CMPCPP | GE23077, TRANSCRIPTION INHIBITOR, TRANSCRIPTION OPEN COMPLEX, TRANSCRIPTION INITIATION COMPLEX, I SITE, I+1 SITE, CMPCPP, RNA POLYMERASE, DNA/RNA/NTP BINDING, POLYMERIZATION OF RIBONUCLEOTIDES, NUCLEOID, TRANSCRIPTION, TRANSFERASE-ANTIBIOTIC COMPLEX
1ltj:F (GLY165) to (THR192) CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY-HIS-ARG-PRO-AMIDE | BLOOD COAGULATION, FIBRINOGEN, FIBRINOGEN FRAGMENT D, RECOMBINANT FIBRINOGEN FRAGMENT D, RECOMBINANT FIBRINOGEN, RECOMBINANT FIBRINOGEN FRAGMENT D WITH TWO PEPTIDE LIGANDS, BLOOD CLOTTING
4oir:C (PRO93) to (ASN130) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE TRANSCRIPTION INITIATION COMPLEX SOAKED WITH GE23077 AND RIFAMYCIN SV | GE23077, TRANSCRIPTION INHIBITOR, TRANSCRIPTION OPEN COMPLEX, TRANSCRIPTION INITIATION COMPLEX, RIFAMYCIN SV, I SITE, I+1 SITE, RNA POLYMERASE, DNA/RNA/NTP BINDING, POLYMERIZATION OF RIBONUCLEOTIDES, NUCLEOID, TRANSCRIPTION, TRANSFERASE-ANTIBIOTIC COMPLEX
1xmn:F (GLN30) to (THR54) CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN | BLOOD CLOTTING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2zbu:B (VAL203) to (VAL242) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMOTOGA MARITIMA | UNCHARACTERIZED CONSERVED PROTEIN, STRUCTURAL GENOMICS, UNKNOWN FUNCTION, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
2zbv:A (VAL203) to (VAL242) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMOTOGA MARITIMA | UNCHARACTERIZED CONSERVED PROTEIN, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
1m1j:F (GLY165) to (THR192) CRYSTAL STRUCTURE OF NATIVE CHICKEN FIBRINOGEN WITH TWO DIFFERENT BOUND LIGANDS | COILED COILS, DISULFIDE RINGS, FIBRINOGEN, BLOOD CLOTTING
3k8x:C (GLY1876) to (GLU1914) CRYSTAL STRUCTURE OF THE CARBOXYLTRANSFERASE DOMAIN OF ACETYL-COENZYME A CARBOXYLASE IN COMPLEX WITH TEPRALOXYDIM | TRANSFERASE, ACETYL-COA CARBOXYLASE, CARBOXYLTRANSFERASE, ACC, CT, TEPRALOXYDIM, ATP-BINDING, BIOTIN, FATTY ACID BIOSYNTHESIS, LIGASE, LIPID SYNTHESIS, MANGANESE, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN
2zdq:B (ARG196) to (PRO239) CRYSTAL STRUCTURE OF D-ALANINE:D-ALANINE LIGASE WITH ATP AND D-ALANINE:D-ALANINE FROM THERMUS THERMOPHIUS HB8 | D-ALANINE-D-ALANINE LIGASE, PEPTIDOGLYCAN BIOSYNTHESIS, CELL SHAPE, CELL WALL BIOGENESIS/DEGRADATION, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
2zf8:A (ASN64) to (GLY98) CRYSTAL STRUCTURE OF MOTY | BETA BARREL, 2-LAYER SANDWICH, FLAGELLUM, STRUCTURAL PROTEIN
1xpt:A (ILE81) to (ALA122) BOVINE RIBONUCLEASE A (PHOSPHATE-FREE) | HYDROLASE (PHOSPHORIC DIESTER)
1m4q:A (ILE59) to (THR92) STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP "LATE DOMAIN" PEPTIDE, CNS ENSEMBLE | TSG101 UEV DOMAIN, VIRUS BUDDING, VACUOLAR PROTEIN SORTING, LATE DOMAIN, PEPTIDE BINDING PROTEIN
2zk9:X (ASN68) to (ASP103) CRYSTAL STRUCTURE OF PROTEIN-GLUTAMINASE | DEAMIDATION GLUTAMINASE, HYDROLASE
1xsq:B (ARG25) to (ILE54) CRYSTAL STRUCTURE OF UREIDOGLYCOLATE HYDROLASE FROM E.COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET81. | NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI, ET81, X-RAY, HYDROLASE
1m6w:A (PHE129) to (ASP160) BINARY COMPLEX OF HUMAN GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE AND 12-HYDROXYDODECANOIC ACID | GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE, CLASS III ALCOHOL DEHYDROGENASE, OXIDOREDUCTASE
2zwl:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH HIGHLY SELECTIVE PEPTIDE INHIBITOR | SERINE PROTEASE, ALTERNATIVE SPLICING, BLOOD COAGULATION, CALCIUM, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, EGF-LIKE DOMAIN, GAMMA-CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, HYDROLASE, HYDROXYLATION, PHARMACEUTICAL, POLYMORPHISM, PROTEASE, ZYMOGEN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, HYDROLASE/BLOOD CLOTTING COMPLEX, SECRETED
4afu:A (ILE51) to (LYS94) HUMAN CHYMASE - FYNOMER COMPLEX | HYDROLASE-DE NOVO PROTEIN COMPLEX, INHIBITOR, SERINE PROTEASE
4afu:B (ARG49) to (LYS94) HUMAN CHYMASE - FYNOMER COMPLEX | HYDROLASE-DE NOVO PROTEIN COMPLEX, INHIBITOR, SERINE PROTEASE
4p1y:B (GLY52) to (LEU91) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE | PORE FORMING TOXIN
4p1y:D (GLY52) to (LEU91) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE | PORE FORMING TOXIN
4p1y:F (GLY52) to (LEU91) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE | PORE FORMING TOXIN
4p1y:H (GLY52) to (LEU91) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE | PORE FORMING TOXIN
1y7e:A (PRO134) to (GLY195) THE CRYSTAL STRUCTURE OF AMINOPEPTIDASE I FROM BORRELIA BURGDORFERI B31 | AMINOPEPTIDASE I, BORRELIA BURGDORFERI B31, YSCI, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, HYDROLASE
2zzj:A (GLN68) to (THR110) CRYSTAL STRUCTURE OF ENDO-BETA-1,4-GLUCURONAN LYASE FROM FUNGUS TRICHODERMA REESEI | BETA-JELLY ROLL, LYASE
2zzu:H (LEU64) to (ARG107) HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5- (3-CARBOXYBENZYLOXY)-TRP-GLN-P-AMINOBENZAMIDINE | SERINE PROTEASE, BLOOD COAGULATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, EGF-LIKE DOMAIN, GAMMA-CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, HYDROLASE, HYDROXYLATION, PROTEASE, ZYMOGEN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, HYDROLASE-BLOOD CLOTTING COMPLEX, SECRETED
1y9g:A (THR129) to (THR165) CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI COMPLEXED WITH FRUCTOSE | EXO-INULINASE, ASPERGILLUS AWAMORI, GLYCOSIDE HYDROLASE FAMILY 32, CRYSTALLOGRAPHIC STRUCTURE, COMPLEX WITH FRUCTOSE, HYDROLASE
3a55:B (ASN182) to (ASP217) CRYSTAL STRUCTURE OF THE A47Q2 MUTANT OF PRO- PROTEIN-GLUTAMINASE | MUTANT STRUCTURE LIKE THE REACTION INTERMEDIATE, HYDROLASE
1yfs:A (GLY167) to (PRO210) THE CRYSTAL STRUCTURE OF ALANYL-TRNA SYNTHETASE IN COMPLEX WITH L-ALANINE | ALPHA-BETA FOLD, HELIX-LOOP-HELIX MOTIF, AMINO ACID BINDING, LIGASE
1ygc:H (LEU64) to (ARG107) SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR | INVERTED OXY-ANION HOLE, HYDROLASE
4pc1:B (PRO328) to (PRO352) ELONGATION FACTOR TU:TS COMPLEX WITH A BOUND PHOSPHATE | G:GEF COMPLEX, ELONGATION FACTOR, PROTEIN SYNTHESIS, TRANSLATION
1mwr:B (ARG94) to (TRP127) STRUCTURE OF SEMET PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R (TRIGONAL FORM) AT 2.45 A RESOLUTION. | PENICILLIN BINDING PROTEIN, BETA-LACTAM, D, D- TRANSPEPTIDASE, D-CARBOXYPEPTIDASE, BIOSYNTHETIC PROTEIN
1mws:A (ALA97) to (TRP127) STRUCTURE OF NITROCEFIN ACYL-PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 2.00 A RESOLUTION. | PENICILLIN BINDING PROTEIN, BETA-LACTAM, D, D- TRANSPEPTIDASE, D-CARBOXYPEPTIDASE, NITROCEFIN, BIOSYNTHETIC PROTEIN
1mwu:A (GLN98) to (TRP127) STRUCTURE OF METHICILLIN ACYL-PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 2.60 A RESOLUTION. | PENICILLIN BINDING PROTEIN, BETA-LACTAM, D,D-TRANSPEPTIDASE, D,D- CARBOXYPEPTIDASE, METHICILLIN, BIOSYNTHETIC PROTEIN
5dab:A (PHE79) to (LYS107) CRYSTAL STRUCTURE OF FTO-IN115 | FAT MASS AND OBESITY ASSOCIATED (FTO) PROTEIN, SMALL MOLECULE, OXIDOREDUCTASE
3kvg:A (TYR30) to (GLY67) CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HSP70 (CGD2_20) FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH AMPPNP | ATP BINDING DOMAIN, HEAT SHOCK PROTEIN, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, ATP-BINDING, NUCLEOTIDE-BINDING, STRESS RESPONSE, CHAPERONE
1mzd:A (PRO64) to (LYS107) CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K | GRANZYME, APOPTOSIS, SERINE PROTEASE, S1 FAMILY, HYDROLASE
4pfz:A (SER79) to (PRO123) X-RAY CRYSTAL STRUCTURE OF 5-CARBOXYMETHYL-2-HYDROXYMUCONATE DELTA- ISOMERASE FROM MYCOBACTERIUM SMEGMATIS | STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, ISOMERASE
1yx9:A (THR12) to (PRO41) EFFECT OF DIMETHYL SULPHOXIDE ON THE CRYSTAL STRUCTURE OF PORCINE PEPSIN | PEPSIN, DIMETHYL SULPHOXIDE, PROTEIN DENATURATION, HYDROLASE
5dm6:R (VAL51) to (LEU83) CRYSTAL STRUCTURE OF THE 50S RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS | PROTEIN SYNTHESIS, PEPTIDYLTRANSFERASE, RIBOZYME, RIBONUCLEOPROTEIN, RIBOSOME
1z3u:C (TYR298) to (ILE325) STRUCTURE OF THE ANGIOPOIETIN-2 RECPTOR BINDING DOMAIN AND IDENTIFICATION OF SURFACES INVOLVED IN TIE2 RECOGNITION | TIE2 BINDING, ANGIOGENESIS, EXTRACELLULAR LIGAND, SIGNALING PROTEIN
1z3u:D (TYR298) to (ILE325) STRUCTURE OF THE ANGIOPOIETIN-2 RECPTOR BINDING DOMAIN AND IDENTIFICATION OF SURFACES INVOLVED IN TIE2 RECOGNITION | TIE2 BINDING, ANGIOGENESIS, EXTRACELLULAR LIGAND, SIGNALING PROTEIN
1z5y:D (VAL64) to (ASN88) CRYSTAL STRUCTURE OF THE DISULFIDE-LINKED COMPLEX BETWEEN THE N-TERMINAL DOMAIN OF THE ELECTRON TRANSFER CATALYST DSBD AND THE CYTOCHROME C BIOGENESIS PROTEIN CCMG | DSBD, N-TERMINAL DOMAIN, IMMUNOGLOBULIN-LIKE, CCMG, THIOREDOXIN-LIKE, DISULFIDE-LINKED, OXIDOREDUCTASE/BIOSYNTHETIC PROTEIN COMPLEX
1z6d:A (ILE81) to (ALA122) RIBONUCLEASE A- IMP COMPLEX | HYDROLASE, RIBONUCLEASE
1z6j:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR | BLOOD COAGULATION, SERINE PROTEASE, THROMBOSIS, GLA, PYRAZINONE, BENZAMIDINE, TISSUE FACTOR, COFACTOR, ENZYME INHIBITOR COMPLEX, HYDROLASE
1z6s:A (ILE81) to (ALA122) RIBONUCLEASE A- AMP COMPLEX | HYDROLASE, RIBONUCLEASE
4pt6:A (THR72) to (LEU104) THE DISCOBODY: AN ENGINEERED DISCOIDIN DOMAIN FROM FACTOR VIII THAT BINDS V 3 INTEGRIN WITH ANTIBODY-LIKE AFFINITIES | INTEGRIN BINDING, INTEGRIN, CELL ADHESION
4pt6:B (THR72) to (LEU104) THE DISCOBODY: AN ENGINEERED DISCOIDIN DOMAIN FROM FACTOR VIII THAT BINDS V 3 INTEGRIN WITH ANTIBODY-LIKE AFFINITIES | INTEGRIN BINDING, INTEGRIN, CELL ADHESION
3akq:A (GLY33) to (GLY64) CRYSTAL STRUCTURE OF XYLANASE FROM TRICHODERMA LONGIBRACHIATUM | XYLANASE, HYDROLASE
5dq0:A (THR340) to (VAL374) STRUCTURE OF HUMAN NEUROPILIN-2 B1 DOMAIN WITH NOVEL AND UNIQUE ZINC BINDING SITE | NEUROPILIN, VEGF, SIGNALING PROTEIN
5dq1:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 34 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dq1:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 34 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dq5:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 209 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1z93:A (GLU106) to (ILE144) HUMAN CARBONIC ANHYDRASE III:STRUCTURAL AND KINETIC STUDY OF CATALYSIS AND PROTON TRANSFER. | CARBONIC ANHYDRASE III, PROTON WIRE, CHEMICAL RESCUE, LYASE
5dr0:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 203 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr1:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 278 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr4:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 231 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr8:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 330 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
3lin:B (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI- 10562 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3lin:D (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI- 10562 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3lin:H (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI- 10562 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3lin:J (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI- 10562 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3liq:B (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR, KNI- 10673 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3liv:B (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR KNI- 10683 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3lix:B (VAL74) to (ILE101) CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH THE INHIBITOR KNI- 10729 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3lq6:A (GLY333) to (SER377) CRYSTAL STRUCTURE OF MURINE NOROVIRUS PROTRUDING (P) DOMAIN | VIRAL CAPSID PROTEIN, PROTRUDING (P) DOMAIN, VIRAL PROTEIN
5e17:C (PRO93) to (ASN130) T. THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX HAVING A RRR DISCRIMINATOR SEQUENCE AND A NONTEMPLATE-STRAND LENGTH CORRESPONDING TO TSS SELECTION AT POSITION 7 (RPO-GGG-7) | DNA, SINGLE-STRANDED, DNA-DIRECTED RNA POLYMERASES, GENE EXPRESSION REGULATION, BACTERIAL, PROMOTER REGIONS, PROTEIN CONFORMATION, SIGMA FACTOR, THERMUS THERMOPHILUS, TRANSCRIPTION INITIATION, START SITE SELECTION, PROMOTER ESCAPE, INITIAL TRANSCRIPT, ABORTIVE PRODUCT, SIGMA FINGER, TRANSCRIPTION-DNA-RNA COMPLEX
4q4z:C (PRO93) to (ASN130) THERMUS THERMOPHILUS RNA POLYMERASE DE NOVO TRANSCRIPTION INITIATION COMPLEX | TRANSCRIPTION, DNA AND NTP, TRANSCRIPTION-DNA COMPLEX
5e24:E (THR259) to (TYR318) STRUCTURE OF THE SU(H)-HAIRLESS-DNA REPRESSOR COMPLEX | NOTCH SIGNALING, SUPPRESSOR OF HAIRLESS, HAIRLESS, CSL, TRANSPORT-DNA BINDING-DNA COMPLEX
4q5s:C (PRO93) to (ASN130) THERMUS THERMOPHILUS RNA POLYMERASE INITIALLY TRANSCRIBING COMPLEX CONTAINING 6-MER RNA | TRANSCRIPTION, TRANSCRIPTION-DNA-RNA COMPLEX
1zun:B (MSE338) to (PRO363) CRYSTAL STRUCTURE OF A GTP-REGULATED ATP SULFURYLASE HETERODIMER FROM PSEUDOMONAS SYRINGAE | BETA BARREL, SWITCH DOMAIN, HETERODIMER, PYROPHOSPHATE, G PROTEIN, GTPASE, TRANSFERASE
3ltf:A (GLN78) to (ILE109) CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN IN COMPLEX WITH SPITZ | RECEPTOR-LIGAND COMPLEX ECTODOMAIN CYSTEINE RICH DOMAIN EGF DOMAIN, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE, TYROSINE-PROTEIN KINASE, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, DISULFIDE BOND, EGF-LIKE DOMAIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, GOLGI APPARATUS, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, TRANSFERASE-TRANSFERASE REGULATOR COMPLEX
3ltf:C (GLN78) to (ILE109) CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN IN COMPLEX WITH SPITZ | RECEPTOR-LIGAND COMPLEX ECTODOMAIN CYSTEINE RICH DOMAIN EGF DOMAIN, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE, TYROSINE-PROTEIN KINASE, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, DISULFIDE BOND, EGF-LIKE DOMAIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, GOLGI APPARATUS, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, TRANSFERASE-TRANSFERASE REGULATOR COMPLEX
3ltg:A (GLN78) to (ILE109) CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN COMPLEXED WITH A LOW AFFINITY SPITZ MUTANT | RECEPTOR-LIGAND COMPLEX ECTODOMAIN CYSTEINE RICH DOMAIN EGF DOMAIN, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE, TYROSINE-PROTEIN KINASE, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, DISULFIDE BOND, EGF-LIKE DOMAIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, GOLGI APPARATUS, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, TRANSFERASE-TRANSFERASE REGULATOR COMPLEX
3ltg:C (GLN78) to (ILE109) CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN COMPLEXED WITH A LOW AFFINITY SPITZ MUTANT | RECEPTOR-LIGAND COMPLEX ECTODOMAIN CYSTEINE RICH DOMAIN EGF DOMAIN, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE, TYROSINE-PROTEIN KINASE, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, DISULFIDE BOND, EGF-LIKE DOMAIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, GOLGI APPARATUS, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, TRANSFERASE-TRANSFERASE REGULATOR COMPLEX
4avs:A (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-L-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, GLYCOPROTEIN, DISULFIDE BOND, LECTIN, METAL-BINDING
4avs:B (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-L-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, GLYCOPROTEIN, DISULFIDE BOND, LECTIN, METAL-BINDING
4avs:C (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-L-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, GLYCOPROTEIN, DISULFIDE BOND, LECTIN, METAL-BINDING
4avs:D (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-L-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, GLYCOPROTEIN, DISULFIDE BOND, LECTIN, METAL-BINDING
4avs:E (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-L-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, GLYCOPROTEIN, DISULFIDE BOND, LECTIN, METAL-BINDING
4avv:A (PHE33) to (ASN59) STRUCTURE OF CPHPC BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, LECTIN, METAL-BINDING
4avv:B (PHE33) to (ASN59) STRUCTURE OF CPHPC BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, LECTIN, METAL-BINDING
4avv:E (PHE33) to (ASN59) STRUCTURE OF CPHPC BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, LECTIN, METAL-BINDING
5e5f:A (ILE81) to (ALA122) X-RAY STRUCTURE OF THE COMPLEX BETWEEN RNASE A AND COMPOUND 4-PF6 ([(PPH3)AU(MI-PBI)PT(ME)(DMSO)][PF6]), THE HETEROBIMETALLIC DERIVATIVE OBTAINED IN THE REACTION BETWEEN THE ORGANOMETALLIC COMPOUND [PT(PBI)(ME)(DMSO)], PBI=2-(2'-PYRIDIL)BENZIMIDAZOLE (COMPOUND 3) AND THE GOLD(I) COMPOUND [AU(PH3P)][PF6] | HYDROLASE
1zyr:D (GLY697) to (HIS729) STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH THE ANTIBIOTIC STREPTOLYDIGIN | RNA POLYMERASE; STREPTOLYDIGIN; TRANSCRIPTION; HOLOENZYME, TRANSCRIPTION,TRANSFERASE
1zyr:M (PRO93) to (ASN130) STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH THE ANTIBIOTIC STREPTOLYDIGIN | RNA POLYMERASE; STREPTOLYDIGIN; TRANSCRIPTION; HOLOENZYME, TRANSCRIPTION,TRANSFERASE
5e7o:I (ASP302) to (PRO374) CRYSTAL STRUCTURE OF THE PERCHLORATE REDUCTASE PCRAB MUTANT W461E OF PCRA FROM AZOSPIRA SUILLUM PS | OXIDOREDUCTASE MO-BISMGD FE-S CLUSTER PERCHLORATE DISSMILATION, OXIDOREDUCTASE
2a2q:H (LEU64) to (ARG107) COMPLEX OF ACTIVE-SITE INHIBITED HUMAN COAGULATION FACTOR VIIA WITH HUMAN SOLUBLE TISSUE FACTOR IN THE PRESENCE OF CA2+, MG2+, NA+, AND ZN2+ | FACTOR VIIA, SOLUBLE TISSUE FACTOR, MG2+, CA2+, NA+, ZN2+, HYDROLASE/BLOOD CLOTTING COMPLEX
3lzy:A (ASP92) to (SER113) CRYSTAL STRUCTURE OF ENDOTHIAPESIN IN COMPLEX WITH XENON | PROTEIN-XE COMPLEX, HYDROLASE, B-SECRETASE, ENDOTHIAPEPSIN, ASPARTYL PROTEASE, PROTEASE, ZYMOGEN
2a3x:H (ASN32) to (ASN59) DECAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY- 2-METHYL-1,3-DIOXANE]- 5-YLOXYCARBONYL}- PIPERAZINE | MULTIVALENT LIGAND, SERUM AMYLOID, METAL BINDING PROTEIN
2a3x:I (PHE33) to (ASN59) DECAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY- 2-METHYL-1,3-DIOXANE]- 5-YLOXYCARBONYL}- PIPERAZINE | MULTIVALENT LIGAND, SERUM AMYLOID, METAL BINDING PROTEIN
2a3y:A (ASN32) to (ASN59) PENTAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}- ETHANE. | METAL BINDING PROTEIN
2a3y:B (PHE33) to (ASN59) PENTAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}- ETHANE. | METAL BINDING PROTEIN
2a3y:C (PHE33) to (ASN59) PENTAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}- ETHANE. | METAL BINDING PROTEIN
2a3y:D (ASN32) to (ASN59) PENTAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}- ETHANE. | METAL BINDING PROTEIN
2a3y:E (ASN32) to (ASN59) PENTAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}- ETHANE. | METAL BINDING PROTEIN
2a68:N (GLY697) to (HIS729) CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC RIFABUTIN | RNA POLYMERASE HOLOENZYME, RIFABUTIN, ANTIBIOTIC, TRANSCRIPTION REGULATION, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, TRANSFERASE
4qdr:A (THR340) to (HIS377) PHYSICAL BASIS FOR NRP2 LIGAND BINDING | COAGULATION FACTOR DOMAIN, DISCOIDIN DOMAIN, RECEPTOR, VEGF-C, MEMBRANE, CELL ADHESION
4qds:A (THR340) to (VAL374) PHYSICAL BASIS FOR NRP2 LIGAND BINDING | COAGULATION FACTOR DOMAIN, DISCOIDIN DOMAIN, RECEPTOR, VEGF-C, SECRETED, CELL ADHESION
2a69:N (GLY697) to (HIS729) CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC RIFAPENTIN | RNA POLYMERASE HOLOENZYME, RIFAPENTIN, ANTIBIOTIC, TRANSCRIPTION REGULATION, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, TRANSFERASE
5ech:A (TYR360) to (LYS408) CRYSTAL STRUCTURE OF FIN219-FIP1 COMPLEX WITH JA AND ATP | JASMONATE-AMIDO SYNTHETASE, GLUTATHIONE S-TRANSFERASE, LIGASE- TRANSFERASE COMPLEX
5ee4:A (THR53) to (PHE83) THE CRYSTAL STRUCTURE OF HPUA FROM KINGELLA DENITRIFICANS IN COMPLEX WITH HUMAN HAEMOGLOBIN | OUTER MEMBRANE, RECEPTOR, BETA BARREL, METAL TRANSPORT
5ee4:B (THR53) to (PHE83) THE CRYSTAL STRUCTURE OF HPUA FROM KINGELLA DENITRIFICANS IN COMPLEX WITH HUMAN HAEMOGLOBIN | OUTER MEMBRANE, RECEPTOR, BETA BARREL, METAL TRANSPORT
3m9b:B (PRO98) to (PHE155) CRYSTAL STRUCTURE OF THE AMINO TERMINAL COILED COIL DOMAIN AND THE INTER DOMAIN OF THE MYCOBACTERIUM TUBERCULOSIS PROTEASOMAL ATPASE MPA | COIL COIL WITH 5 BETA-STRAND BARREL INTER DOMAIN, CHAPERONE
3m9d:N (PRO98) to (PHE155) CRYSTAL STRUCTURE OF THE PROKARYOTIC UBIQUINTIN-LIKE PROTEIN PUP COMPLEXED WITH THE HEXAMERIC PROTEASOMAL ATPASE MPA WHICH INCLUDES THE AMINO TERMINAL COILED COIL DOMAIN AND THE INTER DOMAIN | ALPHA HELIX COIL COIL, 5 BETA-STRAND BARREL, ATP-BINDING, CHAPERONE, NUCLEOTIDE-BINDING, PROTEASOME, S-NITROSYLATION, VIRULENCE, ISOPEPTIDE BOND, UBL CONJUGATION PATHWAY
2aas:A (SER80) to (ALA122) HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF RIBONUCLEASE A IN SOLUTION BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | HYDROLASE(ENDORIBONUCLEASE)
2aeg:A (THR123) to (ASP185) X-RAY CRYSTAL STRUCTURE OF PROTEIN ATU5096 FROM AGROBACTERIUM TUMEFACIENS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ATR63. | ALPHA-BETA PROTEIN., STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
2aeh:B (LYS259) to (ASP285) FOCAL ADHESION KINASE 1 | FERM DOMAIN, TRANSFERASE
2aer:H (LEU64) to (ARG107) CRYSTAL STRUCTURE OF BENZAMIDINE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX. | SERINE PROTEASE, CALCIUM, MAGNESIUM, ZINC, SODIUM, FACTOR VIIA, TISSUE FACTOR, BENZAMIDINE, BLOOD COAGULATION, CLOTTING, BLOOD, COAGULATION, CLOTTING FACTOR, COAGULATION FACTOR, BLOOD CLOTTING
3b7m:D (ASN42) to (ARG71) CRYSTAL STRUCTURE OF A MESO-ACTIVE THERMO-STABLE CELLULASE (MT CEL12A) DERIVED BY MAKING NON-CONTIGUOUS MUTATIONS IN THE ACTIVE SURFACE OF THE CEL12A CELLULASE OF RHODOTHERMUS MARINUS | CELLULASE, HYDROLASE, ENDOGLUCANASE, STRUCTURE, CRYSTAL, BETA-JELLY, BETA-SHEET
3b8l:D (ALA88) to (ARG127) CRYSTAL STRUCTURE OF A PUTATIVE AROMATIC RING HYDROXYLASE (SARO_3538) FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM AT 1.75 A RESOLUTION | PUTATIVE AROMATIC RING HYDROXYLASE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE
3bb9:B (ILE109) to (SER147) CRYSTAL STRUCTURE OF A PUTATIVE KETOSTEROID ISOMERASE (SFRI_1973) FROM SHEWANELLA FRIGIDIMARINA NCIMB 400 AT 1.80 A RESOLUTION | STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, UNKNOWN FUNCTION
3bcm:A (ILE81) to (ALA122) CRYSTAL STRUCTURE OF THE UNSWAPPED FORM OF P19A/L28Q/N67D BS-RNASE | DOMAIN SWAPPING, BOVINE SEMINAL RIBONUCLEASE, NON COVALENT DIMER, ANTITUMOR ACTIVITY, ALLOSTERIC ENZYME, ENDONUCLEASE, HYDROLASE, NUCLEASE, SECRETED
4bek:A (GLY74) to (GLY102) CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | HYDROLASE
3mm6:B (GLY117) to (SER148) DISSIMILATORY SULFITE REDUCTASE CYANIDE COMPLEX | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
3mm6:E (GLY117) to (SER148) DISSIMILATORY SULFITE REDUCTASE CYANIDE COMPLEX | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
3mm7:B (GLY117) to (SER148) DISSIMILATORY SULFITE REDUCTASE CARBON MONOXIDE COMPLEX | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
3mma:B (GLY117) to (SER148) DISSIMILATORY SULFITE REDUCTASE PHOSPHATE COMPLEX | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
3mma:E (GLY117) to (SER148) DISSIMILATORY SULFITE REDUCTASE PHOSPHATE COMPLEX | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
3mmb:B (GLY117) to (SER148) DISSIMILATORY SULFITE REDUCTASE IN COMPLEX WITH THE ENDPRODUCT SULFIDE | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
3mmc:B (GLY117) to (SER148) STRUCTURE OF THE DISSIMILATORY SULFITE REDUCTASE FROM ARCHAEOGLOBUS FULGIDUS | ALPHA-BETA-PROTEIN, OXIDOREDUCTASE
5es4:A (VAL93) to (PRO120) RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION | COMPLEMENT RECEPTOR-4 ALPHAXBETA2, CELL ADHESION
5et4:C (ILE81) to (ALA122) STRUCTURE OF RNASE A-K7H/R10H IN COMPLEX WITH 3'-CMP | RNASE A, P2 SUBSITE, EXONUCLEASE ACTIVITY, HYDROLASE
5et4:D (ILE81) to (ALA122) STRUCTURE OF RNASE A-K7H/R10H IN COMPLEX WITH 3'-CMP | RNASE A, P2 SUBSITE, EXONUCLEASE ACTIVITY, HYDROLASE
4bl3:A (ALA97) to (ASP126) CRYSTAL STRUCTURE OF PBP2A CLINICAL MUTANT N146K FROM MRSA | HYDROLASE, MRSA, ALLOSTERIC SITE, B-LACTAM ANTIBIOTICS
3bn6:A (THR71) to (LYS105) CRYSTAL STRUCTURE OF THE C2 DOMAIN OF BOVINE LACTADHERIN AT 1.67 ANGSTROM RESOLUTION | ANTICOAGULATION, ANTI-COAGULATION, ANTICOAGULANT, ANTI- COAGULANT, MEMBRANE BINDING, PHOSPHATIDYL-SERINE BINDING, PHOSPHATIDYLSERINE BINDING, BLOOD COAGULATION FACTOR V C2 HOMOLOGUE, BLOOD COAGULATION FACTOR VIII C2 HOMOLOGUE, MILK FAT GLOBULE, APOPTOSIS, DISCOIDIN DOMAIN, FA58C, F5_F8_TYPE_C, ALTERNATIVE SPLICING, CELL ADHESION, EGF-LIKE DOMAIN, FERTILIZATION, GLYCOPROTEIN, BLOOD CLOTTING
4qwg:M (VAL6) to (GLY38) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:a (VAL6) to (GLY38) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3brz:A (VAL214) to (ASP267) CRYSTAL STRUCTURE OF THE PSEUDOMONAS PUTIDA TOLUENE TRANSPORTER TODX | BETA BARREL, OUTER MEMBRANE PROTEIN, TRANSPORT PROTEIN
4qyz:J (THR80) to (LEU122) CRYSTAL STRUCTURE OF A CRISPR RNA-GUIDED SURVEILLANCE COMPLEX, CASCADE, BOUND TO A SSDNA TARGET | CRISPR-ASSOCIATED, BACTERIAL IMMUNITY, CAS3, IMMUNE SYSTEM-DNA-RNA COMPLEX
3n2c:D (GLY9) to (GLU34) CRYSTAL STRUCTURE OF PROLIDASE EAH89906 COMPLEXED WITH N- METHYLPHOSPHONATE-L-PROLINE | UNKNOWN SOURCE, AMIDOHYDROLASE, SARGASSO SEA, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI, NEW YORK STRUCTURAL GENOMIX RESEARCH CONSORTIUM, PROLIDASE, NYSGXRC, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, HYDROLASE
4bxs:V (THR1181) to (LYS1215) CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS | BLOOD CLOTTING, BLOOD COAGULATION, PROTHROMBINASE, HYDROLASE
3n7m:A (LYS1173) to (PHE1225) CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995 | BOTULINUM NEUROTOXIN, W1252A MUTANT, GM1A, GANGLIOSIDE BINDING LOOP, TOXIN
4r71:C (LYS1324) to (PRO1352) STRUCTURE OF THE QBETA HOLOENZYME COMPLEX IN THE P1211 CRYSTAL FORM | OB FOLD, TRANSLATION, VIRAL PROTEIN-RIBOSOMAL PROTEIN COMPLEX
3n8d:B (ARG219) to (PRO262) CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS VRSA-9 D-ALA:D-ALA LIGASE | VANCOMYCIN DEPENDENCE, CELL WALL SYNTHESIS, D-ALA:D-ALA LIGASE, LIGASE
4bzy:A (ASP668) to (ASP699) CRYSTAL STRUCTURE OF HUMAN GLYCOGEN BRANCHING ENZYME (GBE1) | TRANSFERASE
4rcn:A (ARG205) to (PRO244) STRUCTURE AND FUNCTION OF A SINGLE-CHAIN, MULTI-DOMAIN LONG-CHAIN ACYL-COA CARBOXYLASE | HOLOENZYME, ACYL-COA CARBOXYLASE, PROTEIN STRUCTURE, ALPHA/BETA, CARBOXYLASE, COA BINDING, LIGASE
4rcn:B (ASP203) to (PRO244) STRUCTURE AND FUNCTION OF A SINGLE-CHAIN, MULTI-DOMAIN LONG-CHAIN ACYL-COA CARBOXYLASE | HOLOENZYME, ACYL-COA CARBOXYLASE, PROTEIN STRUCTURE, ALPHA/BETA, CARBOXYLASE, COA BINDING, LIGASE
5fr8:A (GLY642) to (ASN698) CRYSTAL STRUCTURE OF THE SIDEROPHORE RECEPTOR PIRA FROM ACINETOBACTER BAUMANNII | TRANSPORT PROTEIN, TONB-DEPENDENT RECEPTOR, OUTER-MEMBRANE PROTEIN
5fsw:A (GLY357) to (TYR382) RNA DEPENDENT RNA POLYMERASE QDE-1 FROM THIELAVIA TERRESTRIS | TRANSFERASE, SMALL RNAS, QDE-1 ORTHOLOGUES, EVOLUTION
4rn5:A (THR337) to (THR371) B1 DOMAIN OF HUMAN NEUROPILIN-1 WITH ACETATE ION IN A LIGAND-BINDING SITE | VEGF BINDING, PROTEIN BINDING
5fua:2 (LEU68) to (TRP111) CRYO-EM OF BK POLYOMAVIRUS | VIRUS, BKPYV, BK, POLYOMAVIRUS
3nxj:B (ALA81) to (ALA114) CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE D99N FROM PSEUDOMONAS TESTOSTERONI (TKSI) | ISOMERASE
4ckp:B (VAL141) to (THR178) STRUCTURE OF AN N-TERMINAL FRAGMENT OF LEISHMANIA SAS-6 THAT CONTAINS PART OF ITS COILED COIL DOMAIN | STRUCTURAL PROTEIN, BASAL BODY, CENTRIOLE, CARTWHEEL, TRYPANOSOMATIDS
4s18:A (ILE81) to (ALA122) THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND OXALIPLATIN | RIBONUCLEASE FOLD, CLEAVAGE OF RNA, RNA, BOVINE PANCREAS, HYDROLASE
5g3a:A (THR48) to (GLU90) PSBO SUBUNIT OF PHOTOSYSTEM II, BETA BARREL DOMAIN AT 100K, PH 10 | PHOTOSYNTHESIS, CARBOXYLATE CLUSTER, PH, PROTON ANTENNA
4std:C (GLN105) to (GLY146) HIGH RESOLUTION STRUCTURES OF SCYTALONE DEHYDRATASE-INHIBITOR COMPLEXES CRYSTALLIZED AT PHYSIOLOGICAL PH | LYASE
3d8y:A (ILE81) to (ALA122) RNASE A- 5'-DEOXY-5'-N-PIPERIDINOTHYMIDINE COMPLEX | RIBONUCLEASE, HYDROLASE, LIGAND BINDING, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, NUCLEASE, SECRETED
5gjw:F (THR592) to (PRO627) STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX FOR CLASSII MAP | COMPLEX, CHANNEL, MEMBRANE PROTEIN
3dhw:H (THR8) to (ALA39) CRYSTAL STRUCTURE OF METHIONINE IMPORTER METNI | ABC-TRANSPORTER, METHIONINE UPTAKE TRANSPORTER, MEMBRANE PROTEIN, AMINO-ACID TRANSPORT, INNER MEMBRANE, TRANSMEMBRANE, ATP-BINDING, HYDROLASE, NUCLEOTIDE-BINDING, MEMBRANE PROTEIN-HYDROLASE COMPLEX
5gjv:F (THR592) to (PRO627) STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT NEAR ATOMIC RESOLUTION | COMPLEX, CHANNEL, MEMBRANE PROTEIN
3ohn:A (VAL266) to (VAL320) CRYSTAL STRUCTURE OF THE FIMD TRANSLOCATION DOMAIN | BETA-BARREL, PROTEIN TRANSLOCATION, OUTER MEMBRANE, MEMBRANE PROTEIN
3di9:A (ALA81) to (ALA122) CRYSTAL STRUCTURE OF BOVINE PANCREATIC RIBONUCLEASE A VARIANT (I81A) | RIBONUCLEASE, RNASE A, HYDROLASE, BOVINE PANCREAS, ENDONUCLEASE, GLYCATION, GLYCOPROTEIN, NUCLEASE, SECRETED
4ttx:D (ARG27) to (ILE67) N-TERMINAL DOMAIN OF C. REINHARDTII SAS-6 HOMOLOG BLD12P VARIANT G94C K146C (NN19) | HOMODIMER, STABILIZATION, MUTATION, CENTRIOLE SAS-6, CARTWHEEL, STRUCTURAL PROTEIN, BETA-SANDWICH, ALPHA-BETA PROTEIN, CENTRIOLAR
4ttz:B (HIS32) to (SER68) N-TERMINAL DOMAIN OF C. REINHARDTII SAS-6 HOMOLOG BLD12P VARIANT G94E F145W Q147K (NN26) | STABILIZATION, CENTRIOLE SAS-6, CARTWHEEL, STRUCTURAL PROTEIN, BETA- SANDWICH, ALPHA-BETA PROTEIN, CENTRIOLAR
3djp:A (ILE81) to (ALA122) BOVINE SEMINAL RIBONUCLEASE- URIDINE 3' PHOSPHATE COMPLEX | RIBONUCLEASE, HYDROLASE, ALLOSTERIC ENZYME, ENDONUCLEASE, NUCLEASE, SECRETED
3djq:A (ILE81) to (ALA122) BOVINE SEMINAL RIBONUCLEASE- URIDINE 5' DIPHOSPHATE COMPLEX | RIBONUCLEASE, HYDROLASE, ALLOSTERIC ENZYME, ENDONUCLEASE, NUCLEASE, SECRETED
3djq:B (ILE81) to (ALA122) BOVINE SEMINAL RIBONUCLEASE- URIDINE 5' DIPHOSPHATE COMPLEX | RIBONUCLEASE, HYDROLASE, ALLOSTERIC ENZYME, ENDONUCLEASE, NUCLEASE, SECRETED
3djv:A (ILE81) to (ALA122) BOVINE SEMINAL RIBONUCLEASE- CYTIDINE 3' PHOSPHATE COMPLEX | RIBONUCLEASE, HYDROLASE, ALLOSTERIC ENZYME, ENDONUCLEASE, NUCLEASE, SECRETED
3djx:A (ILE81) to (ALA122) BOVINE SEMINAL RIBONUCLEASE- CYTIDINE 5' PHOSPHATE COMPLEX | RIBONUCLEASE, HYDROLASE, ALLOSTERIC ENZYME, ENDONUCLEASE, NUCLEASE, SECRETED
4tw1:B (ILE87) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
4tw1:D (ILE87) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
4tw1:F (ILE87) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
4tw1:H (ILE87) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
4tw1:L (HIS88) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
4tw1:N (ILE87) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
4tw1:P (HIS88) to (ASP127) CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH | OCTAMER LEUKOCIDIN PORE-FORMING TOXIN, TOXIN
3om5:A (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT N252A | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3om5:B (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT N252A | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3om5:C (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT N252A | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3om6:C (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT Y247A | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3om6:D (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT Y247A | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3om7:C (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT Y247W | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3om7:B (LYS183) to (GLY220) CRYSTAL STRUCTURE OF B. MEGATERIUM LEVANSUCRASE MUTANT Y247W | FIVE FOLD BETA-PROPELLER, LEVANSUCRASE, TRANSFERASE
3omh:C (ARG70) to (GLN103) CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE | HYDROLASE, TYROSINE PHOSPHATASE
3oqy:B (ILE81) to (ALA122) SEMI-SYNTHETIC RIBONUCLEASE S: PARA-CYANO-PHENYLALANINE AT POSITION 8 | ARTIFICIAL, NON-NATURAL, VIBRATIONAL, PROBE, NITRILE, CYANO, CYANOPHENYLALANINE, HYDROLASE
3oqz:B (ILE81) to (ALA122) SEMI-SYNTHETIC RIBONUCLEASE S: META-CYANO-PHENYLALANINE AT POSITION 8 | ARTIFICIAL, NON-NATURAL, VIBRATIONAL, PROBE, NITRILE, CYANO, CYANOPHENYLALANINE, HYDROLASE
3or0:B (ILE81) to (ALA122) SEMI-SYNTHETIC RIBONUCLEASE S: CYANYLATED HOMOCYSTEINE AT POSITION 13 | ARTIFICIAL, NON-NATURAL, VIBRATIONAL, PROBE, NITRILE, CYANO, THIOCYANATE, HYDROLASE
4u2i:A (ARG27) to (SER68) N-TERMINAL DOMAIN OF C. RHEINHARDTII SAS-6 HOMOLOG BLD12P Q93E G94D K146R Q147R (NN23) | CENTRIOLE SAS-6, CARTWHEEL, STRUCTURAL PROTEIN, BETA-SANDWICH, ALPHA- BETA PROTEIN, CELL CYCLE
4u2i:B (HIS32) to (ILE67) N-TERMINAL DOMAIN OF C. RHEINHARDTII SAS-6 HOMOLOG BLD12P Q93E G94D K146R Q147R (NN23) | CENTRIOLE SAS-6, CARTWHEEL, STRUCTURAL PROTEIN, BETA-SANDWICH, ALPHA- BETA PROTEIN, CELL CYCLE
4u30:A (ARG62) to (LYS107) HUMAN MESOTRYPSIN COMPLEXED WITH BIKUNIN KUNITZ DOMAIN 2 | SERINE PROTEASE, PROTEASE INHIBITOR, PROTEIN-PROTEIN INTERACTION, PROTEIN DEGRADATION, PROTEOLYSIS, SUBSTRATE SPECIFICITY, ENZYME KINETICS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5hd2:A (GLU195) to (PRO219) THE CRYSTAL STRUCTURE OF SEMET-CRY51AA2-L11M | TOXIN, CRY51AA2, BT, CRY
3dxj:N (GLY697) to (HIS729) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH THE ANTIBIOTIC MYXOPYRONIN | RNA POLYMERASE; RNAP; DRUG COMPLEX; INHIBITOR; CORALLOPYRONIN; RIPOSTATIN; TRANSCRIPTION; HOLOENZYME; CRYSTALLOGRAPHY; TWINNING; HEMIHEDRAL, DNA-DIRECTED RNA POLYMERASE, NUCLEOTIDYLTRANSFERASE, TRANSCRIPTION, TRANSFERASE, DNA-BINDING, SIGMA FACTOR, TRANSCRIPTION REGULATION, TRANSCRIPTION,TRANSFERASE
3owr:B (ALA115) to (LYS159) CRYSTAL STRUCTURE OF A PUTATIVE SECRETED PROTEIN (BF4250) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 1.81 A RESOLUTION | CARBOHYDRATE METABOLISM, PUTATIVE GLYCOSIDE HYDROLASE, IG-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN FUNCTION
3owv:A (SER235) to (GLN274) STRUCTURAL INSIGHTS INTO CATALYTIC AND SUBSTRATE BINDING MECHANISMS OF THE STRATEGIC ENDA NUCLEASE FROM STREPTOCOCCUS PNEUMONIAE | SEQUENCE NONSPECIFIC ENDONUCLEASE, HYDROLASE
4dg4:A (ARG62) to (LYS107) HUMAN MESOTRYPSIN-S39Y COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) | HUMAN MESOTRYPSIN, CANONICAL INHIBITOR, BPTI, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4dg4:G (THR61) to (LYS107) HUMAN MESOTRYPSIN-S39Y COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) | HUMAN MESOTRYPSIN, CANONICAL INHIBITOR, BPTI, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4dki:B (GLN98) to (ASP126) STRUCTURAL INSIGHTS INTO THE ANTI- METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) ACTIVITY OF CEFTOBIPROLE | ENZYME, HYDROLASE-ANTIBIOTIC COMPLEX
3p69:B (ALA115) to (LYS159) CRYSTAL STRUCTURE OF A PUTATIVE SECRETED PROTEIN (BF4250) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.05 A RESOLUTION | CARBOHYDRATE METABOLISM, PUTATIVE GLYCOSIDE HYDROLASE, IG-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN FUNCTION
3pau:A (GLY55) to (GLN81) CUEO IN THE RESTING OXIDIZED STATE | MULTICOPPER OXIDASE, OXIDOREDUCTASE
3pb5:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pbd:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pbz:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5hx0:A (VAL221) to (TYR248) CRYSTAL STRUCTURE OF UNKNOWN FUNCTION PROTEIN DFER_1899 FROMDYADOBACTER FERMENTANS DSM 18053 | MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION, PSI- BIOLOGY, STRUCTURAL GENOMICS
5hx0:B (VAL221) to (TYR248) CRYSTAL STRUCTURE OF UNKNOWN FUNCTION PROTEIN DFER_1899 FROMDYADOBACTER FERMENTANS DSM 18053 | MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION, PSI- BIOLOGY, STRUCTURAL GENOMICS
5hx2:E (LYS103) to (SER147) IN VITRO ASSEMBLED STAR-SHAPED HUBLESS T4 BASEPLATE | T4, BASEPLATE, COMPLEX, VIRAL PROTEIN
5hx2:E (LYS522) to (ILE554) IN VITRO ASSEMBLED STAR-SHAPED HUBLESS T4 BASEPLATE | T4, BASEPLATE, COMPLEX, VIRAL PROTEIN
4udk:C (TRP226) to (PHE259) CRYSTAL STRUCTURE OF B-1,4-MANNOPYRANOSYL-CHITOBIOSE PHOSPHORYLASE AT 1.76 ANGSTROM FROM UNKNOWN HUMAN GUT BACTERIA (UHGB_MP) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE, BETA-D-MANNOPYRANOSE AND INORGANIC PHOSPHATE | TRANSFERASE, GLYCOSIDE HYDROLASE FAMILY 130, B-1, 4-MANNOPYRANOSYL- CHITOBIOSE PHOSPHORYLASE, N-GLYCAN PHOSPHOROLYSIS
3pgi:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pi0:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4dyo:A (ASP133) to (ALA192) CRYSTAL STRUCTURE OF HUMAN ASPARTYL AMINOPEPTIDASE (DNPEP) IN COMPLEX WITH ASPARTIC ACID HYDROXAMATE | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, HYDROLASE
4dyw:A (VAL72) to (GLY96) CRYSTAL STRUCTURE OF MUTT NUDIX HYDROLASE FROM BURKHOLDERIA PSEUDOMALLEI | STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, MUTT, NUDIX HYDROLASE, NUCLEOTIDE DIPHOSPHATE X HYDROLASE, HYDROLASE
3pm4:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pm4:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4usg:B (MET69) to (PRO98) CRYSTAL STRUCTURE OF PC4 W89Y MUTANT COMPLEX WITH DNA | TRANSCRIPTION
3prs:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH RITONAVIR | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5ijl:A (ILE701) to (PRO739) D-FAMILY DNA POLYMERASE - DP2 SUBUNIT (CATALYTIC SUBUNIT) | DNA POLYMERASE D-FAMILY, TRANSFERASE
3pww:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH SAQUINAVIR | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4emo:A (ALA27) to (LEU60) CRYSTAL STRUCTURE OF THE PH DOMAIN OF SHARPIN | PLECKSTRIN HOMOLOGY (PH) DOMAIN, LUBAC, SIPL1, LINEAR UBIQUITIN, HOIL-1L, HOIP, PROTEIN BINDING
5ipl:C (PRO95) to (ASN139) SIGMAS-TRANSCRIPTION INITIATION COMPLEX WITH 4-NT NASCENT RNA | TRANSCRIPTION INITIATION, RNA POLYMERASE, GENERAL STRESS SIGMA FACTOR, PYROPHOSPHATE RELEASE, TRANSCRIPTION, TRANSFERASE-DNA-RNA COMPLEX
5ipl:D (HIS419) to (HIS450) SIGMAS-TRANSCRIPTION INITIATION COMPLEX WITH 4-NT NASCENT RNA | TRANSCRIPTION INITIATION, RNA POLYMERASE, GENERAL STRESS SIGMA FACTOR, PYROPHOSPHATE RELEASE, TRANSCRIPTION, TRANSFERASE-DNA-RNA COMPLEX
5ipm:C (PRO95) to (ASN139) SIGMAS-TRANSCRIPTION INITIATION COMPLEX WITH 4-NT NASCENT RNA | TRANSCRIPTION INITIATION, RNA POLYMERASE, GENERAL STRESS SIGMA FACTOR, PYROPHOSPHATE RELEASE, TRANSCRIPTION, TRANSFERASE-DNA-RNA COMPLEX
5ipm:D (HIS419) to (HIS450) SIGMAS-TRANSCRIPTION INITIATION COMPLEX WITH 4-NT NASCENT RNA | TRANSCRIPTION INITIATION, RNA POLYMERASE, GENERAL STRESS SIGMA FACTOR, PYROPHOSPHATE RELEASE, TRANSCRIPTION, TRANSFERASE-DNA-RNA COMPLEX
5ipn:C (PRO95) to (ASN139) SIGMAS-TRANSCRIPTION INITIATION COMPLEX WITH 4-NT NASCENT RNA | TRANSCRIPTION INITIATION, RNA POLYMERASE, GENERAL STRESS SIGMA FACTOR, PYROPHOSPHATE RELEASE, TRANSCRIPTION, TRANSFERASE-DNA-RNA COMPLEX
5ipn:D (HIS419) to (HIS450) SIGMAS-TRANSCRIPTION INITIATION COMPLEX WITH 4-NT NASCENT RNA | TRANSCRIPTION INITIATION, RNA POLYMERASE, GENERAL STRESS SIGMA FACTOR, PYROPHOSPHATE RELEASE, TRANSCRIPTION, TRANSFERASE-DNA-RNA COMPLEX
4eqv:F (GLU176) to (THR212) STRUCTURE OF SACCHAROMYCES CEREVISIAE INVERTASE | GLYCOSIDASE GH32, BETA-PROPELLER, HYDROLASE, CARBOHYDRATE/SUGAR BINDING
3qdo:A (GLN64) to (GLY85) CRYSTAL STRUCTURE OF PDZ DOMAIN OF SORTING NEXIN 27 (SNX27) FUSED TO THE GLY-GLY LINKER FOLLOWED BY C-TERMINAL (ESESKV) OF GIRK3 | PDZ DOMAIN, PDZ BINDING, GIRK3 REGULATION, EARLY ENDOSOMES, BRAIN, NEURONS, PROTEIN BINDING
4f2a:A (ASP42) to (GLN87) CRYSTAL STRUCTURE OF CHOLESTRYL ESTERS TRANSFER PROTEIN IN COMPLEX WITH INHIBITORS | CHOLESTRYL ESTER TRANSFER PROTEIN, HIGH-DENSITY LIPOPROTEIN, LOW- DENSITY LIPOPROTEIN, CHOLESTRYL ESTER TRANSFER PROTEIN-INHIBITOR COMPLEX, LIPID TRANSPORT-INHIBITOR COMPLEX
3ql2:B (ILE81) to (ALA122) CRYSTAL STRUCTURE OF RIBONUCLEASE A VARIANT A4C/D83E/V118C | RIBONUCLEASE A, DISULFIDE BOND, SALT BRIDGE, STABILITY, FOLDING, PROTEOLYSIS, SITE-DIRECTED MUTAGENESIS, HYDROLASE
4ux7:A (PHE77) to (LYS136) STRUCTURE OF A CLOSTRIDIUM DIFFICILE SORTASE | HYDROLASE, SORTASE
4fbo:A (SER2) to (ASP42) CRYSTAL STRUCTURE OF THE PSEUDOMONAS FLUORESCENS AGGLUTININ (PFA) | BETA-BARREL, HIV-INACTIVATING, CARBOHYDRATE BINDING PROTEIN
4fbo:A (ASN69) to (ASP109) CRYSTAL STRUCTURE OF THE PSEUDOMONAS FLUORESCENS AGGLUTININ (PFA) | BETA-BARREL, HIV-INACTIVATING, CARBOHYDRATE BINDING PROTEIN
3qow:A (LEU7) to (ALA33) DOT1L STRUCTURE IN COMPLEX WITH SAM | H3K79 METHYLATION, TRANSFERASE
3qsk:A (ILE81) to (ALA122) 5 HISTIDINE VARIANT OF THE ANTI-RNASE A VHH IN COMPLEX WITH RNASE A | ANTIBODY, SINGLE DOMAIN, CAMELID, VHH, SDAB, RNASE A, RIBONUCLEASE A, PH, SENSITIVITY, SWITCH, DEPENDENCE, LINKED, EQUILIBRIA, EQUILIBRIUM, PROTEIN ENGINEERING, COMBINATORIAL, HISTIDINE, SCANNING, PHAGE DISPLAY, DUAL-FUNCTION, PROTEIN-PROTEIN INTERACTION, PROTON BINDING, HYDROLASE-IMMUNE SYSTEM COMPLEX
4w7j:A (GLN404) to (PRO438) CRYSTAL STRUCTURE OF A DECOLORIZING PEROXIDASE (DYP) FROM AURICULARIA AURICULA-JUDAE | DECOLORIZING PEROXIDASE (DYP), OXIDOREDUCTASE, HEME
4w7j:B (GLN404) to (PRO438) CRYSTAL STRUCTURE OF A DECOLORIZING PEROXIDASE (DYP) FROM AURICULARIA AURICULA-JUDAE | DECOLORIZING PEROXIDASE (DYP), OXIDOREDUCTASE, HEME
4w7j:C (GLN404) to (PRO438) CRYSTAL STRUCTURE OF A DECOLORIZING PEROXIDASE (DYP) FROM AURICULARIA AURICULA-JUDAE | DECOLORIZING PEROXIDASE (DYP), OXIDOREDUCTASE, HEME
3r0n:A (GLY90) to (LEU120) CRYSTAL STRUCTURE OF THE IMMUNOGLOBULIN VARIABLE DOMAIN OF NECTIN-2 | IG-DOMAIN, CELL-ADHESION MOLECULE, VIRUS ENTRY RECEPTOR, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, CELL ADHESION
3r7k:D (ASP185) to (ASP236) CRYSTAL STRUCTURE OF A PROBABLE ACYL COA DEHYDROGENASE FROM MYCOBACTERIUM ABSCESSUS ATCC 19977 / DSM 44196 | SSGCID, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, OXIDOREDUCTASE
3rat:A (ILE81) to (ALA122) EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X- RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | HYDROLASE (NUCLEIC ACID,RNA)
5jml:A (ILE81) to (ALA122) X-RAY STRUCTURE OF THE COMPLEX BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND PENTHACHLOROCARBONYLIRIDATE(III) (2 MONTHS OF SOAKING) | HYDROLASE, IRIDIUM COMPOUND, CORM, PROTEIN IRIDIUM INTERACTION
5jqg:F (LYS198) to (PHE264) AN APO TUBULIN-RB-TTL COMPLEX STRUCTURE USED FOR SIDE-BY-SIDE COMPARISON | APO STRUCTURE, STRUCTURAL PROTEIN
5jr8:A (ASN65) to (LEU94) DISPOSAL OF IRON BY A MUTANT FORM OF SIDEROCALIN NGAL | FE-SIDEROPHORE BINDING PROTEIN MUTANT, SIDEROPHORE BINDING PROTEIN
4g7z:M (PRO93) to (ASN130) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX CONTAINING 5-BRU AT TEMPLATE-STRAND POSITION +1 | PROTEIN-DNA COMPLEX, TRANSCRIPTION INITIATION COMPLEX, RNAP-PROMOTER COMPLEX, RNAP-PROMOTER OPEN COMPLEX, OPEN COMPLEX, RPO, RNA POLYMERASE, TRANSCRIPTION INITIATION, TRANSCRIPTION INITIATION FACTOR SIGMA A, PROMOTER DNA, NUCLEOID, TRANSCRIPTION, TRANSFERASE- DNA COMPLEX
5kg8:A (VAL11) to (ARG35) RIGOR MYOSIN X CO-COMPLEXED WITH AN ACTIN FILAMENT | MYOSIN MOLECULAR MOTORS CYTOSKELETAL MOTILITY, MOTOR PROTEIN
5kli:C (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH STIGMATELLIN AND ANTIMYCIN | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
5kli:G (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH STIGMATELLIN AND ANTIMYCIN | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
5kli:M (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH STIGMATELLIN AND ANTIMYCIN | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
5kli:Q (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH STIGMATELLIN AND ANTIMYCIN | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
5kkz:G (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH FAMOXADONE | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
5kkz:M (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH FAMOXADONE | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
5kkz:Q (GLY146) to (GLY187) RHODOBACTER SPHAEROIDES BC1 WITH FAMOXADONE | MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, CYTOCHROME BC1, INHIBITORS, ELECTRON TRANSFER, OXIDOREDUCTASE
4gnk:B (LYS27) to (THR55) CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3 | GTP-BINDING PROTEIN ALPHA SUBUNITS, PHOSPHOLIPASE C BETA, COILED-COIL DOMAIN, PH DOMAIN, EF HAND, C2 DOMAIN, TIM BARREL DOMAIN, PHOSPHOLIPASE, GTP HYDROLYSIS, G-PROTEIN SIGNALING, MEMBRANE TARGETING, LIPASE, HYDROLASE, CALCIUM BINDING, GTP BINDING, PHOSPHOLIPIDS, GTP-BINDING PROTEIN-HYDROLASE COMPLEX
4gnk:D (LYS27) to (THR55) CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3 | GTP-BINDING PROTEIN ALPHA SUBUNITS, PHOSPHOLIPASE C BETA, COILED-COIL DOMAIN, PH DOMAIN, EF HAND, C2 DOMAIN, TIM BARREL DOMAIN, PHOSPHOLIPASE, GTP HYDROLYSIS, G-PROTEIN SIGNALING, MEMBRANE TARGETING, LIPASE, HYDROLASE, CALCIUM BINDING, GTP BINDING, PHOSPHOLIPIDS, GTP-BINDING PROTEIN-HYDROLASE COMPLEX
5l2y:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 1-[(2R,15R)-2-[(1-AMINO-4- FLUOROISOQUINOLIN-6-YL)AMINO]-4,15,20-TRIMETHYL-3,12-DIOXO-13-OXA-4, 11-DIAZATRICYCLO[14.2.2.1~6,10~]HENICOSA-1(18),6,8,10(21),16,19- HEXAEN-7-YL] CYCLOBUTANE-1-CARBOXYLIC ACID | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l2z:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 1-[(2R,15R)-2-[(1-AMINO-4- FLUOROISOQUINOLIN-6-YL)AMINO]-4,15,17-TRIMETHYL-3,12-DIOXO-13-OXA-4, 11-DIAZATRICYCLO[14.2.2.1~6,10~]HENICOSA-1(18),6(21),7,9,16,19- HEXAEN-7-YL]CYCLOHEXANE-1-CARBOXYLIC ACID | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5oys:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 3 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oys:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 3 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyt:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 4 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyu:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 5 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyv:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 6 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyw:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 7 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyx:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 8 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz0:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 11 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz0:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 11 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz3:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 14 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz5:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 16 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz7:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 18 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz7:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 18 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz9:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 20 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oza:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 21 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozb:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 22 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozb:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 22 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozc:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 23 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozd:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 24 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oze:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 25 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozf:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 26 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozg:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 27 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozg:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 27 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozh:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 28 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozi:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 29 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozm:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 33 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozn:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 34 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozo:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 35 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozp:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 36 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozq:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 37 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozr:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 38 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozs:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 39 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozt:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 40 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozu:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 41 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozv:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 42 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozw:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 43 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozw:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 43 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozx:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 44 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozx:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 44 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozy:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 45 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozz:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 46 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p02:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 49 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p04:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 51 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p06:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 53 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p07:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 54 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p08:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 55 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p09:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 56 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 58 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 60 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 62 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 63 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0h:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 64 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 65 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0j:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 66 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0k:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 67 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 68 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 69 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0n:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 70 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 71 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0p:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 72 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 73 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 74 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 75 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 76 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 77 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 78 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0x:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 80 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 81 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0z:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 82 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p10:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 83 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p11:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 84 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p12:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 85 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p14:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 87 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p15:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 88 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p16:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 89 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p17:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 90 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p18:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 91 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p19:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 92 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 94 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 96 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 97 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 98 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 99 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 101 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1j:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 102 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 104 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1p:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 108 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 110 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 111 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 113 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 115 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1x:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 116 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 117 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p20:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 119 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p22:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 120 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p25:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 123 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p28:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 126 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p29:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 127 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 131 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 133 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 134 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2k:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 138 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 139 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 140 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2n:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 141 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 142 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 143 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 144 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 146 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 147 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 148 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 149 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p31:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 154 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p32:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 155 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p33:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 156 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p34:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 157 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p35:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 158 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p38:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 161 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3c:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 165 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 166 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 167 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 169 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 171 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 174 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 175 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 177 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 179 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 182 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 183 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 185 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3x:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 186 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 187 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3z:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 188 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p40:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 189 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p41:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 190 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p42:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 191 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p43:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 192 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p44:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 193 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p45:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 194 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p46:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 195 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p47:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 196 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p48:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 197 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p49:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 198 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 199 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 200 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4c:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 201 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 202 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 203 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 204 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4h:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 206 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4k:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 209 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 210 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 211 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 213 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 215 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 216 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 217 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 220 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 221 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 223 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4z:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 224 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p53:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 228 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p54:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 229 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p55:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 230 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p56:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 231 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p58:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 233 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p59:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 234 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 235 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5c:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 237 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 238 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 239 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 240 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 241 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5h:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 242 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 243 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5j:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 244 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5k:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 245 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 246 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 247 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 249 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 251 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 252 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 253 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 254 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 255 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 256 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 257 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5x:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 258 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 259 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5z:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 260 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p61:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 262 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p63:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 264 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p64:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 265 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p65:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 266 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p66:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 267 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p68:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 269 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 271 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 275 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 277 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6h:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 278 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 279 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6j:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 280 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 282 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 283 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6n:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 284 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 285 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6p:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 286 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 287 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 288 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 289 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 290 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 291 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 292 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 295 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6z:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 296 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p70:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 297 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p71:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 298 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p72:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 299 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p76:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 303 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p77:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 304 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p78:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 305 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 307 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 308 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 310 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 311 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 315 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7j:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 316 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 319 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7n:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 320 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7n:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 320 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7p:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 322 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 323 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 326 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 327 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 328 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 329 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7x:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 330 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7y:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 331 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7z:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 332 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p80:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 333 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p81:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 334 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p82:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 335 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p83:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 336 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p84:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 337 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p85:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 338 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p86:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 339 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p87:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 340 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p88:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 341 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p89:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 342 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 343 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 344 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8c:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 345 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8d:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 346 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8e:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 347 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 348 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8h:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 350 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8j:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 352 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8k:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 353 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 354 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8m:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 355 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8n:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 356 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 357 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8p:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 358 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8r:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 360 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 361 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 362 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 363 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 364 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5rat:A (ILE81) to (ALA122) EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X- RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | HYDROLASE (NUCLEIC ACID,RNA)
5sv8:A (THR57) to (ILE90) CRYSTAL STRUCTURE OF THE CATALYTIC NUCLEOPHILE AND SURFACE CYSTEINE MUTANT OF VVEG16 IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE | CELL WALL, DIETARY FIBER, MIXED-LINKAGE GLUCAN, XYLOGLUCAN, BETA- GLUCAN, GLYCOSIDE HYDROLASE, ENDO-GLUCANASE, GRAPES, PLANTS, PROTEIN STRUCTURE, GH16, BETA-JELLY ROLL, PHYLOGENY, OLIGOSACCHARIDE, CELLOTETRAOSE, HYDROLASE
5tmc:D (GLY697) to (HIS729) RE-REFINEMENT OF THERMUS THERMOPILES DNA-DIRECTED RNA POLYMERASE STRUCTURE | SYMMETRY DOWNSHIFTING, VALIDATION OF SYMMETRY, TRANSFERASE
5tmf:C (PRO93) to (ASN130) RE-REFINEMENT OF THERMUS THERMOPHILUS RNA POLYMERASE | SYMMETRY DOWNSHIFTING, VALIDATION OF SPACE GROUP, TRANSFERASE
5upj:A (GLU63) to (PHE85) HIV-2 PROTEASE/U99283 COMPLEX | HYDROLASE, ACID PROTEASE, HIV-2 PROTEASE-INHIBITOR COMPLEX, PROTEIN- SUBSTRATE INTERACTION, ASPARTYL PROTEASE
6rat:A (ILE81) to (ALA122) EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | HYDROLASE (NUCLEIC ACID,RNA)
7rat:A (ILE81) to (ALA122) EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X- RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | HYDROLASE (NUCLEIC ACID,RNA)
1a2v:C (GLY444) to (ALA480) COPPER AMINE OXIDASE FROM HANSENULA POLYMORPHA | AMINE OXIDASE, QUINOPROTEIN, TOPAQUINONE ENZYME, TPQ
1a2v:F (GLY444) to (ALA480) COPPER AMINE OXIDASE FROM HANSENULA POLYMORPHA | AMINE OXIDASE, QUINOPROTEIN, TOPAQUINONE ENZYME, TPQ
1afu:B (ILE81) to (ALA122) STRUCTURE OF RIBONUCLEASE A AT 2.0 ANGSTROMS FROM MONOCLINIC CRYSTALS | HYDROLASE, RIBONUCLEASE, ENDONUCLEASE
2orx:A (THR337) to (LEU372) STRUCTURAL BASIS FOR LIGAND BINDING AND HEPARIN MEDIATED ACTIVATION OF NEUROPILIN | NEUROPILIN, VEGF, TUFTSIN, SIGNALING PROTEIN, MEMBRANE PROTEIN
1apt:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1apu:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1apv:E (ASP88) to (SER109) CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2b7f:C (VAL74) to (GLY102) CRYSTAL STRUCTURE OF HUMAN T-CELL LEUKEMIA VIRUS PROTEASE, A NOVEL TARGET FOR ANTI-CANCER DESIGN | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnu:C (ASN241) to (ALA278) CRYSTAL STRUCTURE OF K442E MUTANT OF S. AUREUS PYRUVATE CARBOXYLASE | LIGASE
4x8t:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-CHLORO-3,4- DIHYDROISOQUINOLIN-1(2H)-ONE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM- BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
2q15:A (MET18) to (GLY41) STRUCTURE OF BACE COMPLEXED TO COMPOUND 3A | BACE INHIBITOR COMPLEX, HYDROLASE
1owj:A (PHE15) to (SER42) SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | PLASMINOGEN ACTIVATION, HYDROLASE, SERINE PROTEASE, GLYCOPROTEIN, KRINGLE, EGF-LIKE DOMAIN
2q7t:B (ALA1121) to (VAL1161) CRYSTAL STRUCTURE OF THE F PLASMID TRAI RELAXASE DOMAIN WITH THE SCISSILE THYMIDINE BASE | RELAXASE, HYDROLASE, CONJUGATION
1d6y:A (ASN540) to (ILE606) CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE. | REACTION INTERMEDIATE MIMIC, OXIDOREDUCTASE
1d6y:B (ASN540) to (ILE606) CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE. | REACTION INTERMEDIATE MIMIC, OXIDOREDUCTASE
1d6z:A (ASN540) to (ILE606) CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE-DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER-CONTAINING AMINE OXIDASE. | REACTION INTERMEDIATE, OXIDOREDUCTASE
1d6z:B (ASN540) to (ILE606) CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE-DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER-CONTAINING AMINE OXIDASE. | REACTION INTERMEDIATE, OXIDOREDUCTASE
3g60:A (GLY1035) to (SER1067) STRUCTURE OF P-GLYCOPROTEIN REVEALS A MOLECULAR BASIS FOR POLY- SPECIFIC DRUG BINDING | P-GLYCOPROTEIN, PGP, MULTIDRUG RESISTANCE, MEMBRANE PROTEIN, CYCLIC PEPTIDE
3g60:B (GLY1035) to (SER1067) STRUCTURE OF P-GLYCOPROTEIN REVEALS A MOLECULAR BASIS FOR POLY- SPECIFIC DRUG BINDING | P-GLYCOPROTEIN, PGP, MULTIDRUG RESISTANCE, MEMBRANE PROTEIN, CYCLIC PEPTIDE
4in4:B (GLY378) to (ALA407) CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN | TRANSCRIPTION
3gcn:A (VAL61) to (THR93) CRYSTAL STRUCTURE OF DEGS H198P/D320A MUTANT MODIFIED BY DFP IN COMPLEX WITH OMP PEPTIDE (YQF) | PROTEASE, PDZ DOMAIN, STRESS-SENSOR, HTRA, OMP, HYDROLASE, SERINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
4ish:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR BMS-593214 ALSO KNOWN AS 2'-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H- INDENO[2,1-C]QUINOLIN-6-YL]-5'-HYDROXY-4'-METHOXYBIPHENYL-4- CARBOXYLIC ACID | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3t6i:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH AN AZEPIN DERIVATIVE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y39:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 75 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3f:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 78 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3z:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 41 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y41:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 112 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
1e36:B (THR64) to (ARG107) PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE | HYDROLASE(SERINE PROTEASE), SERINE PROTEASE, HYDROLASE, SERINE PROTEINASE
4y4g:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B53 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y4u:A (ASP92) to (SER113) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 14 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y4x:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 51 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y50:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 81 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1e81:E (ASP87) to (SER108) ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395 | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2r7e:B (HIS2082) to (THR2114) CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII | CERULOPLASMIN FOLD, CUPPER PROTEIN FOLD, C2 DOMAIN FOLD, ACUTE PHASE, BLOOD COAGULATION, DISEASE MUTATION, GLYCOPROTEIN, HEMOPHILIA, METAL-BINDING, SECRETED, SULFATION, BLOOD CLOTTING
4yd4:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 227 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd7:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 255 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1elc:A (THR67) to (ARG113) ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, SERINE PROTEINASE
1ept:B (SER61) to (LYS107) REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN | HYDROLASE (SERINE PROTEASE)
1esb:A (THR67) to (ARG113) DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE | HYDROLASE, SERINE PROTEINASE
4jxe:B (LEU285) to (ASP321) CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE SST2 CATALYTIC DOMAIN | HELIX-BETA-HELIX SANDWICH, UBIQUITIN, DEQUBIQUITINATION, ZINC METALLOPROTEASE, DEUBIQUITINATION, CYTOSOL, HYDROLASE
4jyu:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1- AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N- (PHENYLSULFONYL)ETHANAMIDE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4jzf:H (LEU64) to (ARG107) STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(3- CARBAMOYLPHENYL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY- 3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID | GLYCOPROTEIN, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2ex3:C (LYS490) to (GLU515) BACTERIOPHAGE PHI29 DNA POLYMERASE BOUND TO TERMINAL PROTEIN | DNA POLYMERASE: PROTEIN PRIMER COMPLEX, TRANSFERASE-REPLICATION COMPLEX
2ex3:E (LYS490) to (GLU515) BACTERIOPHAGE PHI29 DNA POLYMERASE BOUND TO TERMINAL PROTEIN | DNA POLYMERASE: PROTEIN PRIMER COMPLEX, TRANSFERASE-REPLICATION COMPLEX
2ex3:K (LYS490) to (GLU515) BACTERIOPHAGE PHI29 DNA POLYMERASE BOUND TO TERMINAL PROTEIN | DNA POLYMERASE: PROTEIN PRIMER COMPLEX, TRANSFERASE-REPLICATION COMPLEX
1rbb:A (ILE81) to (ALA122) THE CRYSTAL STRUCTURE OF RIBONUCLEASE B AT 2.5-ANGSTROMS RESOLUTION | HYDROLASE (NUCLEIC ACID, RNA)
1rbb:B (ILE81) to (ALA122) THE CRYSTAL STRUCTURE OF RIBONUCLEASE B AT 2.5-ANGSTROMS RESOLUTION | HYDROLASE (NUCLEIC ACID, RNA)
1rbf:A (ILE81) to (ALA122) CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | HYDROLASE(PHOSPHORIC DIESTER, RNA), HYDROLASE(PHOSPHORIC DIESTER,RNA)
1rbg:A (ILE81) to (ALA122) CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | HYDROLASE(PHOSPHORIC DIESTER, RNA), HYDROLASE(PHOSPHORIC DIESTER,RNA)
4kc7:B (GLN381) to (GLY409) CRYSTAL STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1 | BETA-PROPELLER, GH43, GLYCOSIDE HYDROLASE, ARABINANASE, HYDROLASE
4kc7:C (GLY378) to (GLY409) CRYSTAL STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1 | BETA-PROPELLER, GH43, GLYCOSIDE HYDROLASE, ARABINANASE, HYDROLASE
4ki5:M (THR2241) to (PHE2274) CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99 | IMMUNOGLOBULIN FOLD, DISCOIDIN FOLD, ANTIBODY, BLOOD COAGULATION FACTOR, ANTIGEN BINDING, BLOOD PLASMA, IMMUNE SYSTEM
2fqd:A (GLY55) to (GLN81) CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS | AZURIN-LIKE DOMAIN, OXIDOREDUCTASE
4ze6:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B39 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
3v4h:B (MET5) to (ASP55) CRYSTAL STRUCTURE OF A TYPE VI SECRETION SYSTEM EFFECTOR FROM YERSINIA PESTIS | STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, UNKNOWN FUNCTION
4zfu:B (LEU104) to (LEU144) STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH N-ACETYL D GALACTOSAMINE | BETA-TREFOIL, TYPE II RIPS, GALACTOSE BINDING LECTIN, HYDROLASE
3i97:A (ARG62) to (THR99) B1 DOMAIN OF HUMAN NEUROPILIN-1 BOUND WITH SMALL MOLECULE EG00229 | NEUROPILIN-1, DRUG, VEGF, ANGIOGENESIS, NEUROPILIN, ALTERNATIVE SPLICING, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, DISULFIDE BOND, GLYCOPROTEIN, HEPARAN SULFATE, MEMBRANE, NEUROGENESIS, PHOSPHOPROTEIN, POLYMORPHISM, PROTEOGLYCAN, RECEPTOR, SECRETED, TRANSMEMBRANE, MEMBRANE PROTEIN, SIGNALING PROTEIN
1h0d:C (SER74) to (SER118) CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F | IMMUNE SYSTEM/HYDROLASE, COMPLEX (ANTIBODY/HYDROLASE), RIBONUCLEASE, ANTIBODY
2w08:A (ASN32) to (ASN59) THE STRUCTURE OF SERUM AMYLOID P COMPONENT BOUND TO 0- PHOSPHO-THREONINE | GLYCOPROTEIN, POLYMORPHISM, METAL-BINDING, TAU, LECTIN, CALCIUM, AMYLOID, SECRETED, ALZHEIMERS
2w08:B (ASN32) to (ASN59) THE STRUCTURE OF SERUM AMYLOID P COMPONENT BOUND TO 0- PHOSPHO-THREONINE | GLYCOPROTEIN, POLYMORPHISM, METAL-BINDING, TAU, LECTIN, CALCIUM, AMYLOID, SECRETED, ALZHEIMERS
2w08:C (PHE33) to (ASN59) THE STRUCTURE OF SERUM AMYLOID P COMPONENT BOUND TO 0- PHOSPHO-THREONINE | GLYCOPROTEIN, POLYMORPHISM, METAL-BINDING, TAU, LECTIN, CALCIUM, AMYLOID, SECRETED, ALZHEIMERS
2w08:D (ASN32) to (ASN59) THE STRUCTURE OF SERUM AMYLOID P COMPONENT BOUND TO 0- PHOSPHO-THREONINE | GLYCOPROTEIN, POLYMORPHISM, METAL-BINDING, TAU, LECTIN, CALCIUM, AMYLOID, SECRETED, ALZHEIMERS
2w08:E (ASN32) to (ASN59) THE STRUCTURE OF SERUM AMYLOID P COMPONENT BOUND TO 0- PHOSPHO-THREONINE | GLYCOPROTEIN, POLYMORPHISM, METAL-BINDING, TAU, LECTIN, CALCIUM, AMYLOID, SECRETED, ALZHEIMERS
1h8x:B (ILE181) to (ALA222) DOMAIN-SWAPPED DIMER OF A HUMAN PANCREATIC RIBONUCLEASE VARIANT | HYDROLASE, RIBONUCLEASE, RNASE, HUMAN PANCREATIC RIBONUCLEASE, DOMAIN- SWAPPED DIMER
2w5g:A (ILE81) to (ALA122) RNASE A-5'-ATP COMPLEX | ENDONUCLEASE, HYDROLASE, INHIBITOR, NUCLEOTIDE, ENZYME, NUCLEASE
1hc1:D (ASP427) to (ILE480) CRYSTAL STRUCTURE OF HEXAMERIC HAEMOCYANIN FROM PANULIRUS INTERRUPTUS REFINED AT 3.2 ANGSTROMS RESOLUTION | OXYGEN TRANSPORT
2wec:A (ASP88) to (SER109) ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1- NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE
1tza:B (THR33) to (GLY65) X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SOR45 | STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
1hyl:B (VAL62) to (LYS107) THE 1.8 A STRUCTURE OF COLLAGENASE FROM HYPODERMA LINEATUM | HYDROLASE (SERINE PROTEASE)
2wof:A (ASN540) to (ILE606) EDTA TREATED E. COLI COPPER AMINE OXIDASE | OXIDOREDUCTASE, AMINE OXIDATION, TPQ, METAL-BINDING
2wof:B (ASN540) to (ILE606) EDTA TREATED E. COLI COPPER AMINE OXIDASE | OXIDOREDUCTASE, AMINE OXIDATION, TPQ, METAL-BINDING
1u6q:A (TRP14) to (SER42) SUBSTITUTED 2-NAPHTHAMADINE INHIBITORS OF UROKINASE | HYDROLASE
4mey:C (PRO95) to (ASN139) CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNA POLYMERASE HOLOENZYME | RNA POLYMERASE, DNA BINDING, TRANSFERASE
4mey:I (PRO95) to (ASN139) CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNA POLYMERASE HOLOENZYME | RNA POLYMERASE, DNA BINDING, TRANSFERASE
2x34:B (GLY91) to (ASN129) STRUCTURE OF A POLYISOPRENOID BINDING DOMAIN FROM SACCHAROPHAGUS DEGRADANS IMPLICATED IN PLANT CELL WALL BREAKDOWN | CARBOHYDRATE-BINDING PROTEIN, OXIDOREDUCTION, MARINE BACTERIA, POLYISOPRENOID TRANSPORT
2x6c:A (HIS236) to (PHE271) POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM | INTEGRAL MEMBRANE PROTEIN, ION CHANNEL, METAL TRANSPORT
2x8t:B (GLY382) to (GLY413) CRYSTAL STRUCTURE OF THE ABN2 H318A MUTANT | HYDROLASE
1jb1:A (HIS201) to (SER229) LACTOBACILLUS CASEI HPRK/P BOUND TO PHOSPHATE | CATABOLITE REPRESSION, HPR PHOSPHORYLATION, LACTOBACILLUS CASEI, P-LOOP, PROTEIN KINASE, HEXAMER, TRANSFERASE/HYDROLASE COMPLEX
3wnn:B (GLN624) to (ILE658) D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOOCTAOSE | C2 TYPE IMMUNOGLOBULIN FOLD, (BETA/ALPHA)8-BARREL, BETA-JELLY ROLL, GREEK KEY, GLYCOSIDE HYDROLASE, ALPHA-1,6-GLUCAN, TRANSFERASE
4mo3:M (THR2241) to (GLN2276) CRYSTAL STRUCTURE OF PORCINE C2 DOMAIN OF BLOOD COAGULATION FACTOR VIII | BLOOD COAGULATION DOMAIN, BLOOD CLOTTING
4mv6:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH PHOSPHONOACETAMIDE | ATP-GRASP, LIGASE
4mv8:A (ARG208) to (ALA243) CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH AMPPCP AND PHOSPHATE | ATP-GRASP, LIGASE
1jrq:A (ASN540) to (ILE606) X-RAY STRUCTURE ANALYSIS OF THE ROLE OF THE CONSERVED TYROSINE-369 IN ACTIVE SITE OF E. COLI AMINE OXIDASE | COPPER AMINE OXIDASE, TPQ, MUTANT, OXIDOREDUCTASE
1jrq:B (ASN540) to (ILE606) X-RAY STRUCTURE ANALYSIS OF THE ROLE OF THE CONSERVED TYROSINE-369 IN ACTIVE SITE OF E. COLI AMINE OXIDASE | COPPER AMINE OXIDASE, TPQ, MUTANT, OXIDOREDUCTASE
3wz5:B (ILE164) to (GLY205) STRUCTURE OF THE PERIPLASMIC DOMAIN OF DOTI (CRYSTAL FORM II) | TYPE IVB SECRETION, UNKNOWN FUNCTION
3zbw:B (VAL77) to (SER117) CRYSTAL STRUCTURE OF MURINE ANGIOGENIN-3 | HYDROLASE, RIBONUCLEASE A
5b7e:A (GLY55) to (GLN81) STRUCTURE OF PERDEUTERATED CUEO | MULTICOPPER OXIDASE, PERDEUTERATED, OXIDOREDUCTASE
3zof:A (VAL20) to (SER53) CRYSTAL STRUCTURE OF FMN-BINDING PROTEIN (YP_005476) FROM THERMUS THERMOPHILUS WITH BOUND BENZENE-1,4-DIOL | FMN-BINDING PROTEIN
2m5t:A (GLY56) to (GLU80) SOLUTION STRUCTURE OF THE 2A PROTEINASE FROM A COMMON COLD AGENT, HUMAN RHINOVIRUS RV-C02, STRAIN W12 | HUMAN RHINOVIRUS C, 2A PROTEINASE, CYSTEINE PROTEINASE, VIRAL PROTEIN
5cch:F (THR223) to (ASP261) STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM) | SYNAPTIC FUSION COMPLEX, SYNAPTOTAGMIN1, NEURONAL SNARE COMPLEX, ENDOCYTOSIS, EXOCYTOSIS
5ch7:E (ASP302) to (PRO374) CRYSTAL STRUCTURE OF THE PERCHLORATE REDUCTASE PCRAB - PHE164 GATE SWITCH INTERMEDIATE - FROM AZOSPIRA SUILLUM PS | ELECTRON-SHUTTLING PROTEIN, OXIDOREDUCTASE
2yzb:F (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH URIC ACID (SUBSTRATE) | URICASE, OXIDOREDUCTASE, URIC ACID
2yzb:G (PHE113) to (GLY152) CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH URIC ACID (SUBSTRATE) | URICASE, OXIDOREDUCTASE, URIC ACID
4oiq:C (PRO93) to (ASN130) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX SOAKED WITH GE23077 AND RIFAMPICIN | GE23077, TRANSCRIPTION INHIBITOR, TRANSCRIPTION OPEN COMPLEX, TRANSCRIPTION INITIATION COMPLEX, I SITE, I+1 SITE, RIFAMPICIN, RIF, RIFAMPIN, RNA POLYMERASE, DNA/RNA/NTP BINDING, POLYMERIZATION OF RIBONUCLEOTIDES, NUCLEOID, TRANSCRIPTION, TRANSFERASE-ANTIBIOTIC COMPLEX
1lvn:A (ASN540) to (ILE606) CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE COMPLEXED WITH TRANYLCYPROMINE | INHIBITOR COMPLEX, OXIDOREDUCTASE
4okf:B (ILE81) to (ALA122) RNASE S IN COMPLEX WITH AN ARTIFICIAL PEPTIDE | HYDROLASE, S-PEPTIDE
2zdg:C (ARG196) to (PRO239) CRYSTAL STRUCTURE OF D-ALANINE:D-ALANINE LIGASE WITH ADP FROM THERMUS THERMOPHIUS HB8 | D-ALANINE-D-ALANINE LIGASE, PEPTIDOGLYCAN BIOSYNTHESIS, CELL SHAPE, CELL WALL BIOGENESIS/DEGRADATION, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
2zdg:D (ARG196) to (PRO239) CRYSTAL STRUCTURE OF D-ALANINE:D-ALANINE LIGASE WITH ADP FROM THERMUS THERMOPHIUS HB8 | D-ALANINE-D-ALANINE LIGASE, PEPTIDOGLYCAN BIOSYNTHESIS, CELL SHAPE, CELL WALL BIOGENESIS/DEGRADATION, PEPTIDOGLYCAN SYNTHESIS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
4a8j:A (LEU380) to (GLU414) CRYSTAL STRUCTURE OF THE ELONGATOR SUBCOMPLEX ELP456 | TRANSCRIPTION
4a8j:D (LEU380) to (GLN415) CRYSTAL STRUCTURE OF THE ELONGATOR SUBCOMPLEX ELP456 | TRANSCRIPTION
2zg3:A (LEU40) to (ASN81) CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5 IN COMPLEX WITH 3'-SIALYLLACTOSE | SIGLEC-5 INHIBITORY RECEPTOR, TWO-DOMAIN STRUCTURE, V-SET, C2-SET, IG-LIKE DOMAIN, SIALIC ACID, 3'-SIALYLLACTOSE COMPLEX, CELL ADHESION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, LECTIN, MEMBRANE, POLYMORPHISM, TRANSMEMBRANE, IMMUNE SYSTEM/CARBOHYDRATE BINDING PROTEIN COMPLEX
4or4:A (GLU344) to (GLY370) STRUCTURE OF INFLUENZA B PB2 CAP-BINDING DOMAIN WITH Q325F MUTATION COMPLEX WITH M7GDP | CAP BINDING, VIRAL PROTEIN
4or4:B (GLU344) to (CYS369) STRUCTURE OF INFLUENZA B PB2 CAP-BINDING DOMAIN WITH Q325F MUTATION COMPLEX WITH M7GDP | CAP BINDING, VIRAL PROTEIN
2zr1:D (LEU112) to (PHE152) AGGLUTININ FROM ABRUS PRECATORIUS | RIBOSOME-INACTIVATING PROTEIN, IMMUNOTOXIN, AGGLUTININ ABRIN, GLYCOPROTEIN, HYDROLASE, LECTIN, PLANT DEFENSE, PROTEIN SYNTHESIS INHIBITOR, PYRROLIDONE CARBOXYLIC ACID, TOXIN, PLANT PROTEIN
2zr1:D (MET157) to (PRO188) AGGLUTININ FROM ABRUS PRECATORIUS | RIBOSOME-INACTIVATING PROTEIN, IMMUNOTOXIN, AGGLUTININ ABRIN, GLYCOPROTEIN, HYDROLASE, LECTIN, PLANT DEFENSE, PROTEIN SYNTHESIS INHIBITOR, PYRROLIDONE CARBOXYLIC ACID, TOXIN, PLANT PROTEIN
1m9u:B (ILE64) to (HIS107) CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT A FROM EISENIA FETIDA | HYDROLASE, SERINE PROTEASE (ELASTASE-LIKE), FIBRINOLYTIC ENZYME
1m9u:C (ILE64) to (HIS107) CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT A FROM EISENIA FETIDA | HYDROLASE, SERINE PROTEASE (ELASTASE-LIKE), FIBRINOLYTIC ENZYME
4afz:B (TYR14) to (LEU41) HUMAN CHYMASE - FYNOMER COMPLEX | HYDROLASE-DE NOVO PROTEIN COMPLEX, INHIBITOR, SERINE PROTEASE
4afz:B (ARG49) to (LYS94) HUMAN CHYMASE - FYNOMER COMPLEX | HYDROLASE-DE NOVO PROTEIN COMPLEX, INHIBITOR, SERINE PROTEASE
4p2b:A (ILE483) to (GLU542) CRYSTAL STRUCTURE OF THE APO FORM OF THE GLUTAMINYL-TRNA SYNTHETASE CATALYTIC DOMAIN FROM TOXOPLASMA GONDII. | AMINOACYL TRNA SYNTHETASE, LIGASE
4ahl:A (GLN77) to (GLN117) P112L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS | HYDROLASE, NEOVASCULARISATION
1ymr:A (ILE81) to (ALA122) THE STUDY OF REDUCTIVE UNFOLDING PATHWAYS OF RNASE A (Y92A MUTANT) | HYDROLASE
3l8q:B (GLU8) to (ASP44) STRUCTURE ANALYSIS OF THE TYPE II COHESIN DYAD FROM THE ADAPTOR SCAA SCAFFOLDIN OF ACETIVIBRIO CELLULOLYTICUS | DOCKERIN-BINDING MODULE, PROTEIN-PROTEIN INTERACTIONS, LINKER SEGMENT, SCAFFOLDIN ARRANGEMENT, BETA SANDWICH, ALPHA HELIX, BETA FLAPS, STRUCTURAL PROTEIN, PROTEIN BINDING
3l8q:C (GLU8) to (ASP44) STRUCTURE ANALYSIS OF THE TYPE II COHESIN DYAD FROM THE ADAPTOR SCAA SCAFFOLDIN OF ACETIVIBRIO CELLULOLYTICUS | DOCKERIN-BINDING MODULE, PROTEIN-PROTEIN INTERACTIONS, LINKER SEGMENT, SCAFFOLDIN ARRANGEMENT, BETA SANDWICH, ALPHA HELIX, BETA FLAPS, STRUCTURAL PROTEIN, PROTEIN BINDING
1z3s:A (GLY296) to (ILE325) ANGIOPOIETIN-2 RECEPTOR BINDING DOMAIN | ANGIOGENESIS, TIE2 BINDING, SIGNALING PROTEIN
1z3s:B (TYR298) to (ILE325) ANGIOPOIETIN-2 RECEPTOR BINDING DOMAIN | ANGIOGENESIS, TIE2 BINDING, SIGNALING PROTEIN
5dr3:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 333 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr7:A (TRP197) to (PRO228) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 311 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4ayu:B (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-D-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, LECTIN
4ayu:C (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-D-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, LECTIN
4ayu:D (ASN32) to (ASN59) STRUCTURE OF N-ACETYL-D-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, LECTIN
2a3w:A (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:B (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:C (PHE33) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:D (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:E (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:F (PHE33) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:G (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:I (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:K (PHE33) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:L (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:M (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:N (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:O (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:P (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:Q (ASN32) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:R (PHE33) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:S (PHE33) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
2a3w:T (PHE33) to (ASN59) DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1, 2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE | MULTIVALENT LIGAND COMPLEX, METAL BINDING PROTEIN
5ecr:A (TYR360) to (ILE410) CRYSTAL STRUCTURE OF FIN219-FIP1 COMPLEX WITH JA, VAL AND MG | JASMONATE-AMIDO SYNTHETASE, GLUTATHIONE S-TRANSFERASE, LIGASE- TRANSFERASE COMPLEX
3b07:B (GLY52) to (LEU91) CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS | PROTEIN COMPLEX, TOXIN
3b07:D (GLY52) to (LEU91) CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS | PROTEIN COMPLEX, TOXIN
3b07:F (GLY52) to (LEU91) CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS | PROTEIN COMPLEX, TOXIN
3b07:H (GLY52) to (LEU91) CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS | PROTEIN COMPLEX, TOXIN
3cdz:B (MET2079) to (THR2114) CRYSTAL STRUCTURE OF HUMAN FACTOR VIII | BLOOD CLOTTING, BLOOD COAGULATION, COFACTOR, FACTOR VIII, REFACTO, ACUTE PHASE, DISEASE MUTATION, GLYCOPROTEIN, HEMOPHILIA, METAL- BINDING, SECRETED, SULFATION
3ckp:B (MET18) to (GLY41) CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH INHIBITOR | BETA-SECRETASE, ASPARTYL PROTEASE, ALTERNATIVE SPLICING, GLYCOPROTEIN, HYDROLASE, MEMBRANE, TRANSMEMBRANE, ZYMOGEN
4rl8:C (GLU209) to (GLY245) CRYSTAL STRUCTURE OF THE COG4313 OUTER MEMBRANE CHANNEL FROM PSEUDOMONAS PUTIDA F1 | BETA BARREL, CHANNEL, BACTERIAL OUTER MEMBRANE, MEMBRANE PROTEIN
4rl8:D (GLU209) to (GLY245) CRYSTAL STRUCTURE OF THE COG4313 OUTER MEMBRANE CHANNEL FROM PSEUDOMONAS PUTIDA F1 | BETA BARREL, CHANNEL, BACTERIAL OUTER MEMBRANE, MEMBRANE PROTEIN
3db0:B (GLY19) to (PRO46) CRYSTAL STRUCTURE OF PUTATIVE PYRIDOXAMINE 5'-PHOSPHATE OXIDASE (NP_472219.1) FROM LISTERIA INNOCUA AT 2.00 A RESOLUTION | NP_472219.1, PUTATIVE PYRIDOXAMINE 5'-PHOSPHATE OXIDASE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE
4tpz:D (HIS32) to (SER71) N-TERMINAL DOMAIN OF C. REINHARDTII SAS-6 HOMOLOG BLD12P F145W (NN2) | HOMODIMER, STABILIZATION, MUTATION, CENTRIOLE SAS-6, CARTWHEEL, STRUCTURAL PROTEIN, BETA-SANDWICH, ALPHA-BETA PROTEIN, CENTRIOLAR
4dfh:A (GLY60) to (LEU90) CRYSTAL STRUCTURE OF CELL ADHESION MOLECULE NECTIN-2/CD112 VARIABLE DOMAIN | CELL ADHESION, DNAM-1, CELL SURFACE
4um8:C (LYS42) to (PRO69) CRYSTAL STRUCTURE OF ALPHA V BETA 6 | IMMUNE SYSTEM, CELL SURFACE RECEPTOR
4urr:F (SER420) to (VAL449) TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O-ANTIGEN OCTASACCHARIDE FRAGMENT | HYDROLASE, CARBOHYDRATE INTERACTION, TAILSPIKE PROTEIN, BETA HELIX
5ig8:A (THR174) to (ALA212) CRYSTAL STRUCTURE OF MACROCYCLASE MDNB FROM MICROCYSTIS AERUGINOSA MRC | RIPP, MACROCYCLASE, LIGASE
4ehc:A (THR77) to (PRO100) CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF RV0977 OF MYCOBACTERIUM TUBERCULOSIS | ASPARTIC PROTEINASE, HYDROLASE
4ux1:A (GLN176) to (ALA210) CRYO-EM STRUCTURE OF ANTAGONIST-BOUND E2P GASTRIC H,K-ATPASE (SCH.E2.ALF) | TRANSPORT PROTEIN, POTASSIUM-TRANSPORTING ATPASE
5l30:H (LEU64) to (ARG107) FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R,15R)-2-[(1- AMINOISOQUINOLIN-6-YL)AMINO]-4,15,17-TRIMETHYL-7-[1-(1H-TETRAZOL-5- YL)CYCLOPROPYL]-13-OXA-4,11-DIAZATRICYCLO[14.2.2.1~6,10~]HENICOSA- 1(18),6(21),7,9,16,19-HEXAENE-3,12-DIONE | GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5oz4:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 15 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozj:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 30 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0a:A (ASP92) to (SER113) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 57 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 57 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0w:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 79 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p13:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 86 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1c:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 95 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1o:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 107 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1t:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 112 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1v:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 114 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 145 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p39:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 162 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3a:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 163 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 168 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4n:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 212 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4u:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 219 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4x:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 222 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p50:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 225 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p51:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 226 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p52:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 227 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 236 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5p:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 250 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p60:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 261 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p67:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 268 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6b:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 272 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 276 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p73:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 300 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p74:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 301 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p79:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 306 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7f:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 312 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 313 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7h:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 314 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7k:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 317 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7l:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 318 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7s:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 325 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8g:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 349 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8i:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 351 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8q:A (TRP197) to (PRO228) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 359 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5th7:B (LYS349) to (ALA369) COMPLEX OF SETD8 WITH MS453 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE
9cgt:A (GLN646) to (THR680) STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A THIO-MALTOPENTAOSE | GLYCOSYLTRANSFERASE, STARCH DEGRADATION, CYCLODEXTRIN
9rat:A (ILE81) to (ALA122) EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | HYDROLASE (NUCLEIC ACID,RNA)